University of South Florida

Scholar Commons
Graduate Theses and Dissertations

Graduate School

November 2018

Moffitt Cancer Center: Leadership, Culture and
Transformation
W. James Wilson
University of South Florida, wjameswilson@hotmail.com

Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the Business Administration, Management, and Operations Commons
Scholar Commons Citation
Wilson, W. James, "Moffitt Cancer Center: Leadership, Culture and Transformation" (2018). Graduate Theses and Dissertations.
https://scholarcommons.usf.edu/etd/7594

This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.

Moffitt Cancer Center: Leadership, Culture and Transformation

by

W. James Wilson

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Business Administration
Muma College of Business
University of South Florida

Co-Major Professor: Timothy B. Heath, PhD
Co-Major Professor: James A. Stikeleather, DBA
Eric M. Eisenberg, PhD
Joann Farrell Quinn, PhD, MBA

Date of Approval:
November 14, 2018

Keywords: decisions, founder, interdisciplinary, transformation, visionary
Copyright © 2018, W. James Wilson

DEDICATION

To all who suffer from cancer.
To the visionary leadership of a founder and leaders who created a transformational institution.
To the physicians and care professionals who impact the lives of patients.
To the brilliant researchers who dedicate themselves to discovery to eradicate the burden of cancer.
To all who contribute to the prevention and cure of cancer.

ACKNOWLEDGMENTS

I am grateful for the guidance, support and encouragement from the Co-Chairs and Members of
the Dissertation Committee: Timothy B. Heath, PhD, James A. Stikeleather, DBA, Eric M. Eisenberg, PhD
and Joann Farrell Quinn, PhD, MBA.
Thank you to the Muma School of Business DBA Program founders, T. Grandon Gill, DBA and
Matthew T. Mullarkey, PhD.
Thank you to Michele Walpole and Lauren Baumgartner, and my 2018 cohort colleagues.

TABLE OF CONTENTS
List of Tables ................................................................................................................................................ iii
List of Figures ............................................................................................................................................... iv
Abstract ......................................................................................................................................................... v
Chapter 1: Introduction and Motivation....................................................................................................... 1
Significance of Study ........................................................................................................................ 4
Aims of Study ................................................................................................................................... 5
Organization of Chapters ................................................................................................................. 6
Chapter 2: Research Methodology ............................................................................................................... 8
Research Design ............................................................................................................................... 8
Data Collection ................................................................................................................................. 9
Methods of Analysis....................................................................................................................... 10
Chapter 3: Literature Review ...................................................................................................................... 12
Introduction to Literature Review ................................................................................................. 12
Founder .......................................................................................................................................... 14
Visionary Leadership ...................................................................................................................... 16
Culture ........................................................................................................................................... 18
Transformational Organizations and Societal Benefit ................................................................... 20
Chapter 4: The Founder .............................................................................................................................. 28
Introduction: The Founder ............................................................................................................. 28
Personal Insights ............................................................................................................................ 29
The Hon. Ralph H. Haben, Jr., Esq. .................................................................................... 29
Jennifer (Jenny) L. Moffitt, PhD ........................................................................................ 36
L. David de la Parte, Esq. ................................................................................................... 39
Theodore (Ted) J. Couch, Sr. ............................................................................................. 42
Professional Insights ...................................................................................................................... 44
The Hon. Connie Mack III .................................................................................................. 44
Timothy (Tim) J. Adams.................................................................................................... 46
Edward (Ed) C. Droste ....................................................................................................... 48
Alan F. List, MD ................................................................................................................. 49
William (Bill) S. Dalton, PhD, MD ...................................................................................... 50
G. Douglas (Doug) Letson, MD .......................................................................................... 51
John (Jack) A. Kolosky, CPA, MBA ..................................................................................... 53
Yvette Tremonti, CPA, MBA .............................................................................................. 53
The Hon. William (Will) W. Weatherford.......................................................................... 54
i

Chapter 5: Transformational Events ........................................................................................................... 58
Introduction: Transformational Events.......................................................................................... 58
A Brief Case Study .......................................................................................................................... 59
Setting the Course: People and Decisions ..................................................................................... 61
People ............................................................................................................................... 61
Decisions ........................................................................................................................... 62
Leaders, Culture and Imprinted DNA ............................................................................................. 62
1990 Legislative Initiative .............................................................................................................. 71
The Legislative Process ..................................................................................................... 71
Passing of a Bill.................................................................................................................. 73
A Defining Moment........................................................................................................... 77
The Bill(s)........................................................................................................................... 81
Conflict .............................................................................................................................. 82
Interdisciplinary Care ..................................................................................................................... 88
Comprehensive Cancer Center (CCC)............................................................................................. 96
Moving Faculty to MCC (MMG and MRI) ..................................................................................... 104
Chapter 6: Discussion and Conclusion ...................................................................................................... 109
Summary of Major Findings ......................................................................................................... 109
Key Findings .................................................................................................................... 110
Explanation of Model ...................................................................................................... 113
Discussion .................................................................................................................................... 114
Foundational Factors ...................................................................................................... 116
Transformational Events ................................................................................................. 117
Limitations ................................................................................................................................... 121
Contributions ............................................................................................................................... 122
Conclusion .................................................................................................................................... 123
References ................................................................................................................................................ 126
Appendix A: Florida Statue 240.299 ......................................................................................................... 133
Appendix B: Interview Questions.............................................................................................................. 136
Appendix C: Interviewee Bios ................................................................................................................... 138
Appendix D: Florida Constitution, Article iii .............................................................................................. 160
Appendix E: 1990 Legislation .................................................................................................................... 162
Appendix F: Materials from MCC Board Meeting ..................................................................................... 178
Appendix G: Summary Table of Themes – 1990 Legislation ..................................................................... 207

ii

LIST OF TABLES
Table 1.

MCC Awards and Recognition ................................................................................................... 3

Table 2.

Selected States Population, Cancer Incidence and Mortality, and CCCs .................................. 4

Table 3.

Literature Review Summary Table .......................................................................................... 27

Table 4.

MCC Interdisciplinary Departments, 2017 .............................................................................. 96

iii

LIST OF FIGURES
Figure 1.

Conceptual Model of Foundational Factors of the Transformational Institution ................... 12

Figure 2.

MCC Community Benefit by Category, July 1, 2016 – June 30, 2017...................................... 22

Figure 3.

Depiction of Four Transformational Events ............................................................................ 58

Figure 4.

Model of Foundational Factors and Events of a Transformational Institution ..................... 115

Figure 5.

Final Depiction of Four Transformational Events .................................................................. 119

iv

ABSTRACT

Purpose – The purpose of this project was to extrapolate knowledge of successful leadership
practices, determine what led to and nurtured what became an integrated organizational culture and
identify any decisions and/or transformational events that re-defined Moffitt Cancer Center’s (MCC)
course or helped propel it to levels far beyond what was originally imagined. The aims of this study were
discovery of the foundational factors and events that significantly impacted the creation, growth and
evolution of the center, making MCC an institution of transformational change that had achieved state
and national prominence.
Design – This was an exploratory study guided by a qualitative phenomenological research
methodology using an interpretivist approach. Data was derived from twenty one-on-one interviews
with people who had the specific knowledge and expertise necessary to obtain a better understanding
of the leadership, culture and transformational events that transformed MCC into the institution that it
is today. Interviewees included former and current MCC executive leaders, board members and key
program directors, as well as the founder and two other former Speakers of the Florida House of
Representatives. A literature review was conducted to explore founders, visionary leadership,
organizational culture, and transformational organizations.
Findings – Key findings included discovery of the factors and events that impacted MCC’s
growth and success. The interview process revealed three foundational factors pertaining to visionary
leadership qualities of the founder and others, a mission-based culture and four transformational events
that set MCC on a course of independence and self-governance. The literature review, with an emphasis

v

on founders, visionary leadership, culture and transformational institutions, revealed useful information
to draw comparisons and differences in the historical context of MCC’s growth and impact.
Value – MCC, created in Florida statute, existed as a private not-for-profit entity that,
statutorily, served as an instrumentality of the state. As such, it had an interestingly distinct role as a
hybrid organization that served a public and private sector need; while, very specifically, serving the
cancer research and care needs of patients throughout the state and beyond. While the previously
mentioned business literary research works are plentiful in the private and public sectors, a gap exists
for hybrid organizations such as MCC. Future research could focus on organization founders who did not
become part of the executive leadership structure.
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CHAPTER 1: INTRODUCTION AND MOTIVATION

Discovery and invention are deeply rooted in the history and progression of humankind. From
the manipulation of stone creating weapons for hunting, innovations changed societies and laid the
groundwork for new or better solutions. Likewise, business organizations have been created out of
necessity, new and innovative ideas, creativity or passion. Many businesses existed to meet a public
need; food supply, materials, tools or specialized services. Innovation created utility companies, public
and private, to provide electrical power and indoor plumbing, contributing to the evolution of societal
norms. Additionally, telephone and cable created instant communication and information flow. It was
not always necessary for businesses created out of necessity to be much, if at all different from those in
other communities or even across town. They served a purpose and delivered the goods and/or services
to meet demand.
Transformational business organizations broke from the status quo and created solutions that
changed or redefined markets, while creating societal benefit. Henry Ford didn’t create the automobile
industry, but he disrupted and refined it through the innovation of mass production, making
automobiles more readily available and affordable. Steve Jobs didn’t invent the computer, but through
innovation and vision Apple changed the landscape and made computers available to households
everywhere.
The basis of Innovation is an idea. Ideas, coupled with drive, ambition, perseverance and vision
have led to the creation of remarkable enterprises that became engines of social change for societal
benefit. Former Speaker of the House of Representatives in the Florida Legislature, H. Lee Moffitt
(Moffitt) authored legislation to create the H. Lee Moffitt Cancer Center and Research Institute (MCC).
1

Moffitt envisioned building a cancer center, on the University of South Florida campus in Tampa, FL, to
serve the needs of Florida’s cancer patients and as a cancer research resource. Originally called the
University of South Florida Cancer and Chronic Disease Research and Treatment Center and designated
in statute as a direct-support organization (DSO), the institute was statutorily renamed for the founder
by his colleagues in the legislature.
In the 32 years since opening its doors in 1986, MCC grew from a modest cancer hospital with
409 employees to a workforce of over 6,100 employees serving more than 64,000 patients annually. By
2018, Florida had more cases of cancer diagnosed each year than all other states except California. MCC
occupied 17 acres on the University of South Florida (USF) campus but had its own governing board and
an annual reporting responsibility to the Board of Governors, which oversaw the state university system.
The founder played a predominant role in the creation of MCC and in the molding of culture and
mission. As a lawyer, Moffitt had no training in medicine or research, and he acknowledged the need to
rely on the expertise of others to guide the fledgling center. Many founders in business assume
leadership roles of Chief Executive Officer (CEO) or board chairman to maintain control of their
organization. Moffitt did not. For more than three decades, he served as a board member but did not
allow MCC to devote office space for him and never received compensation for his continued efforts as
a lawyer-lobbyist in the decades following his legislative tenure. While Moffitt dedicated a great portion
of his life to MCC, his legacy included visionary leadership and recruitment of mission-driven individuals;
the creation of an enduring culture.
Moffitt had an idea. Due to the death of three close friends, Moffitt envisioned a cancer center
in Florida to serve the needs of the state. Over a three-decade period, Moffitt’s vision grew into a
nationally renowned cancer center that achieved numerous recognitions, recruited some of the best
and brightest minds from around the globe and led cancer care and research in Florida and beyond. The
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institution that started with an idea became not only an economic engine for the community and state
but also served as a center for societal benefit.

Table 1. MCC Awards and Recognition
•

Ranked No. 8 on U.S. News & World Report’s Best Hospitals for Cancer rankings in 2018, making
Moffitt the best cancer hospital in Florida and top-ranked in the Southeast.
• Ranked No. 40 out of 319 eligible hospitals in the Best Hospital for Gynecology category by U.S. News &
World Report in 2018.
• Named LGBTQ Healthcare Equality Leader by the Human Rights Campaign Foundation in 2018.
• Achieved exemplar status for its Nurses Improving Care for Healthsystem Elders (NICHE) program, the
highest designation in an international nurse-driven initiative designed to help hospitals improve the
care of older adults. Moffitt is one of only 38 medical centers in the nation to have achieved this status.
• Ranked No. 4 health care facility on DiversityInc’s 2018 Top Hospitals & Health Systems list. Moffitt is
the only cancer center and the only Florida health institution on the specialty list.
• Ranked in Computerworld’s 100 Best Places to Work in IT in 2018.
• Named one of the 2018 Top 10 Nonprofit Companies for Executive Women by the National Association
for Female Executives (NAFE).
• Ranked on the Tampa Bay Times Top Workplaces. The Top Workplaces lists are based solely on an
employee feedback survey administered by WorkplaceDynamics, LLC, a leading research firm that
specializes in organizational health and workplace improvement. Several aspects of workplace culture
were measured.
• Received Gold Standard Accreditation for the 10th consecutive year in 2018.
• Named 2017 Nonprofit of the Year by the Tampa Bay Business Journal. Moffitt was also recognized as
the category winner in the Health & Human Services category.
• Named a 2017 Business of Pride honoree by the Tampa Bay Business Journal and recognized for its
commitment to LGBTQ diversity and non-discrimination policies.
• Best and Brightest winner recognized by the National Association for Business Resources. The cancer
center has been named one of the Best and Brightest Companies To Work For®, as well as one of the
Best and Brightest Companies in Wellness.
• Magnet® designation in recognition of nursing excellence. Magnet recognition is granted by the
American Nurses Credentialing Center (ANCC), the credentialing body of the American Nurses
Association, to honor outstanding health care organizations for nursing professionalism, teamwork,
quality patient care and innovations in nursing practices.
• Named a Working Mother Best Company.
• Recognized as a winner of the 2015 Press Ganey Guardian of Excellence Award for commitment to
offering an exceptional patient experience.
• Recognized by the Institute for Patient- and Family-Centered Care.
• Named a Fertile Hope Center of Excellence, an award presented to "cancer centers for proactively
addressing cancer-related fertility".
• Becker’s Hospital Review, 100 Accountable Care Organizations to Know.
• Becker's Hospital Review, 150 Great Places to Work in Healthcare – 2016.
• Ranked No. 6 on the 2016 Top 10 Hospitals and Healthcare Systems list.
Source: Moffitt Cancer Center, Awards and Recognition
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Significance of Study
MCC became more than one person’s personal mission. The institute grew in size and stature,
earning the coveted Comprehensive Cancer Center (CCC) Designation from the National Cancer Institute
(NCI) and other awards, including numerous top ten ratings for cancer centers by U.S. News and World
Report. In fact, MCC earned an abundance of local, state and national awards and recognitions over the
years. These acknowledgements, shown in Table 1 above, demonstrated MCC’s commitment to serving
patients, families, employees and the community. The uniqueness of MCC, however, extended well
beyond these impressive recognitions. In the beginning, MCC operated as a DSO, defined in chapter
240.299 of Florida Statute, to USF. These statutory requirements, shown in Appendix A, meant that MCC
lacked independence in its governance and utilization of space.

Table 2. Selected States Population, Cancer Incidence and Mortality, and CCCs
Population

Cancer

% of
US
Total

Annual
Growth

New
Cases
(2015)

100%

0.72%

1,607,321

New
Cases
Rank

State

Population
(2017)

All States

325,719,178

California

39,536,653

1

12.14%

0.61%

163,946

1

59,629

1

8

Texas

28,304,596

2

8.69%

1.43%

105,108

4

39,120

3

3

Florida

20,984,400

3

6.44%

1.59%

110,045

2

44,027

2

1

New York

19,849,399

4

6.09%

0.07%

109,495

3

35,088

4

3

North Carolina

10,273,419

9

3.15%

1.15%

53,526

8

19,321

9

3

Maryland

6,052,177

19

1.86%

0.46%

30,480

19

10,567

20

2

Rank

Deaths
(2015)

CCCs
Deaths
Rank

595,919

CCCs
49

Sources:
U.S. Census Bureau, Population Division, Annual Estimates of the Resident Population: April 1, 2010 to July 1, 2017.
National Cancer Institute, State Cancer Profiles, 2015.
National Cancer Institute, NCI-Designated Cancer Centers, 2018.

As of 2018, MCC was one of the 49 NCI-Designated CCCs in the U.S., and the only CCC based in
Florida. Table 2 shows the number of CCCs in states selected for comparison, along with population and
cancer incidence and mortality information. Population was based on U.S. Census Bureau estimates for
4

2017. Cancer incidence and mortality numbers were from the NCI State Cancer Profiles (2015 was the
latest year for which these data are available).
Notably, Florida had the third largest population, second highest cancer burden and least
number of NCI-designated CCCs. Florida’s estimated population growth was also higher than these
states with at least two or more CCCs. From its humble beginnings as a DSO, MCC grew into one of the
nation’s premier cancer centers, and the only CCC in Florida, a state in which nearly 6.5% of the US
population resides.
Aims of Study
This project was designed to extrapolate knowledge of successful leadership practices,
determine what led to and nurtured what became an integrated organizational culture and identify any
decisions and/or transformational events that re-defined MCC’s course or helped propel it to levels far
beyond what was originally imagined. The aims of this study were discovery of the foundational factors
and events that significantly impacted the creation, growth and evolution of the center, making MCC an
institution of transformational change that had achieved state and national prominence. Ultimately, the
information derived from addressing these inquiries would help determine what course MCC should
take moving forward.
To achieve these goals, twenty-one individual interviews were conducted. Interviews were
transcribed, and the data was assessed using thematic analysis and sensemaking. An extensive review of
existing literature regarding founders, visionary leadership, culture and transformational organizations
in business was conducted to help inform this study by identifying key theoretical concepts and
elucidating the potential contributions of this work in adding to the current knowledge base.
This study was intended to uncover not only why but also how MCC came to be the intuition
that it was after three decades of existence. The research design employed in this work allowed for the
5

discovery of information about factors and events based on interpretations of individuals with historical
knowledge and key expertise. Following analysis of data from individual interviews, the greater focus
became the evolution of MCC to an institution of transformational change and the impact of the
transformed institution on the region and state that invested in it and the patient population it served.
The following research questions were developed to specifically address the goals of this study:
1. Can we ascertain factors that were critical to the foundation of MCC as a transformational
institution?
2. Can we determine events that set MCC on a course to become and institution of
transformational change?
3. What does MCC need to do to continue to be an institution of transformational change with
societal benefit?
Findings from this study surfaced the factors and events that led to MCC’s evolution from a DSO
to an institution of transformational change. The founder and other visionary leaders impacted the
organization in a number of ways, leading to a mission-driven culture and bold actions that triggered the
occurrence of transformational events. The transformed institution went on to expand into ventures
and partnerships beyond what the founder could have imagined. The business literature reviewed for
this study was plentiful, yet gaps were identified. This study’s findings led to the discovery of potential
areas for future research, as well as the development of a model that could be applicable for other
businesses.
Organization of Chapters
Chapter 2 describes the methodological approach used for this study. The chapter provides a
discussion of the data collection method of individual interviews, including the strategy employed for
selecting participants, conducting interviews and extrapolating key themes from the data. Chapter 3
6

provides a review of the relevant literature and discussion of these studies in relation to MCC. Chapter 4
offers an in-depth picture of who the founder, Moffitt, was as a person, a professional, a politician, a
founder and a driving force for MCC. Chapter 5 describes the instrumental leadership and four
transformational events that this research determined had a significant impact on MCC’s first 30 years.
The final chapter, Chapter 6, includes a discussion of the major study findings, limitations and
contributions of this work, recommendations for future research, and concluding thoughts.
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CHAPTER 2: RESEARCH METHODOLOGY

Research Design
This was an exploratory study guided by a qualitative phenomenological research methodology
using an interpretivist approach designed to achieve the study aims and address the three research
questions. Data was collected from individual interviews with people who had the specific knowledge
and expertise necessary to obtain a better understanding of the leadership, culture and events that
transformed Moffitt Cancer Center (MCC) into the institution that it is today. To assess the data,
thematic analysis was used to identify patterns and relationships.
The strategy of inquiry and methods employed to gather and analyze data were deemed to be
an appropriate fit based on the overarching goals of this study. Phenomenological research aims to
describe the common meaning for study participants who have experienced a particular phenomenon
or concept (Creswell, 2013, p. 76). A focus of this project was understanding what situations, actions and
events meant to the individuals who were involved with them. Such focus on not only the occurrence of
events but also individuals’ perspectives and the actions shaped by such perspectives is central to the
interpretivist approach (Maxwell, 2005, p. 22). Furthermore, interpretivism accepts that a social reality
may change according to multiple perspectives based on individuals’ unique backgrounds and
experiences; data collected by having a dialogue with participants of a study can lead to a better
understanding of the social world by uncovering the not only the people’s experiences but also the
subjective meanings they have attribute to it (Wahyuni, 2012, p. 71).

8

Data Collection
This project utilized the qualitative data collection method of individual interviews. Individuals
were purposefully selected for this research based on their areas of experience and personal
experiences. The purposeful selection strategy was useful in addressing the study’s research questions,
as individuals were deliberately selected to derive information that other possible choices could not
have provided (Maxwell, 2005, p. 88).
One-on-one interviews were conducted with twenty-one individuals. Interviewees included
MCC board chairs and members, chief executive officers (CEO) and executive leaders, and program
leaders. Two interviewees served in the in Florida House of Representatives. Like Moffitt, these former
legislators ascended to the role of Speaker of the House. Interviewee bios are shown in Appendix B.
Interviews were scheduled with individuals in advance and conducted either in-person or by phone.
Each interview was recorded and transcribed using a transcription service. Signed consent was received
from each interview participant. Interviews varied in length from as little as eighteen minutes to more
than 59 minutes.
A quasi-structured approach was used to conduct interviews. All but two of the participants
were asked fifteen identical questions that were developed specifically for this study. The exceptions
included Moffitt’s closest friend, Ralph Haben, Esq. who served as Speaker of the House in the term
prior to Moffitt’s tenure. Haben knew Moffitt from law school and the two maintained a close
relationship. Haben, having no affiliation with MCC, was asked to describe Moffitt as a person, his
manner, style and personality. Additionally, Moffitt’s daughter, Jenny, was asked to add additional
insight. Jenny Moffitt served on the Moffitt Hospital Board and, therefore, was also asked many of the
prepared questions. Interview questions are shown in Appendix C.
9

The fifteen interview questions were developed to help facilitate the understanding needed to
address the research questions. Several of the interview questions were designed to illicit responses in
specific areas: current or previous role at MCC; length of affiliation with MCC; description of MCC; and
one direct question about Moffitt. Participants were directly asked about the people, leadership and
decisions that impacted MCC’s success. The intentionally open-ended questions were designed to allow
for personal opinion and/or recollection. The aim was to allow for free-flowing discussion in the words
of those involved, facilitating the format for much of the discussion in this work. Those questions led to
the most fruitful input regarding the differentiators between MCC and other care centers.
Methods of Analysis
This exploratory study sought to ascertain what happened as well as how these events occurred,
as perceived by individuals with distinct knowledge and expertise, in order to address the research
questions. Thematic coding and sensemaking were used to assess and interpret the interview data.
Phenomenological data analysis involved the review of interview transcripts to identify
statements, quotes and/or sentences that offer an understanding of how a phenomenon was
experienced by individuals. From these significant statements, clusters of meaning were developed into
themes, which were then used to describe what individuals experienced and the influence of context on
experiences (Creswell, 2013, p. 83). According to Lin (1998), “Interpretivist questions remind the
researcher to look not only for the presence or absence of a relationship, but also the specific ways in
which it is manifested and in the context in which it occurs” (p. 169). Weick, Sutcliffe and Obstfeld
(2005) state that sensemaking is about the questions of how something came to be an event for
members of an organization, and what the event means. Sensemaking involves the relationship of
action and interpretation instead of the influence of evaluation on choice, recognizes that large
consequences can come from short moments (pp. 409-410).
10

It should be noted that a few of the program directors who were interviewed provided a
detailed description of their specific work and responsibilities. With the goal to maintain focus on the
people and decisions, the excluded responses were deemed beyond the scope of the current project.
These contributions will be used to help inform future research.
Discovery of the factors that impacted MCC and the decisions made to propel the institution to
become an institution of transformational change were the primary areas of interest. The design
enabled input on numerous topics. The results of question #10, “Who or what has impacted Moffitt
greatly?” became a focal point of this work. The foundational factors identified through this analysis are
discussed in Chapter 3. Chapter 4 includes an in-depth look at the founder, as perceived by several key
participants with personal and professional insights. Chapter 5 provides an in-depth look at the pivotal
events, including the leadership and decisions that made MCC an institution of transformational change.
A detailed summary and discussion of study findings are included in Chapter 6.
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CHAPTER 3: LITERATURE REVIEW

Introduction to Literature Review
Review of the literature focused on three key themes brought forth through analysis of the
interview data; founder, visionary leadership and culture. Each were explored to discover existing
findings and to add to existing knowledge. Additionally, a fourth subject, transformational companies
and societal benefit, was included in the literature review. Many transformational businesses have
impacted local, regional, state, national or international communities. Moffitt Cancer Center (MCC)
exemplified transformational change in cancer patient care and research in Florida and beyond.
Relevant literature on this topic was examined to assess what is contained in the current body of
knowledge regarding impactful, transformational businesses.

Figure 1. Conceptual Model of Foundational Factors of the Transformational Institution
12

The research produced three key factors: founder, visionary leadership and culture. Further,
four transformational events occurred that caused MCC to evolve into an institution of transformational
change. A model, shown in Figure 1, was created utilizing the factors and events to describe an
evolutionary construction of an organization that, utilizing the model, could learn from and repeat the
process for continued growth and impact. Breaking the model into its individual components and
describing its causality explain the significance of the events and outcomes.
A highly skilled, trained, impassioned leader, the first box, signified a leader who had an idea or
motivation to create an entity to serve a specific purpose or address a specific need. That committed
leader created an organization, the second box, with drive and determination and had a vision for how it
would succeed. Additionally, the leader also impacted the corporate culture which emanated from the
leaders’ style, passion or personality (Schein, 1983). Arrows, moving from left to right, indicated
causality; one component directly impacted the next component. An arrow led from the leader to the
created organization. Similarly, arrows led to the top circle, visionary leadership, and to the lower circle,
integrated culture. Arrows indicated the founder had impact on each.
Visionary leaders, the founder and/or others recruited to lead the organization, possessed or
adopted commitment to that vision. Visionary leadership enabled a business thought process to identify
actions to impact the organization’s future.
Integrated culture was also impacted directly by the founder. As discussed in literature,
founders’ history, experiences or personality was imprinted on organization’s executives and
employees, which created the corporate culture. Integrated culture was a necessary component, like
visionary leadership, to move the organization forward.
Visionary leadership and culture, as designated by the arrows, created an environment within
the organization for transformational events to take place. The organization, with visionary leadership
13

and integrated culture, identified transformational events. The successful execution of those events, an
arrow from events to institution of transformational change, created a new, changed, adapted
organization with potential to impact business and/or society in ways it was not possible to under its
previous construct.
A Literature Review Summary Table was developed for this study and is shown in Table 3 at the
end of this chapter. While numerous other sources were informative and contributed to this review, the
studies included in Table 3 were found to be most pertinent in this review.
Founder
Founder-focused literature was found to focus primarily on founders running the companies
they founded. In the case of this work, founders who do not take on the CEO role or a board chair role is
not as prevalent. That said, drawing pertinent information regarding founders’ impact regarding culture,
mission and values was fruitful.
Exploring the role of the founder in the literature, Schein (1983) wrote extensively on
organizational culture. Discussing the creation of culture, Schein described how organizational culture
begins and the founder’s impact. As with political groups, new religions or social movements, a business
founder has an idea about the creation of a business and surrounds him/herself with like-minded people
to create a culture reflective of his/her goals “by force of his or her personality” (p. 13).
Abebe and Alvero (2013) describe the role of the founder-CEO. While, in the case of MCC,
Moffitt did not assume the CEO role, as the founder, he directed much of early stages of the center’s
foundation. Through their research, a study of 41 founder led and 41 non-founder led companies, they
found that founder-CEO led organizations have a negative relationship with company performance.
Contemplating the value of this paper for the review, there were a few interesting components that
made it notable. The authors concluded that “founder leadership is critical in establishing the identity
14

and architecture of the emerging firm” (p. 354). Founder impact is a recurrent theme in much of the
literature. Additionally, much of the research concludes that founders don’t always make the best longterm leaders. What made this area of discovery pertinent was that Moffitt never occupied a leadership
position at the executive or board levels within the organization. He passionately participated in the
process from inception through three decades but was aware of his personal and professional
limitations. He chose to lead by example, recruiting experts and giving them control. Serving on the
board, he preferred to influence from the bench as opposed to on the field of play.
Founder-centered research encompasses numerous focus areas with varying studies and
outcomes. The recurrent theme of the literature is that the founder has an indelible impact on the early
phase(s) of company development (Conte, Siano, & Vollero, 2017; Ellis, Aharonson, Drori, & Shapira,
2017). “Founders…transmit this knowledge as they shape the behavior of their organizations and may
influence the behavior of other individual members of their organizations (Ellis, et al., 2017, p. 500). This
short passage, as with much of the literature, highlights the role of the founder as it relates to
organizational culture impact (to follow).
Conte, Siano, and Vollero (2017) state “personal history and the experiences of the founder are
actively addressed and kept alive through communication campaigns, aimed at creating a distinctive
brand heritage….” and “corporate identity and personality of the founders represent a significant
opportunity for brand building…” (p. 276).
Crotts, Dickson, and Ford (2005) recognized founder influence as leaders that instill
commitment in employees. “Too often, the do as I say not as I do mentality interferes with the
alignment between the mission statement on the wall and actual employee behaviors.” Utilizing J.W.
Marriott as an example, they point to Marriott’s tradition of visiting his properties and visiting with
employees at all levels “…reaffirming the Marriott mission and values” (p. 61). For more than 30 years,
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Moffitt walked the halls at the cancer center, appeared unannounced at doorways and attended
meetings covering nearly every area of focus at the cancer center.
As described in numerous interviews in Chapters 4 and 5, Moffitt’s attention to employees at all
levels and his concern for the center’s patients made a lasting impact that many wanted to emulate.
Founders who created transformational institutions created vision that emanated from their original
idea. Passionate leaders don’t stop once the bricks and mortar are complete, they remain involved and
influence institutions by dedication to continued advancement and success. The literature clearly
identifies numerous impacts founders have on the institutions they created. Whether management
style, vision, cultural imprinting or instilling their truths and beliefs, founders have impacted their
organizations.
Visionary Leadership
A recurrent theme that surfaced across multiple interviews was that of visionary leadership. The
literature reveals an inordinate amount of material on leadership and many wide-ranging aspects.
Findings included research highlighting the role of leadership (Sarros, Cooper, & Santora, 2011),
personality (Church & Waclawski, 1998; Howell & Avolio, 1992), traits and attributes (Kishore,
Majumdar, & Kiran, 2012; Muczyk & Adler, 2002), leadership style (Klein, Wallis, & Cooke, 2013), and
leadership development (Locander, Hamilton, Ladik, & Stuart, 2002; Manning & Robertson, 2002). This
review narrowed the focus to “visionary leadership” as it related to business leaders and the institutions
in which they founded or worked. In its early years, MCC’s leadership evolved as the center expanded.
Early leadership set the course for how the center was governed and the creation of a corporate culture
(to follow) that gave MCC its unique identity. There was no particular training as to how to lead the
young center. However, the leaders recruited to MCC had particular characteristics that blended with or
augmented the vision and passion of the founder.
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According to Collins and Porras (1995), “…all leaders, no matter how charismatic or visionary,
eventually die. But a visionary company does not necessarily die, not if it has the organizational strength
to transcend any individual leader and remain visionary and vibrant decade after decade and through
multiple generations” (p. 87). Visionary leadership in literature covers a multitude of subject areas. The
interviews in this work accentuated not only the leadership qualities of the founder, but also that of
ensuing leaders. Moffitt accomplished his initial mission of creating a cancer center, but his ultimate
goal was an enduring institution recognized as transformative in care and research. Visionary leadership
at the executive and board levels was necessary in order to create a visionary organization that would
benefit the citizens of Florida.
Westley and Mintzberg (1989) identified varieties of visionary leadership style; the creator, the
proselytizer, the idealist, the bricoleur, and the diviner. With each style variation, time and context are
still critical factors; visionary leaders possess individual gifts and talents but are also products of the
opportunities and other environmental aspects of the time during which they emerged (pp. 22-30). In
the case of the proselytizer, Apple founder Steve Jobs was an interesting choice as it relates to the MCC
founder. Westley and Mintzberg described Jobs as lacking the imagination or creativity that some other
leadership styles possessed. Apple co-founder Steve Wozniak has been credited for the actual design of
the computer yet did have the thought to sell the machines. Wozniak stated that computers were not in
fact something that Jobs understood, but it was Jobs’ idea for the two to ‘hold them up in the air and
sell a few.’ Thus, Jobs’ attribute and significant contribution was “…his evangelical zeal to show people
the future potential of the product” (p. 25). Likewise, Moffitt, who knew nothing about running a cancer
center, served as a proselytizer for a young institution and enabled the experts in areas of scientific
knowledge to lead through innovation and discovery. As the research showed, the chosen leaders
adopted visionary attributes and led by affording others the opportunity to discover and advance
science and medicine.
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Herb Kelleher, former CEO, President and Chairman of the Board with Southwest Airlines was
not only a business leader but also a thought leader in industry. In his leadership analysis paper, Cote
(2018) highlighted Kelleher’s fourteen characteristics of leadership and further discusses those qualities
in three leadership categories. First, Spiritual & Servant leadership, not in the vain of religious or faithbased literature (Sendjaya & Sarros, 2002) or comparative research (Smith, Montagno, & Kuzmenko,
2004), but his inspiration attributed to listening, conceptualization, foresight and building community.
Second, charismatic leadership qualities including acting as a role model, adherence to ethical beliefs
and “…created a culture that promotes affiliation among employees that drives productivity.” Lastly,
Cote believed Kelleher to be both a transactional and a transformational leader; evaluating employees
while also empowering them (pp. 118-120).
As MCC’s founder, Moffitt inherently possessed many leadership qualities that, through his
passion, drove the recruitment process to hire uniquely qualified committed to the cause and vision.
MCC had a hospital, subsequently built a research enterprise, and was multifaceted in its approach to
patient care and discovery. Manufacturing facilities trained people to specific jobs. In the medical and
research fields, those recruited bought their own set of skills and knowledge. Leading through
empowerment, MCC leadership adopted many of the attributes described in the literature.
Culture
“There is a constant interplay between culture and leadership” (Bass & Avolio, 1993, p. 113).
The founding leadership at MCC created a culture within the organization that blended the leadership
qualities of the early adopters and the innovative knowledge physicians and scientists possessed. The
culture, as with most businesses, had a genesis but also an evolution. Based on the vision and values of
early leadership, MCC sought committed individuals who would not only embrace the MCC mission, but
also had the acumen to adopt and perpetuate a culture. Business culture literature pertaining to this
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work centered on organizational culture, leadership and culture, founders and culture, and people
(employees) and culture.
“How do the entrepreneur/founders of organizations create organizational cultures?” (Schein,
1983, p. 13). Pertinent questions about the creation of culture are equal to the evolution and
perpetuation of culture. In his 1983 work, Schein focused on the role of the founder and the creation of
organizational culture. He stated organizational culture is dependent on a definable organization and a
shared goal in the environment in which they work. Through the founder’s personality, a group begins
to shape a culture. “Organizational culture, then, is the pattern of basic assumptions that a given group
has invented, discovered, or developed in learning to cope with its problems of external adaptation and
internal integration” (pp. 13-14). Companies integrated leaders and employees while evolving their
practices and culture due to outside influences.
In their paper on organizational cultures Mouton, Just, and Gabrielsen (2012) drew attention to
founders as early impact participants of culture creation but, in their comparison with Schein (1983),
made the case that others, “middle managers and experienced employees” have impact on the
development of culture (p. 316). Likely, both conclusions were accurate. Culture may have begun with a
founder, founding group, but a matrix of possibilities existed in cultural maturation over time.
In his short paper regarding Kelleher and Southwest Airlines, Quick (1992), building on (Schein,
1983), stated that while founders are central to early culture creation, “Organizational cultures do not
spring full-blown and mature onto the corporate landscape.” He surmised that while new cultures
emanated from the founders, the adoption of cultural values and beliefs became part of the
organization over time (pp. 46-47).
Literature focused on people and business culture added additional insight. Discussing the factor
of people relating to profitability, Black and La Venture (2017) noted four founding principles of and key
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elements to people-centered culture (pp. 25-29). Despite a differing research focus, the concepts and
elements of culture had multiple similarities; leadership, communication, values, mutual success.
A great deal of the literature focused on the creation and development of culture; some
founder-focused while other material concentrated on CEO or other leadership impact (Brown, Brown &
Gallagher, 2008; Giberson, et al., 2009). While focusing their work on market culture, Brown, Brown,
and Gallagher (2008) pointed to three business leaders, Lou Gerstner (former CEO of IBM), Jack Welsh
(former CEO of GE) and Jack Taylor (founder of Enterprise Rent-A-Car), who either built, or built on, their
company’s culture to drive for success in the marketplace. “Continually strengthening a firm’s market
culture is essential for achieving and sustaining a competitive advantage” (pp. 28-33).
MCC, created in state statute, served as a private non-profit and also as an instrumentality of
the state; a hybrid organization. Culture creation and adaptation in non-profit, quasi-public/
governmental companies, specifically in healthcare, can have unique challenges. Public scrutiny and
media focus could alter public opinion of the institution. Failure to adjust organizational culture to
external business, cultural or environmental evolution could lead to institutional problems. “Failure to
change…could erode public and private confidence in these organizations” (Schraeder, Tears, & Jordan,
2005, p. 494). Organizational culture, emanating from a founder, founding group, leadership or
employees, defined the business. Adaptations and adjusts must be made over time to ensure
institutional success.
Transformational Organizations and Societal Benefit
Transformational enterprises have impacted the business landscape in numerous ways for
generations. The list of organizations that changed the way businesses operate, consumers respond, and
markets react is long and distinguished. The auto industry was abruptly altered through Ford’s mass
production innovation. Apple impacted individual computer ownership and later hand help phones.
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Netflix disrupted the movie rental industry and changed how consumers access entertainment. Amazon
changed the way consumer products were purchased and delivered. All successful organizations; all
impacted people, industry and markets. They all impacted society.
Research on health care entrepreneurship in the Nashville, TN region by Carr, Topping,
Woodard, and Burcham (2004), stated “…the study of entrepreneurship should also capture those
development activities that are more macro-related to include societal impacts on entrepreneurial
action…” The study’s purpose was to describe the relationship “between health care delivery as a
societal institution… and the “business of health care” as a form of regional development.” The authors
stated that Nashville was as an “example of a community of health entrepreneurs who recognize and
exploit entrepreneurial opportunities during periods of revolutionary social change” (p. 49).
Entrepreneurial opportunities may or may not lead to positive impact for societal benefit. The
literature focus in this section sought to discover research regarding business activity, profitability and
transformational impact coupled with societal impact. MCC started as a small cancer center but grew to
highly impactful institution. Subsequently, MCC created, though its mission-based business practices, a
societal benefit to the region, state and beyond.
According to the 2017 MCC Community Benefit report: “Moffitt Cancer Center’s Community
Benefit initiative supports patients, families and clinicians through advancing cancer prevention, early
detection, clinical care and research, especially for those at-risk populations disproportionately
impacted by cancer.” Figure 2 shows MCC’s community benefit by category for Fiscal Year 2016-2017.
Total community benefit dollars for this time period were more than $86 million. The MCC Community
Benefit report describes each category as the following:
•

Research: Clinical and community health research, as well as general health care delivery studies
shared with the public and funded by the government or a tax-exempt entity.
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•

Charity Care: Total cost of services incurred by Moffitt to provide medical services to patients
who are unable to pay.

•

Medicaid Shortfalls: The Medicaid program pays Moffitt less than it costs the organization to
provide care to its Medicaid patients.

•

Health Professions Education: Cost associated with clinical education and training for physicians
and medical students not including government funding.

•

Community Health Improvement Services: Cost of activities carried out to improve community
health beyond patient.

•

Community Benefit Operations: Costs associated with assigned staff and community health
needs assessment.

•

Community Building Activities: Cost of programs that address the root causes of health
problems, including expenses for the development of community-building programs and
partnerships. (Moffitt Cancer Center, Community Benefit Report 2017).

Figure 2. MCC Community Benefit by Category, July 1, 2016 – June 30, 2017
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While examples of impactful organizations are plentiful, the focus of this work and the literature
pertaining, centered on transformational business and the impact/benefit to society from a more
altruistic perspective. Literature focused on those connected issues produced numerous, not explicitly
related, but not explicitly unrelated areas of research. Social entrepreneurs, social organizations, social
innovation, transformative innovation and transformational leadership were all search results in the
review. While each topic provided material on a particular discipline, numerous points of connectivity
are presented.
Social innovation, as described by Mumford (2002) “…refers to the generation and
implementation of new ideas about how people should organize interpersonal activities, or social
interaction, to meet one or more common goals.” Mumford’s paper described ten cases of Benjamin
Franklin’s involvement in creating social organizations including the subscription library, police force, fire
department, the Philadelphia hospital and paper currency (pp. 253-261). Taken for granted more than
two centuries later as basic fabrics of society, those decisions/innovations, benefited society. Globally,
healthcare initiatives and research drove innovation and discovery. Social innovation created
opportunity for new, cutting edge organizations, or transformational change within existing
organizations that impacted societal change and benefit.
“In an effort to create societal value, many companies engage in important corporate social
responsibility (CRS) initiatives (Zimmerman, Gomez, Probst, & Raisch, 2014). In this work, entitled
“Creating Societal Benefits and Corporate Profits,” the authors examine how businesses embraced
ventures that served society while earning profits. “…CSR programs depend on the commitment of
current management and the profitability of the core business” (pp. 18-21). MCC undertook numerous
initiatives that generated benefit including an annual Men’s Forum, providing physical examinations
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targeted uninsured or underinsured men, a Mole Patrol mobile unit conducting skin cancer exams at
different public locations. While the programs had targeted impact, they were part of a larger
community benefit initiative to promote early detection and healthier lifestyles.
Drews (2010) combined qualitative and quantitative research regarding business and the social
benefits of CSR. Stating that research was usually conducted in one approach or the other, the study was
intended to use a combined approach to evaluate CSR “from a business as well as a societal perspective.
The case study concluded that businesses can use theoretical models to analyze the cost and societal
impact on initiatives (p. 428-429). Not every CSR initiative is successful, and businesses need to be aware
of the fiscal impact as it relates to benefit. Sustainable businesses could create more initiatives
impacting societal benefit by utilizing methods of evaluation, assessing business viability/ profitability,
and corporate ability to engage in additional endeavors.
Transformative innovation (TI) exists when companies “…embrace social, environmental, ethical
or similar initiatives as an integral part of their strategic missions” (Bright, et al., 2006, p. 17). “TI plays
out in at least one of three ways: (1) it capitalizes on and extends mutually beneficial interdependencies
of business, and society or the environment, (2) it invokes a deep shift in values, assumptions and
behaviors, or (3) it increases the scope of enacted human strengths.” TI, when successfully executed,
created mutually beneficial results where corporate profitability and the creation of societal benefit
were not mutually exclusive events (pp. 17-20).
The founder’s intent, to provide cancer care to Floridians, and four institutional events
(decisions) created a transformational institution through transformative means. As discussed in
Chapter 5, four key events took place that aligned MCC’s business goals to benefit cancer patients. One
transformational decision, a multidisciplinary approach, transformed antiquated methods of care
delivery and benefited patients through a streamlined process and, more importantly, statistically better
treatment as measured by patient satisfaction and health outcomes.
24

Social entrepreneurship and social innovation in business are growing areas of interest in
research. Much of the existing literature describes the topics as businesses either created for, or
adapted to, impacting the greater good through their mission and culture of societal betterment (Barki,
Comini, Hart, & Rai, 2015; Ebrashi, 2011; Martinez, O'Sullivan, Smith, & Esposito, 2016; Steiner &
Teasdale, 2016; Wilson & Post, 2013). The creation organizations designed to serve a specific market
sector, while benefitting a geographical and/or societal need is pertinent.
Social entrepreneurs created organizations with a particular social initiative as the centerpiece
of the organization (Nicholls, 2006) or via for profit ventures (Cleveland & Anderson, 2001), or though
cross partnerships with commercial companies (Ebrashi, 2011; Nicholls, 2006). Social entrepreneurialism
at MCC took on many forms. From its founding, MCC was created to provide services, with superior
results, to a state that did not have a nationally recognized institution at the time.
Linking to Ebrashi’s research, MCC partnered with many commercial enterprises, Merck as an
example, to engage in clinical research trails with the intent to find pharmaceutical treatments for
cancer patients. In order to augment that partnership, MCC created a for-profit subsidiary, M2Gen, to
partner with pharmaceutical companies seeking clinical annotated data and tissue samples. As a forprofit subsidiary, any profit from that venture was to be rolled back into the research enterprise at the
non-profit organization. MCC sought to capitalize on potential from a new market venture, with the
overarching goal of enhancing the research arm of the institution. MCC also partnered with other
institutions in Florida, other states and nations including a personalized medicine partnership with Tiajin
Taishan Cancer Hospital in China. With the goal of sharing discovery and treating patients closer to
home, these partnerships enabled a high level of care without having to travel to Tampa for all
treatments.
The only cancer center created by the state, MCC’s immediate impact was regional. As the
center grew and the research enterprise was founded, MCC’s reach extended far beyond the Tampa Bay
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area. Previously, many Floridians were forced to seek treatment options out of state at other
institutions with renowned reputations; MD Anderson in Texas, Mayo Clinic in Minnesota or Memorial
Sloan Kettering in New York. As MCC progressed through key transformational events, it served patients
statewide, nationally and internationally. The benefit MCC provided Florida was not simply the number
of patients it served, but the innovative care-model it created. Prior to the center’s inception, Moffitt’s
goal was to impact the lives of Floridians with superior care. After more than three decades and nearly
400,000 patients later, MCC exceeded the expectations of its founder.
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Table 3. Literature Review Summary Table
Source

Sample/Study Description

Purpose/Topic

Results

Conte, F., et al.
CEO communication: engagement, longevity and founder
centrality.
Corporate Communications: An International Journal.
2017; 22(3), 273-291.

Communication development
relating to longevity of tenure.
Exploratory survey of 93 CEOs of
large companies in Italy.

Founder
Founder, CEO,
communication in
business

Corporate communication, CEO communication
influence. Founder centrality.

Schein, E. H.
The Role of the Founder in Creating Organizational
Culture.
Organizational Dynamics, 1983, 13-28.

Paper
Cultural embedding of founders.
Founder types and elements of
involvement and commitment.

Founder/Culture
Founder impact on
development of
business culture.

Qualities of differing founder skill sets. Comparative
discussion of founders and professional managers.
Generational challenges moving from founder to
next generation leadership.

Ellis, S., et al.
Imprinting through inheritance: A multi-genealogical study
of Entrepreneurial Proclivity.
Academy of Management Journal. 2017, 60(2), 500-522.

Data collection in Israeli ITC
industry. 65 CEO interviews
regarding genealogical origin and
impact.

Founder/Culture
Stages of Imprinting

Founders as conduits. Imprinted elements may be
transferred to new business organizations. Lineage
of genealogy between businesses.

Cote, R.
Leadership Analysis: Southwest Airlines- Herb Kelleher,
CEO
Journal of Leadership, Accountability and Ethics, 2018,
15(1), 118-122.

Leadership/Kelleher attributes
Leadership styles.
Analysis and analyzation paper.

Visionary
leadership

Leadership styles. Global leadership. Leadership
approaches. Kelleher/Southwest Airlines

Westley, F. & Mintzberg, H.
Visionary Leadership and Strategic Management
Strategic Management Journal, 1989, 10, 17-32.

Concept of visionary leadership
drawing on the theme of
theater/visionary leadership as
drama.

Visionary
leadership

Visionary leadership vary in leaders
Strategic vs. visionary leadership

Carr, J., et al.
Health Care Entrepreneurship in the Nashville Region:
Societal Linkages, Change Dynamics, and Entrepreneurial
Responses
The Journal of Applied Management and
Entrepreneurship, 2004, 9(1), 49-63.

Study of Nashville, TN healthcare
industry and entrepreneurial
involvement.

Societal benefit

Environment suitable for entrepreneurial
investment for the benefit of the Nashville region.
Transformational change presents opportunities for
entrepreneurial investment.

Ebrashi, R.
Social entrepreneurship theory and sustainable social
impact
Social Responsibility Journal, 2013, 9(2).188-209.

Grounded theory study of social
entrepreneurial activity and
entrepreneurial literature.

Societal benefit
Entrepreneurial
theory

Add to the study of motivation, condition and social
enterprise
Management, outcomes and impacts
Sustainable change
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CHAPTER 4: THE FOUNDER

Introduction: The Founder
Identifying and describing any leader’s personality, drive, ambition, goals and core values can,
on the surface, seem fairly easy. What did they stand for? Did their record reflect their words or actions?
What did they talk about? How were they viewed by their family, friends and colleagues? What were
their accomplishments? However, understanding the core of an individual and how words and actions
are translated into lasting results, redeeming qualities and enduring reputation is more sophisticated.
The benchmark is time. What did they start that was good, continue to do and did not stop doing for any
reason?
A case can be made that H. Lee Moffitt was one of those people who, with fierce passion, made
a difference. The founder of Moffitt Cancer Center (MCC) never stopped pushing, working, and
impacting the cancer center for institutional betterment. Moffitt was born and raised in Tampa, FL. The
son of a welder and a Holiday Inn desk clerk, Moffitt was the first in his family to graduate from college.
After graduating from the University of South Florida in 1968, he attended Stetson Law School for one
year prior to graduating from Cumberland Law School in Alabama. After practicing law in Tampa for five
years, Moffitt successfully ran for a seat in the Florida House of Representatives; ultimately ascending to
Speaker of the House from 1982 to 1984. A cancer survivor himself, Moffitt had three friends diagnosed
with cancer. The three had to seek medical care outside of Florida and all three died. Impacted greatly
by the events, Moffitt made it his legislative, and ultimately his life’s, motivating force to establish a
state of the art cancer center in Florida.
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Moffitt’s passion for fighting cancer and the institute he founded can best be described by the
people who have been around him most or influenced by him greatly, personally or professionally.
Moffitt served for more than 30 years as a founding board member at MCC. He did not receive
compensation for that position, his lobbying efforts for continued state investment in the center or any
other service. He also refused to allow the center to designate an office for him. He practiced law before
and after his legislative time in elective office. He utilized his legislative experience to obtain clients to
represent before state government. He made a good living but was not rich. His constant and consistent
passion was the cancer center that bore his name.
This research project utilized interviews conducted with more than twenty leaders connected
with MCC. Board chairs, members of the board, the CEOs, key executive leadership and program
directors were asked for their opinion on numerous topics, including the founder. The interview
questions are shown in Appendix B. In this chapter, excerpts from several interviews are used describe
Moffitt on a personal level and a professional level.
Personal Insights
Most interviewees were asked identical questions. There were a few exceptions: his best friend,
his daughter, the general counsel at MCC who knew the founder for nearly his entire career and one
other founding board member who was a close confidant of Moffitt. Those individuals were asked to
expand on Moffitt’s personal traits as well as his professional involvement. To get an in-depth picture of
who Moffitt was, these individuals contributed extensive thought, opinion and perspective on H. Lee
Moffitt as a person, a professional, a politician, a founder and a driving force for MCC.
The Hon. Ralph H. Haben, Jr., Esq.
Ralph Haben and H. Lee Moffitt met at the Cumberland School of Law in Birmingham, AL, where
they graduated in 1967. Haben was elected to the Florida House of Representatives in 1972 as a
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democrat representing the Bradenton, FL, area. He was eventually elected by his colleagues as Speaker
of the House, serving from 1980 to 1982. Haben was H. Lee Moffitt’s closest friend. Moffitt stayed with
Haben during the 60-day legislative session in Tallahassee, FL, each year. Haben knew Moffitt better
than most.
For the purpose of introduction, and discovering the essence of H. Lee Moffitt, the man, Haben’s
recollections not only add depth, but also commentary regarding Moffitt as a person, a legislator and
founder of the H. Lee Moffitt Cancer Center and Research Institute.
I began law school at Stetson. Had not been involved politically in any way ever before, just
went to University of Florida. Never was involved in student government, just didn't do it. And
we got there and as a matter of fact Jim Smith at that time was there, he became the attorney
general. (Smith served as Florida Attorney General from 1979 to 1987 and Secretary of State
from 1987 to 1995 and 2002 to 2003). And three or four other people that Lee and I became
friends with.
They had freshmen elections. And so we were going put together a slate of people and Lee was
going to be part of that slate and I kept saying who is Lee Moffitt? I met him, introduced myself
up on the third floor of the law school. And so we went through the election. Somehow or other
he was running for like secretary or treasurer. And Lee lost. We started hanging around then
became friends.
There came a time my senior year, our senior year, when Wilbur Boyd (D-Palmetto) who was
our senator from Manatee County, constitutional revision (the Florida Constitution requires an
appointed body to review the state constitution every twenty years and submit proposed
adjustments) was up. Claude Kirk (R-Jacksonville, elected in 1966) was the governor. And so
Senator Boyd said why don't you come and become my aide because you have some law
experience now and we're going through constitutional revision and you can advise me. And I
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did.
Then contemporaneous {sic}, or within about three or four months, Lee had met Senator (Louis)
de la Parte (D-Tampa) and he became Senator de la Parte’s aide. So now we have transitioned
from law school politics to both working at the same time in the Florida Senate. So we did that
for a while and then we both got admitted to the bar. He went back to Tampa and started
practicing. I went back to Manatee County. In 1972 there was an opening (for a seat in the
Florida House of Representatives); I ran successfully. And then in 1974 he ran successfully.
I had been up here for one term and he was then elected in ‘74. During, and I'm trying to think if
it was before or after, but I remember he got cancer. And I didn't think much about it at the
time. And finally somebody called me and said he is up in the hospital, this is fairly serious, you
probably ought to come up here.
So, we got in the airplane at night and left Sarasota and landed on Davis Island. And went to see
him and I realized that this was a serious fricking {sic} deal, he had a damn hole in his leg about
the size of a damn watermelon. And I realized he's lucky to be alive. And so that was an ordeal
for a while.
Ultimately he started healing up by this time we had run for the legislature and so we came up
here (to Tallahassee, FL) and were friends before we came and it just got closer and closer
because the service up here. Lee was just coming up as a freshman. I knew Lee had this thing
because of what he'd gone through with cancer which was not pretty. And he had this idea that
we should build a cancer center. Now what I did not know at the time, which I now not only
know but live with each and every day, Lee Moffitt is the most stubborn person that I have ever
met and I have met a lot of really stubborn people. He's not unreasonable particularly. He can
be. But he's stubborn. And he got in his mind that we were going to have a cancer place.
But he doesn't know how to do it and so he comes to me and says “Listen, you know Speaker
31

Brown better than I do. I really would like to get some seed money to begin to plan a cancer
facility.” And I said well that's not a problem. He said “Well I just I don't know what to do.” I said
well come with me. And so we went up to the fourth floor (of the State Capitol) and went into
Hyatt's hall and said Hyatt, Lee needs a little over a million dollars. Well, for what? I said listen.
He wants to look at the feasibility of a cancer facility. And he'll take a million dollars and nothing
will ever come of it. But if you do not give it to him, he will wear you out. Just constantly, just
give him the money. And Hyatt said, okay. So he called the appropriations chairman [to] put
money in the budget. And there it began.
For a year, that was his main thing. He did a lot of other things but that was his main influence.
And then and actually the year he was elected, Hyatt called me over and said listen. I need
somebody, one of our people to succeed me. You need to talk to a couple guys and decide if
you're going to do it or not. I wanted to be the United States Attorney for the Middle District I
thought. But then I finally gave that up and stayed and ran and of course back then you had
Hyatt and me and then Lee. We were all extremely close. Ultimately he became Speaker and
was able to complete not what exists today but what existed back then, which was sort of the
focal point. And I'm going to tell you something I think to be emphasized. He has never made
one penny off of that cancer center. And he could have. He could have made several million
dollars. Will not do it, will not talk about it. That's unusual. Lee Moffitt is a good person. I'd like
to kill him sometime, but he is a good person.
Lee Moffitt came from middle class but good parents, both of them. But both of them really
cared about him. And you know he's sort of a typical story, went to Plant High School (in
Tampa), did not have a butt load {sic} of money, but was involved. He went to (University of)
Florida for a short time, was always interested in politics. We were both extremely naïve. Had
no idea about what the real deal was until we got up here, or actually until we started to
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campaign. I mentioned earlier he is the most stubborn person that I know. But that's a good
thing. Lee was sort of on the outside looking in. I mean he was well known, well liked. But the
name Moffitt was like, ‘is that a plumbing part?’ But I had run and so I had some experience on
how to do it.
I remember going door to door in Hillsborough County. It was close but he won. And, of course,
once he won then very quickly moved into a leadership position. What's funny is he's stubborn,
but his nickname in law school… was Mother Moffitt. Very “let's keep everything under control.”
But that's him, it's just “I don't want anything bad to happen, don't want anything bad to
happen.”
Lee's very steady number one. Number two, I didn't do so much of this, he did, he would reach
out to the Hillsborough people, “what do you need, how can I help you?” I mean I sort of knew
but you don’t have to reach out. Believe me they'll be right up here. Don't worry about it. But he
did that, and he was interested in all things Hillsborough, he really was. Because his circle of
friends was Hyatt, speaker, me, next speaker, (Rep. Steve) Pajick (D-Jacksonville), (Rep.) James
Harold Thompson (D-Quincy), all of the leadership people during that period of time, Lee was
close friends with. He was liked and well respected. You ask any one of them though, they will
tell you he was stubborn.
The Lee way is the kind of ... he wants to be right. Not in a bad way, he wants to be right
because he thinks about things, he sometimes studies them to a fault. He does not want to
make a mistake. He doesn't want to do something wrong. He doesn't like controversy. He just
doesn't. He wants everything to work out, he wants everything to be good. And for the most
part he was able to do that. As Speaker, he was able to accomplish it, not through force of will. I
think most of the House of Representatives thought this guy is a good guy. He means well, how
can you refuse him?
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Let me tell you the classic comment. (Rep.) Elvin Martinez (D-Tampa) one night had had many
high balls. And Elvin said you know what? I've looked at the total state budget, I don't know if
we can afford all the Jenny's (Moffitt’s daughter) of the world. Because that was Lee's opening
address, he said he wanted to take care of the children and education, and he means it. The last
line of that opening statement was we need to take care of all the little Jenny's of the world.
And he meant it, of course Elvin was drunk, says we can't afford all the little Jenny's in the
world.’ Which if you think about it really makes the point that he wanted to do the right thing
and he wanted to be right.
He and I are so different. And yet we are the best of friends and have been that way for a long,
long time. The House (of Representatives) really respected (Speaker) Hyatt (Brown) because of
what he was able to do, that he was able to turn it around so that the young guys were now
running the rodeo. And they were a little fearful of me because I knew the rules, I was pretty
good in debate and, I have a quick tongue. But him they loved him. It's like if Lee wants it let's
just do it.
There is nothing wrong with being an advocate. But up here you have to be an advocate within
certain bandwidths. Sometime Lee does not recognize those bandwidths. And let me tell you
why. That cancer center is so much, it's part of who he is, it is a major part. I would like to know
the number of total working hours in a year that he devotes to the cancer center. I guarantee
you, I guarantee you it's more than 70% of his time.
The cure is there. 10, 15 years from now all these people that we lose, they're not going to be
lost. In other words, my momma my daddy my brother, all could have been saved and he knows
that. So it's the best of the best but sometimes when the mission becomes really important, you
still have to work in the system. Let me tell you what the system is. It is frustrating. It frustrates
him on a fairly regular basis.
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I guarantee you, you all are going to have to make a fricken {sic} motorized walker where he can
go to the damn board meetings when he gets about 90 years old. Because he’s not going to quit
until he dies. Just not. I don't know anybody that is as committed to an institution or an idea as
he is.
I don't know any other person that spends the unpaid time that he does, I wouldn't do it. I
couldn't do it. But he does it. And not only does he do it, he loves it when something good
happens.
Do you want me to tell you what is a realistic expectation (about the future) he has or an
unrealistic expectation that he has? Two different things. The unrealistic expectation is to, not
for everything, but to find an accepted cure before he dies. And if not that, to continue to grow
and fund so that we will be better positioned to realize the first. That is to ultimately find the
cure. You're going to find a cure for some of it. You aren’t going to find a cure for all of it. So
Moffitt, when they find a cure, it's almost their mission doesn't end, it begins. Now we got a
handle on it, now how can we develop the procedures and the way to go about getting to where
50 years from now, they used to have cancer back in early 2000's. We don't have that anymore.
Like trichinosis in pork.
If you would have told me in the Speaker’s office, when we asked for about a million dollars,
that I would be talking about a facility that encompassed acres that was famous, not in Florida,
not in the United States, but throughout the world, that it would be ranked in the very top
echelon of facilities and it all started with a hole in his leg.
He had an idea, he had the mental makeup, the stubbornness to just keep on and on and on and
to continue to fund and it continued to grow beyond anything we ever, ever could have
imagined.
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For a lot of people in Tampa, one day there was some bricks and mortar and it seems like it gets
bigger and bigger and bigger and now it's a part of the fabric of Hillsborough County, that whole
area. The jobs, the economic engine that it is, but for me I just remember Hyatt giving him a
million dollars where we can just get the frick {sic} out of here.
Who would have thought, they started building it like it'll be an 80-bed facility and he'll be
happy and we'll name it Moffitt and go on down the road. And that's not what it is now; it's a
world-class program. If any one of those factors would have been different it wouldn't have
happened probably, but the most important was him persevering.
Out of all the questions asked of those interviewed, there was only a single question about the
founder. Interestingly, all but one person mentioned H. Lee Moffitt before the question was asked. That
fact was not completely shocking considering his name was on the door. However, the frequency of
responses and the depth to which the respondents went was enlightening.
Jennifer (Jenny) L. Moffitt, PhD
Adding a bit more flavor to the founder himself, Moffitt’s daughter, Jenny, had insight from a
number of perspectives. She served as a member of the hospital board at MCC. A PhD professor, Jenny
was not politically active like her father and was focused on her career and her interests. She was
“recruited’ to serve on an MCC board in similar fashion to general “encouraging” a child to pursue a
military career by going to West Point. Jenny had grown up with MCC as part of her life.
I don't really remember a time in my life when it (MCC) wasn't part of the conversation or part
of my dad's focus or reason for being. There were discussions about his dream for the center. I
remember it, when the hospital was under construction. Of course, the growth that we've seen
occur in my lifetime from just an idea to something on paper to something that started to
emerge from the ground here in Tampa, just the hospital building at the beginning, and then
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adding on the Research Center and that kind of growth happening.
My earliest memories are the classroom here, the Cynthia King classroom in the hospital. That
was my first introduction to cancer. The first time my dad had cancer was before I was born.
Cynthia would allow me to come and volunteer in the classroom where I got to spend time with,
this was when we were still doing pediatric care, and I would come and spend time with the kids
in the classroom. Those were my first lessons about cancer and cancer treatment, learning from
a young girl being treated for leukemia. I remember her taking me to her room after we left the
classroom and showing me the IV and talking about how she received her treatment and the
effect that it had on her.
Those were really my earliest memories of coming to understand what this place was and the
impact that it had on the lives of the patients that were coming in.
Jenny’s early memories and her father’s eternal drive to propel MCC to the forefront of cancer
care and research were always present. However, she pursued her own path and was not actively
involved with the daily operations at MCC until after she had established herself professionally. Her
board affiliation and her own growth as an adult established her own views on her father’s interest and
drive regarding the cancer center. Her father’s personal experiences with cancer are not only part of her
recollection, but also her awareness of the disease’s impact.
It's always interesting for me because I'm trying now as an adult, and within the Moffitt
community, to see him as a man rather than a father. It's always difficult with our own parents
to imagine them existing in the world outside of their role as parent… I suppose I'm sort of
grateful for Moffitt because it allows me to see my dad in a different perspective than the father
perspective.
He has been an incredible, if not intimidating, role model for me my entire life because he is so
passionate, so determined, so engaged, so willing to give of himself and of his time and never
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resting in his commitment to the cancer center and his pursuits in his goals for this place. It's
been remarkable watching the center develop over the years as well as watching him grow over
the years in terms of what he's learning. He was not someone with medical or healthcare
background. This was a passion project inspired by the loss of friends, and so he had to do a lot
of self-education in order to be able to make this place a reality and then to remain a
participant.
He didn't just say, "Oh, let's get this thing going," and then move on to something else. He will
be here until the bitter end. He will... this is a lifetime commitment for him, so it's been
remarkable to watch him in that capacity.
The friends that he lost, that all happened before I came into the world when he was very
young, as did his first battle with cancer happened before I existed. For me, my memories are of
his second encounter with cancer when I was around 12, I suppose. He hid it from me when he
got sick because, as a parent, you never know what it means when you get that diagnosis, and
especially if your children are of a certain age or not quite sure what the future is and what they
can handle or what they understand.
A lot of it was hidden from me, and I was sort of unaware of him being sick. Then when I did find
out, as any family member or caregiver knows, it's really terrifying, the threat of the loss of a
loved one and the pain of watching someone you love go through the experience, the physical
pain, the emotion pain for them.
Jenny believed that her father’s motivation, his experiences with cancer and the death of three
close friends were always top of mind. But she also grew to understand that there were specific traits
her father exemplified that drove his ambition for excellence in cancer care and research.
I would say visionary, and this comes to me because it's something that I admire so much in him
is to be able to. I mean, we talk about him as being determined and tireless and forever willing
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to fight the good fight but he has this incredible capacity to look into the future, if you will. Or
to imagine possibilities that I think makes him unusual. This was something I've always both
admired and perhaps been a little jealous of, is this ability to say, "Let me think, I'm going to
anticipate needs," and then not just come up with ideas, but actually work to make that a
reality. It's a really remarkable quality.
It never stops with him. It never turns off, where he's always thinking, "Five years from now, 10
years from now, what do we need to be doing, what do we need to be ready for, how is the
culture going to change or technology going to change, how can we adapt to meet changing
needs." It's impressive.
I think he, in part, leads by example in that you see that devotion, you see that commitment,
and I think it's inspiring. It's sort of infectious to those of us around him. I think the other thing
that makes him a great leader, or anyone a great leader, is the capacity to listen to others and to
gather information and know that there are times to be in the driver seat and there are times
not to be, that you have to trust those around you to contribute that this is a team effort, that
this cannot happen without everyone involved in the Moffitt community coming together and
sharing information and helping in the best way that they can. You've probably heard him ask
people a bazillion times, "Have you found the cure yet?"
L. David de la Parte, Esq.
David de la Parte provided an additional look into the history and depth of the founder. de la
Parte, who has long considered Moffitt as a mentor, served as outside General Counsel to MCC from
1990 until moving in house at MCC in 2007 to serve as Executive Vice President (EVP) and General
Counsel. de la Parte’s father, Louis de la Parte, served in the Florida legislature and ultimately ascended
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to the role of President of the Florida Senate for a short period. After law school, Moffitt worked as the
legislative aide for state senator Louis de la Parte.
Dad is why I am here. You can trace pretty much everything back to dad as far as my legal
career, professional career. But Lee Moffitt, for a time, worked for Dad when Dad was in the
legislature. Lee and Ralph Haben were on their way to Tampa having graduated from law school
and decided they would go through Tallahassee and see if they could get a gig in government. At
that time, Dad needed an aide. And gave Lee the job. Dad was in the Florida senate at the time
representing Tampa, Hillsborough County.
That's where Dad and Lee kind of established their first formal relationship. Lee certainly knew
Dad because Dad was active in politics and was elected office and was a lawyer in town. He was
12, 14 years Lee's senior. Lee tells me, and I've heard him tell others, that he kind of caught the
political bug from dad. I don't know about that because Lee was political before he went to work
for dad. He was student body president here at USF so he already had the political bug. Maybe
he just got more refined.
In 1990 I became Moffitt's outside general counsel by virtue of Dad's early retirement (former
Sen. de La Parte had served as MCC’s outside general counsel) because of an illness. I did that
for about 15 years as outside general counsel and private practice. I was recruited to be the
cancer center's in-house general counsel by H. Lee Moffitt and Bill Dalton, the then CEO of the
cancer center in 2007. And so I moved. I sold my practice to my partners.
Over the years of working for MCC in private practice and internally, de la Parte worked closely
with Moffitt on all aspects off MCC business. de la Parte grew to revere Moffitt and learned much about
his personality, drive and motivation.
H. Lee is one of the most extraordinary people I have had the opportunity to interact with. Lee is
definitely probably, next to dad, the most extraordinary person I've known. No human being is
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perfect. Lee certainly isn't perfect, but he is able to bring to bear for us, for the cancer center
traits, talents, energy that is…again, I have not witnessed in any other organization.
It does oftentimes go back to one person and their unique attributes and traits. And a passion
that is just... It's an energy, a life force that Lee has been able to channel to the benefit of this
place in his mind. Working 24/7 on whether it's how do we get the cars through the valet more
efficiently, more quickly so patients don't have to sit and wait and can get into the place and get
the care they needed? To how do we talk the legislature into giving us the hundreds of millions
of dollars we need to build a new research tower or to build a new clinical facility?
It's from the very smallest thing, operational thing to the very largest strategic things that we
do. He's got a mind that's capable of that. And he's got a passion for it. And he is willing to put
himself personally at risk, and he has. If Lee put the energies that he's put to us to his law
practice or his political career, he'd probably have a lot more money or he'd be the President of
the United States or something. But he chose to put his energies into us into this place, into the
Moffitt Cancer Center. And thank goodness we've had someone like Lee who didn't put his own
personal interests ahead of the patients and our mission.
He's a tough task master. He's a bear. He is never satisfied. You've got to be prepared when you
work with him and work for him to be prepared for a grueling experience. But that has a lot of
rewards at the end of it. For me, it was a personal and professional embracing and a leadership
towards a purpose higher than self that Lee personified that for me defined Lee and defines
Lee's and my experience with him and I think the experience of a lot of people here. There's a
lot of people at the cancer center that are here because of Lee, either directly or indirectly.
Because of that culture and a lot of those traits that they see or that they want to emulate in
some small way.
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Theodore (Ted) J. Couch, Sr.
There was likely no one closer to Moffitt in all things MCC than Ted Couch. Couch, a former
Tampa banker and businessman, served as the Chairman of the Board at MCC and subsequently on the
executive committee and the parent board of directors. A term of endearment often used to describe
Couch was “salt of the earth.” Couch was a low-profile, quiet, thoughtful and dedicated driving force in
the growth and success of MCC. He was smart and could process a lot of information, formulate a plan,
get it moving and accomplish an enormous amount without drawing attention to himself. Moffitt
trusted him implicitly. Couch reciprocated with commitment and attention to detail. Couch had a
responsibility to the institute as a whole while, at the same time, he always understood the founder’s
vision.
The way I got involved was, of course, Lee Moffitt. I met Lee through a partner that I had that
owned the Holiday Inn on Fowler Avenue (in Tampa). And so I was introduced to Lee about the
time that he was a House Member, actually, prior to him becoming Speaker, I got to know him
much better after he had become Speaker.
Everybody knows about Lee. He's determined, when he makes up his mind that he's going to do
something, he doesn't let anything distract him. He pushes until he achieves his goals, and his
goals are already, always, or for the most part anyhow, right on target as to what the needs are.
And in addition to that, he's just an amazing person to work with, as long as you understand
what his position is.
Moffitt Cancer Center is probably the greatest thing that has been accomplished in Florida in my
lifetime, and I'm 82 years old. It's all through the genius, I would say, of Lee and his compassion
for others who he knew at the time were suffering from cancer but had to go out of state in
order to get superior treatment. He wanted to remedy that, knowing that the state was growing
at the rate it was growing. The fact that we have as much sun exposure here makes sense I
42

guess even more. What would you say? Eligible for cancers, or at least skin cancers. So that was
his motivation to attempt to get the funding to build a center.
Lee had the motivation to see that a center in the state of Florida was built as he was Speaker,
and he had the influence to be able to push decisions like this. So his inspiration led him to
secure, through the leadership sponsorship, for I think it was like 60 million dollars at the time,
to be dedicated to building the cancer center on the campus of the University of South Florida.
I think what he's accomplished, it speaks for itself. Going all the way back to the time that he
was in the legislature. The fact that he was probably one of the youngest Speakers of the House
that Florida has seen, and the fact that he could actually make a Moffitt happen. Because when
you look at Moffitt, what it's accomplished over 30 short years is just nothing short of incredible.
Matching up to other NCI centers around the country. As a business person, I think with his style
and his brain power, his ability to be able to stay focused, he could have been a very successful
businessman. And fortunately for us, he channeled all this into service for others.
I've been around (MCC) for 33 years. The one thing that I really am grateful to Lee for, Lee, at a
very young age for me, taught me that you can give, even if it's a stretch because that's when he
enticed me into funding a chair in cancer research at the University of South Florida at the time
that he was attempting to get the funding to build the center. At that time, I had not had a
record of giving. It never occurred to me that I could or should be giving. And so he taught me
that I can make a commitment and that I can honor the commitment, and from that time on,
I've been making commitments in philanthropy ever since. And it's probably the best thing that
I've ever learned. It's certainly made a good life for me.
Four people who were close to Moffitt early in his life and career, through their words, give
insight into the person from both a human and professional perspective. They have known and
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observed the man from multiple perspectives: his strengths, weaknesses, drive, ambition and purpose.
Their relationships began before the cancer center existed and they journeyed with him throughout.
Professional Insights
The people who have worked with Moffitt in only a professional setting also have unique
insights into the founder. Their relationships are, for the most part, professional and based on progress,
discovery, care, treatment and success of a single institution. Many people were involved, associated
with, or governed MCC for extended periods of time. Since MCC had been treating patients for only 32
years, a high number of doctors, researchers, clinicians and executives had experience in other
renowned institutions prior to joining MCC. Thus, an additional asset was the experience brought to
MCC from previous cancer centers and businesses. That said, it took a bold person to leave the comforts
of a known, reputable organization and move to MCC. The culture, mission and mindset were ingrained
by the founder and the people who were entrusted to lead the institution early on.
Many of these leaders also add insight into the founder and how the culture was solidified.
Throughout the following section, Moffitt’s vision, determination, passion and commitment were made
clear.
The Hon. Connie Mack III
Former United States Senator Connie Mack (R-FL) served in the US Senate from 1989 to 2001
and in the United States House of Representatives from 1983 to 1989. A banker by trade, he served as
president at a small community bank in Lee County, FL, prior to entering public service. Mack was the
grandson of legendary baseball player and manager, Cornelius McGillicuddy (Connie Mack) of the
Philadelphia Athletics (then the Oakland A’s).
When Mack was a young man, his brother Michael was diagnosed with melanoma, which was
treated and remained in remission for a decade. At age 35, Michael died of melanoma. Mack recalls that
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defining event as a significant motivation for seeking public office. Over the decades, Mack’s family was
impacted greatly by cancer. His father, mother, wife and daughter all experienced the disease. Mack
himself was diagnosed with and treated for melanoma while serving in the Senate. While serving in the
Senate, Mack wanted to impact cancer research and treatment. The National Institutes of Health (NIH)
oversees numerous health related departments/agencies, including the National Cancer Institute (NCI).
Mack had a vision of doubling research funding at the NCI to enable more scientists to focus on these
diseases. The Congress is a representative body that acts and reacts to influences in their districts,
nationally and internationally. Advocates for heart, lung, diabetes, HIV, Alzheimer’s and numerous other
diseases were interested in increased federal funding as well. Mack realized that increasing/doubling
funding for NIH, as opposed to just the NCI, would provide collective support to influence the
congressional budgetary process. That coalition was successful.
Nearing the end of his second term in the Senate, Mack made the decision not to seek a third
term. As he was winding down his tenure in public life, Moffitt approached him about serving MCC on
the board.
I wouldn't have spent 17 years at the Moffitt Cancer Center if it hadn't been for Lee. Lee and I
spent some time together not long after I announced that I wasn't go to run for re-election to
the Senate. We had dinner together. Lee was just wanting to know a little bit more about why I
was doing what I was doing with respect to cancer research and doubling NIH. I think both of us,
even though we were representatives that came from two different parties, we had a mutual
respect from day one.
At some point, and I don't think it was that night, but at some point Lee said to me, "We'd like
for you to join the Board at the Moffitt Cancer Center, and because I know you're the type of
person who doesn't just want to be another member of the Board, we'd like you to be Chairman
of the Board." So, I jumped at the opportunity because it fit right into the way I kind of saw my
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future after getting out of politics and being involved more in cancer research and cancer
treatment was exactly what I was interested in doing.
The experiences and the drive to impact the fight against cancer bonded the two men. While
having the stature of a general, Mack was also a soldier in the war. Moffitt realized that and recruited
him to serve. Moffitt identified and recruited like-minded people, not political but in mission, to serve as
leaders, to become part of the MCC community and mission. Mack saw in Moffitt the qualities and
commitment of an individual who enticed free thinkers to lead and advance the cancer center.
Lee, being the type of person that he is, it was very clear what he was trying to accomplish, what
role he thought that I could play in helping that come about. His commitment to continue effort
to expand the resources for the Moffitt Cancer Center. I love the guy. He really has made a
difference. So, how do you sum him up? Passionate, determined, committed, focused, visionary.
There's a saying "enthusiasm is contagious." His leadership style is kind of based on that. He's
not a rah-rah type, but his actions speak louder than words of his commitment. And because of
that, he can draw others into what he's trying to accomplish.
Timothy (Tim) J. Adams
Tim Adams was the Chairman in 2018, after serving 26 years on the MCC board. Adams was a
retired executive from Time Warner Customer Service.
I'd come to town and I'd just assumed a leadership role at Time Customer Service. And my
predecessor had engaged Lee as a lobbyist, and so we met that way. And an opening came up
on the board; I was 30 at the time. I think Lee wanted to recruit some young folks, so that's how
I ended up here.
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Adams had a front row seat to the rapid growth at the cancer center and had participated on
the board for a great portion of his career. Adams was a Moffitt disciple and understood the founder’s
passion, motivations and drive.
If we didn't have that singular focus, or we let ourselves get distracted, I don't think we'd have
come this far this fast. It all starts with Lee obviously, and the vision and mission. So particularly
the vision and mission, I think, which sprung from Lee. Lee had a lot to do with recruiting of
leadership both on the boards and management that agreed with the vision and mission.
I think Lee is extremely unique, and I don't know of anybody else who's built something like this
from scratch. I don't know the Facebook guys and the Google guys. But if you think about what
Lee's done, it's really been determination and perseverance, but the really cool thing is, he
pretty clearly early on realized, "This is how I can help the institution." By making sure
everybody keeps focused on mission and doing his things with the legislature that he does. And
he also realized, "There are things I can't help with" and surrounded himself with people with
pretty unique skills.
Adams appreciated the thought process that Moffitt possessed and learned over his years on
the board that knowing what you know and knowing what you don’t know is vital to organizational
success in business. Even at a non-profit, where success is not based on bottom line market share or
stock value, Adams knew that MCC’s success depended on smart and successful people, working in
tandem for a singular purpose.
Look at the founding set of board members. They all complemented one another and had
different skills, and I think it takes a big person to say, "Here's what I'm good at and I'm going
pursue that. And here are some other things that I'm willing to cede control to other people to
benefit the institution."
I think the recruiting, the keeping the institution focused on mission, and then obviously, the
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stuff in his wheelhouse that he's done remarkably well over the years, really distinguish him. A
lot of founders, I think, would be unwilling to cede any control to anybody. Lee did a wonderful
job of saying, "Here's the kind of talent I need to bring in to push this place along."
Edward (Ed) C. Droste
Ed Droste was one of the significant examples of how the adopted mission passed from hand to
hand. Droste was a successful business man who owned and operated a large real estate management
company. He also was one of the founding members of the Hooters restaurant enterprise. Droste had
an accomplished career, acquiring wealth and notoriety. He didn’t need to work or devote his time to
philanthropic activities or organizations, but he did both.
Droste had gotten to know Sen. Connie Mack in the early 1990s and became politically active,
supporting candidates and causes that piqued his interest. Mack had come to know Droste as a capable
and personable individual with business acumen accompanied by focus and determination. As Moffitt
recruited Mack, Mack recruited Droste. Droste served as the Chairman of the Moffitt Foundation Board
and as a member of the Executive Committee, making him a member of the MCC parent board. As
Droste immersed himself in the MCC foundation, his relationship with Moffitt grew.
Having been around Lee a lot, I'm amazed at some of these visions. We have a lot of restaurant
concepts that take off, but one vision ended up somewhere else. They're successful but very
dissimilar from what the original goal was. Moffitt, to me, obviously exceeds Lee's wildest
dreams and the legislature's wildest dreams, but I think to be the superior resource and
alternative for Floridians initially and nationwide, they've achieved that in spades.
When you say visionary, that comes with the thing that he sees what he wants this thing to be,
that light on the hill. Whether it's in a legislative session on how to present a position, they
better follow this way because he's got a vision of how that's going to be accomplished. But I
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think it's good. He's not only the pioneer that led the troops over the hill, but he's also the
standard.
He's a pretty demanding leader. But from where I sit, I see him as a tremendous addition to
meetings, to groups, whether it's a fundraising event or a strategic session where our sleeves
are rolled up and it's a five-hour meeting and we've got to come to some decisions. He and
Connie Mack are very similar, I think, (they) bring that statesmanship type of diplomacy, but a
razor sharp focus on some of the priorities and some of the strategies. It's fascinating to watch
them work.
Significant commentary regarding the founder has already been stated, however, MCC’s
executive leadership added additional perspective.
Alan F. List, MD
Dr. Alan List served as CEO of MCC beginning in 2012. Prior to ascending to CEO, List was MCC’s
Physician in Chief. A malignant hematology doctor, List had been recruited to MCC from the University
of Arizona where he led the blood and liver transplant program and leukemia program as Associate
Center Director for Translational Science. List continued to practice medicine and conduct research
while serving as CEO.
List was one of the experts in his field that came to MCC from a university structure, conducting
treatment much differently than the MCC model. It can be difficult for faculty to adjust to an
interdisciplinary model of treatment from a departmental structure that the vast majority of university
medical programs followed at the time. But List was a believer. He was like-minded in that the structure
and delivery of care as organized by MCC far exceeded the standard of care in other institutions. List
concurred that the founder was the early, present and continuous driving force.
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Lee is a guy who's highly motivated, highly focused, and definitely goal-oriented. Initial
motivation came from losing friends that had cancer and his own experience personally. But to
lose such close friends over a short period of time really is what struck him. Lee is someone
{who}, once he gets started with something no one's going to stop him. He pushed and pushed;
he had a lot of resistance, but he had the fortitude and the vision to see this through, and
certainly made it a reality. Still, obviously, very much involved and this is his baby, he wants it to
succeed, and obviously still influences things today. He's the founding father. The good thing
about Lee is he's still visible, comes in not just in the C suite but he's in through the hospital, the
clinics, so when staff see him they want to talk to him, they want to meet the founder. He is the
inspiration for a lot of the staff here. And the other thing about Lee, thinking back to when I first
met him, he's truly a statesman.
William (Bill) S. Dalton, PhD, MD
Dr. Bill Dalton served as MCC’s second CEO. Dalton is a researched-based physician, which is
why he placed the PhD before MD in his title. Dalton had served as Associate Center Director for Clinical
Research from 1997 to 2001. He served as Dean of the University of Arizona School of Medicine for a
short period before being recruited back to MCC to serve as CEO from 2002 to 2012. In 2012, Dalton
transitioned to CEO of M2Gen, a for-profit subsidiary of MCC.
Dalton, like Moffitt was a force to be reckoned with. Not a gentle leader, Dalton had a
commanding presence and a forceful leadership style. In passion and drive, Dalton and Moffitt had
equally strong personalities, like two alpha dogs in the same space. While the personality makeup of
both could, and at times did, lead to the clash of the titans, both men had an appreciation for the
other’s commitment and sense of purpose.
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I remember the first time I met Lee Moffitt. I had not yet decided to join, was visiting and the
passion in his eyes about why I needed to come here was captivating. And I had never seen
anybody... I work with a lot of passionate people. There was an intensity with that passion,
wanting to do the right thing and he is a driven, committed person, who is also transparent
about what he is trying to do and how he is trying to do it. And I think the whole idea of creating
an instrumentality of state was masterful, so he's brilliant in that regard.
When asked about Moffitt’s leadership style, Dalton responded:
You don't have an option. When he says you're going to do something, we're going to do it,
which I appreciate. His leadership is, again, captivating. You want to be part of it. And there is no
other choice.
G. Douglas (Doug) Letson, MD
An orthopedic oncology surgeon, Dr. Doug Letson served as EVP of Clinical Affairs, Physician in
Chief. Letson joined MCC in 1992. Known for his innovative medical thought process and subsequent
surgical innovations, Letson appreciated and respected the design of medical delivery at MCC. He was
one of the early physicians who worked to define interdisciplinary care, a model of care based on
disease site/type and not by individual departments of surgery, radiation etc. Letson also appreciated
the founder, having worked at MCC for a long period of time and developed a personal and professional
relationship.
His internal energy, his drive, and his expectation of perfection, when you begin with H. Lee, and
once you know him, you know that he wants nothing but the best for patients. Lee is a, first of
all, a very, very caring human being. He cares about people. He cares about not only the patients
that are here; he cares about all the employees that work here, and that's not something that
you can teach. That's not something that is learned. That is his internal heart that comes out. He
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wants this to be the best cancer center in the world, and he's driven every day to find out ways
that he can help this cancer center succeed in being one of the best cancer centers in the world.
He leaves no stone unturned.
He's driven for the best care, and he never settles for average. I remember when we first
obtained a US News and World Report (ranking) of (number) 6 (cancer center in the country),
which is the highest we've ever been rated. I was talking to him over the phone, and being in the
physician in chief, I was pretty proud of getting up that level. When I talked to him he never
applauded number 6. Even though down deep inside he was happy, but what came out was how
do we get to five? How do we get to four? How do we get to three? It's always pushing the
needle forward, and how does he get to that next level? And that's what I loved about him, and
that's what I appreciated about him, because you know that, yes, you've accomplished
something, but you can't stop and wait and say, "Okay, pat yourself on the back." We still have
so much more we can do, and so you keep pushing forward.
You don't want to displease him. You don't want him to be unhappy with anything, and so you
work so hard to help him live his vision and help him accomplish his vision. And even though his
expectation is so high out there that it's almost impossible to reach, your drive is to continue to
get there, and it's kind of like the Vince Lombardi approach in the way I look at things. And so,
Vince Lombardi, in his football, your goal is perfection. You want to have perfection in every
play.
Lee doesn't want to be patted on the back, and he doesn't want to be able to be the face of any
of that. He's all about outcomes, and so he wants to influence the outcome, but he doesn't want
to be the one taking any credit for anything that's going on.
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John (Jack) A. Kolosky, CPA, MBA
Jack Kolosky served as EVP, Chief Operating Officer (COO) and President of the MCC Hospital. A
CPA by training, Kolosky joined MCC in 1999 from Georgetown Medical Center in Washington, DC.
Previously he served as Associate Vice President and Chief Financial Officer of the University of Texas
M.D. Anderson Cancer Center in Houston, TX.
Kolosky had executive experience through MCC’s rapid growth and worked with leadership and
the board to ensure a steady bottom line. With his experience from other institutions, Kolosky brought
significant healthcare, specifically cancer care, experience to the cancer center. In his many roles at
MCC, he had the opportunity to interact with founder on financial and operational issues.
The words I always use about Lee is that he's a force of nature. When people said that we didn't
need a cancer center, Lee persisted and achieved it.
I think that Lee's leadership…he brought on a good, smart board in the early days. Lee would say
this himself, I think, that he didn't know everything, but he knew other people who knew a lot of
things that would really help. I think those board members really put the foundation in for the
future success of the cancer center. Lee contributes mightily to the mission and growth of the
cancer center. Even though it's probably infinitely larger than even he thought {it} could be at
that time.
When I walk the hallways and sometimes people will see Mr. Moffitt, the first thing is they'll be
amazed that he's here, and he's around, and he's active in there, because so many places that
are named after somebody, the person is no longer around.
Yvette Tremonti, CPA, MBA
Yvette Tremonti served as EVP/Chief Financial & Administration Officer. She joined MCC in 1996
and has served in numerous positions including Vice President of Human Resources. Prior to joining
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MCC, she worked for Earnst & Young. Tremonti’s experience overseeing HR at MCC gave her a front row
seat to the type of people leadership and the board recruited to the center. Adopting the vision and
forward-thinking mindset of the founder, the board and executive leadership, Tremonti helped to land
some of the best and brightest scientists, physicians and staff that would impact MCC’s success.
The vision of one person is how it started and I think that person's vision has been so big that his
involvement, Mr. Moffitt, such that he is never satisfied.
Lee is definitely a visionary. I think to have this place be what it is today, when it was a vision
and not even out of the ground a little 30 years ago is amazing. So, I definitely think he is a
visionary, I think he is strong-willed and because of that has just continued to push us as an
organization to just continue to be better, so that we can be a resource for the organization and
I think he is passionate about this organization and what it stands for and what it does as far as
providing cutting edge care for patients. And I think he is a tireless advocate for the
organization, as well.
The Hon. William (Will) W. Weatherford
One final perspective from a former elected official who came to understand and appreciate the
focus on cancer research and care as well as the mission of MCC, “…to contribute to the prevention and
cure of cancer.” Former Speaker of the Florida House of Representatives, Will Weatherford (R-Wesley
Chapel) became a warrior for MCC. Weatherford not only represented a geographical area near MCC,
but his family had also been touched by cancer, a brother died at a very young age from a brain tumor in
1995.
During his tenure as Speaker of the House (at the time, the youngest serving Speaker in the
country at 33) Weatherford was a bright, energetic legislator with a fondness for innovative and
entrepreneurial thought. He understood that MCC was a special place, not only in his region but well
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beyond. He visited the center numerous times and formed relationships with the CEOs (Dalton then List)
and other senior executives. He had known the founder for a number of years, beginning when
Weatherford was a staff member in the Florida House. True to form, Moffitt had talked with
Weatherford often about the cancer center, its growth, innovation and its needs, specifically capital for
building and expanding to meet patient demand. Weatherford got it. Throughout his tenure,
Weatherford helped to secure nearly $400 million in cigarette tax revenue for MCC’s expansion needs.
That revenue source, paid annually over a period of time, allowed MCC to bond to build a new
outpatient facility. Weatherford was a believer and appreciated the way MCC focused on cancer and
attracted talent and grant dollars into Florida.
If you grow up in Tampa Bay, which I did, I moved here when I was, I guess it was 1987. From a
timeline standpoint, pretty close to the infancy and the beginning and the genesis of the Moffitt
Cancer Center. If you grow up here, it's kind of hard not to know what Moffitt Cancer Center is.
Some of that's because just the brand is recognizable. The other part of it is, typically you know
someone who has had cancer and unfortunately everybody has experienced it in some way,
shape or form with family member or friend. So just knowing that Florida and more specifically,
Tampa had a cancer center, I knew people who had been treated there and just living in this
community [I] had driven by the campus a few times and knew it was there.
Didn't know who Lee Moffitt was, didn't know the history behind it really until I got involved in
the political process. It kind of morphed and my first job in politics was working for Allan Bense
(R-Panama City) who was the Speaker of the House for 2004-2006. I was his legislative aide and
you are there to kind of field a lot of meetings, some of which you're sitting in with the Speaker
of the House, some of which you're just taking meetings that he can't attend. So Lee Moffitt, as
he does, darkened the hallways of many people's doors in Tallahassee, kind of showed up
unannounced. As the former Speaker, there is a long-standing tradition that you always make
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time for Speakers, but I believe Allen was on the floor of the House at the time and couldn't
come off the floor so somebody said, "Hey, could you go meet with Lee Moffitt?" And I said, "Is
that the Moffitt of the Moffitt Cancer Center in Tampa?" And they said, "Yes". So I said, "Sure,
I'd be honored to do that." So I walked out and, "Hey, Mr. Speaker."
And we came in and he was working on the budget for Moffitt Cancer Center and wanted to talk
about some of the issues that were facing it that year and I just sat there for the first time and
listened to Lee tell me what was going on at the Cancer Center, what they were doing and really,
for the first time, getting an understanding of the history. He actually took the time to walk me
through. He said, "Hey, do you know much about us?" I said, "No." Where you from? I said
Tampa. He said, "Well, you should know about the history of the Moffitt Cancer Center." And he
walked me through the history of the cancer center. And that was my first... that was a long way
of saying that was my first knowledge of the Cancer Center in its truest form and really to
appreciate what had happened from my childhood to that point when I was 25 years old and
how this cancer center had grown to be such a preeminent research and treatment facility.
H. Lee is a person who was a political mentor to me and a friend. His scrappy, never-say-die,
persevere, grit persona is throughout the DNA of that institution and it would not be what it is
today if it wasn't for that grit. I think that Lee was the catalyst for it but because it is in the DNA,
everybody who is there has it to a certain extent. You kind of sense it when you talk to the
employees. Doesn't matter if it's government relations, or you are talking to the CEO, no matter
who I talk to, you get a sense of purpose and a sense of grit with the employees and the leaders
at Moffitt. I think that started with H. Lee and it has worked its way all the way up.
Weatherford, like others, understood and appreciated that the founder could have a disarming
demeanor in social settings. However, when focused on a particular outcome, central to the center’s
future, Moffitt was all business and didn’t particularly tread lightly. Referring to his leadership style:
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It's not always soft. Lee will never be remembered for perfect bedside manner or his softspokenness or being a shrinking violet. This is a guy that, if he has something on his mind, and
he feels really strongly about it, you are going to hear it. And it doesn't matter if you are the
governor of the state of Florida, it doesn't matter if you are Speaker of the House, it doesn't
matter who you are, he is going to tell you what he thinks. And he's going to fight. I can't
remember how many times I would tell Lee over the years, "Lee, it's just not going to work this
year. Let it go." And then he would come back two days later and pulled something out of the
ditch in some committee in the Senate and it was back on again.
It was always amazing to me that he had that personality to not cave. I was too young when he
was Speaker of the House. I wish I could have seen it. I have read about his tenure. It was a very
successful tenure because he worked well with his counterpart. His ability to lead through sheer
force. He's smart, he's strategic, he thinks things through, he's playing the angles, he's
triangulating, but he just won't go away.
There is something to be said for a guy that just won't go away. It's like a Rocky Balboa
mentality. You just keep punching me in the face but I am going to keep getting back up and
eventually, you are going to wear out. Speaker Moffitt has an ability to just keep fighting. When
everybody else is tired, when everybody else is punched out, his leadership style, it's like he
makes up for whatever shortcomings you may think of or come up with {of} his and there aren't
many, he makes up for all of them with just his grit, his desire, his unwillingness to relent and I
think that is a very rare trait in today's world and in politics. That's what makes him great.
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CHAPTER 5: TRANSFORMATIONAL EVENTS

Introduction: Transformational Events
Moffitt Cancer Center (MCC) began as a statutorily-designated direct-support organization
(DSO) to the University of South Florida (USF). The Florida Legislature first appropriated start-up funds
for the proposed hospital in 1981, and in 1986 MCC began serving patients. In 2018, MCC was the only
National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC) based in Florida,
providing interdisciplinary care to annually treat more than 64,000 patients from all 50 states in the U.S.
and more than 130 countries, and employing more than 6,100 faculty and staff.

Figure 3. Depiction of Four Transformational Events

Since its inception, numerous leadership figures and decisions influenced MCC’s culture, growth
and success. Chapter 5 digests and interprets the interviews to identify their commonalities (and in
some cases differences) with which to make sense of MCC’s evolution. This chapter begins with a short
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case study to set the stage. Next, four specific events are addressed: 1) 1990 Legislation, 2)
Interdisciplinary Care, 3) CCC and 4) Moving Faculty to MCC. These are events that the interviews
indicated re-directed and/or transformed MCC in material and often unexpected ways (see Figure 3).
A Brief Case Study
Monday, April 16, 1990 was a spring day in Tampa, Florida and the H. Lee Moffitt Cancer Center
and Research Institute Board of Directors meeting was scheduled at 9:00 AM. Springtime in Florida also
meant that the Florida legislature was in session in Tallahassee, FL. During the 1990’s, the legislature
normally conducted its annual legislative session from the first Tuesday after the first Monday in March
for a period of sixty days, concluding near or in early May.
H. Lee Moffitt (Moffitt/the founder), the founder of Moffitt Cancer Center (MCC), served on the
institution’s Board of Directors. Moffitt was a member of the Florida House of Representatives from
1974 through 1984, ascending to the position of Speaker of the House during his final two years in the
legislature. It was during his time leading up to and serving as speaker that the legislature passed
legislation creating a cancer center, codified in state statute, to serve the citizens of Florida. Originally
called University of South Florida Cancer and Chronic Diseases Research and Treatment Center, Inc., the
center was designated in statute as a direct-support organization (DSO) as defined in chapter 240.299 of
Florida Statute. At that time, MCC had minimal control over its growth, direction and governance. The
original structure mandated that the president of the University of South Florida (USF) and the chairman
of the Board of Regents (later the Board of Governors), or designee, serve on the board, and reporting
requirements were structured through the university.
Since MCC opened its doors and served its first patient in October of 1986, patient demand
grew with the state’s accelerating population. The internal leaders and the founder knew that in order
to achieve the original vision, to serve the cancer needs of the state, the governing structure needed to
59

change. MCC was actively recruiting a center director who would lead the young institution,
establishing a significant research operation and working toward the NCI designation as a Designated
Cancer Center, ultimately seeking designation as a Comprehensive Cancer Center (CCC), the NCI’s
highest designation for cancer centers. The process of recruiting a nationally-recognized center director
proved extremely difficult, as the duties and authority of said position were not clearly defined and were
potentially hindered by the university’s reporting structure.
Moffitt worked with local legislators to develop legislation outlining, in statute, the duties,
responsibilities and authority of the center director position. House Bill 2899 (HB 2899) was filed by Rep.
James Hargrett (D-Tampa) and Senate Bill 1498 (SB 1498) was introduced by Senator John Grant (RTampa). The proposed legislation designed a new structure that would make MCC a self-governing
institution and shift power away from USF.
Tensions were high. The faculty submitted a letter in opposition to the legislation but MCC’s
founder and others pressed forward. A board vote on proceeding with the legislation was on the agenda
for the morning of April 16th. According to the minutes, eight members of the board were present,
including Moffitt (likely via phone). Six members were absent. After a short meeting approving previous
minutes and agenda items, it was moved and seconded to adjourn to executive session at 9:15 AM. In
executive session, a vote to adopt revised Moxley Principles and Policies passed 5 to 1, with H. Lee
Moffitt abstaining.
The minutes simply stated, “After discussion, the flowing motion was proffered.” Motion: “Mr.
Speer moved to recommend the passage of House Bill 2899 related to the governance of Moffitt Cancer
Center: Mr. Smith seconded the motion. The motion failed with four dissenting votes and three in
favor.” The university had won a battle.
What would H. Lee Moffitt do now? The former Speaker of the House and founder of the
institution was stifled, prohibited by a vote of the board from pursuing the legislation that he knew
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would set MCC on a path of self-governance, independence and growth. His board had spoken; he was
on the losing end and it was over for that legislative session…or was it?
Setting the Course: People and Decisions
The research conducted for this project centered on twenty-one interviews with people
involved with the evolution, growth and success of MCC’s first three decades. Interviewee bios are
included in Appendix C. Chapter 4 illustrated the personal and professional traits of the founder, H. Lee
Moffitt and the institutional history; creation, early challenges, growth, space constraints and adoption
and adherence to MCC’s mission. He served as an inspiration throughout the organization’s history. This
chapter focuses on the findings regarding the transformational events that set MCC on a successful
trajectory based on influential leadership and landmark decisions. While it was at different times that
leaders served and that decisions were adopted, all were interrelated and committed to achieving the
institution’s mission “…to contribute to the prevention and cure of cancer.”
People
Leaders at the executive and board levels were instrumental contributors to the advancement
of MCC. The visionary leadership attributes of MCC chief executive officers (CEO) and board chairs not
only moved the institution towards growth and success but also developed a mission-driven
organizational culture that remained a fundamental part of MCC’s DNA. While a countless number of
people helped to advance MCC over the years, the innovation and impact of certain leaders were
notably recognized through the interview process. These groups, CEOs and board chairs, exhibited the
dynamic visionary leadership that contributed to vital actions at key junctures and made MCC the
mission-driven institution it became. The imprint that CEOs and board chairs left on MCC helped to set
the organization on its path to be a highly-regarded institution of transformational change.
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Decisions
The interview data collected for this research showed that decisions made regarding four
transformational events had a great impact on MCC’s first 30 years. Each decision, adopted by the board
and/or leadership, led to a transformative event that set MCC on a course that has positively impacted
patient treatment, research in the fight against cancer, reputation and the business bottom line. The
first event was the pursuit of legislation to enable independent governance over the business, medical
care, research and education endeavors of the institution. The second was the creation of an innovative
model of interdisciplinary care, whereby department organization centered on disease site, not
individualized departments based on training and practice expertise. The third event was the decision to
design and achieve CCC status, the highest-ranking award by the NCI. The fourth was resolving to bring
the physicians and researchers, faculty, in house and forming the Moffitt Medical Group (MMG) and
Moffitt Research Institute (MRI). Chapter 6 later describes that these transformative events were not all
explicitly noted by interview respondents, but rather were identified as important decisions that
transpired into transformational events which ultimately became part of the MCC legacy and propelled
the cancer center forward based on several common themes observed across interviews.
Leaders, Culture and Imprinted DNA
Leadership personalities, descriptions and decisions would be incomplete if not incorporated
with the types of individuals chosen to run the organization. The interview process revealed certain
common attributes of leadership inherent in the institutional prototype. MCC CEOs and board chairs
were instrumental actors in the organization’s evolution. They led the organization in the right direction
at the right time, and showed dedication to advancing the beliefs, values and principles representative
of MCC’s mission-driven culture.
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The three CEOs, Ruckdeschel, Dalton and List had individual leadership styles but a similar
mentality as to moving the institution forward: innovation, commitment, cause and mission. Each
served crucial roles at critical times in MCC’s evolution. An aviation analogy: prior to Ruckdeschel’s
hiring under the new governance structure, Nick Porter taxied the plane down the runway, Ruckdeschel
took it off and ascended to 10,000 feet. Taking the helm, Dalton spirited the plane to a cruising altitude
of 30,000 feet and List flew it across the country. Each leader made progress in his time, having left
indelible fingerprints on the progression of institutional growth and success.
The chairs of the board, in similar fashion, were driven by mission and they led not with iron
fists, but by appreciation of the team of brilliant innovators who surrounded them. To quote Apple
founder, Steve Jobs, “It makes no sense to hire smart people and then tell them what to do. We hire
smart people so they can tell us what to do.” The board’s responsibility was to enable a similar mindset
at MCC. The board chose leaders who unlocked entrepreneurial spirit and innovative corporate,
business and care structure. In addition, the board gave executive leadership freedom to hire likeminded individuals. The board sought not to manage daily operations but to empower those they chose
to lead. While the board was responsible for advising, setting certain goals and making sure the
institution was fiscally stable, the leadership choices reflected the passion and commitment initially
instilled by the founder.
Nick Porter, former EVP and COO spent nearly two decades at MCC on staff, and later served on
the MCC Hospital Board. Porter was an institutional icon who observed board and executive leadership
challenges and successes for nearly 20 years.
Ruckdeschel clearly played that role early on because of his just unbelievable belief in himself.
I've never met anybody closer to Trump than Ruckdeschel. Then you get to Bill Dalton who was
totally driven by science and excellence in science, setting that standard one step higher every
time he could possibly do it. Then an individual like Alan List who is like a concert pianist, totally
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accomplished in everything that he can do and he is the kind of people that others can look up
to.
Then you have the leadership that came at the chairman of the board level, Ted Couch, who's
the salt of the earth. Even (Former USF president) Frank Borkowski, you know, bought a certain
amount. (Former USF president) Betty Castor and others. Frank and Betty were part of the
university system and the University of South Florida. Ted Couch wasn't, Bob Rothman, Connie
Mack, and Tim Adams (were not). These are all individuals who just are great leaders…are
people who are totally dedicated to making sure that the place does what it's supposed to do
and that makes it a success. Then you got Lee Moffitt who's on every single phone call, every
single time.
Porter was the embodiment of instilled mission and regularly spoke of MCC’s phenotype.
It spent a long time building a culture that was, the way I would describe it is, years ago, you
would hear the story of the individual at NASA sweeping the loading dock and the reporter
asked that person, "What are you doing," and that individual said, "I'm putting a man on the
moon." Well what we tried to do at Moffitt was to have every employee that was walking
around say, even though I'm pushing a broom, I'm here to cure cancer. That was the focus and
that's what it was all about.
You are constantly looking for the right DNA. Not that every person looks alike, thinks alike, or
talks alike, but just what drives them is what the place is all about. It was a concerted effort both
on the administrative side, the clinical side and the science side to do that. The scientists were
picked for their expertise, there was a conscious effort to make sure that these people are good
people.
It's kind of like the way NASA was built, it was the way Southwest was built earlier on.
Companies took the time to make sure that they hired the right people who had the right vision
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and wanted to be working together. It's like any set of books that are written. In any given time
people can play a major role in seeing the success of a cancer center happen.
Very few cancer centers think that way, act that way. Cancer researchers, for the most part, are
very individualistic. They are not interested in sharing data. They're not interested in
collaborating. They're interested in being first author on a paper and being the one who stands
up and announces the new insight into whatever it is. Basic science or clinical investigation on
their own. Moffitt is exactly the opposite, where it is a group of people trying to get to an end.
The role of leadership changes with the leader and the leader's philosophy. It's adopting a focus
and a culture of servant leadership and allowing that servant leadership to spread throughout
the organization with the understanding of establishing a very strong mission orientation, very
strong values and you have to support those values and live those values. Make sure that people
believe in those things, and they believe in them the most when they see the leader doing that
stuff. The leader absolutely believes in them.
L. David de la Parte, Esq. served as MCC’s General Counsel externally and then as an employee
for nearly 30 years. Working from both external and internal perspectives, de la Parte observed nearly
every success and every challenge. His close association and mentorship under the founder ingrained in
him the adoption and adherence to the culture set forth by Moffitt and carried on by early adopters of
MCC’s mission.
I think you can think about organizations like Microsoft or Google or Apple or Ford Motor
company and these founders of these institutions, these large, successful historic times
institutions, businesses, companies, enterprises. There's some very good decisions, choices have
been made over the years by Lee and others. This place, over 30 years, has had at least a half a
dozen inflection points where our trajectory could've ended up being flat or downward versus
up. And the selection by the board of some key management, key executives, key scientific
65

leaders have just been critical. And those inflection points again being inflection points to
continue a growth and success versus stagnation or decline.
I'll throw out some names early on, Jack Ruckdeschel, really our first center director. The kind of
talents that Jack had, his boldness, his passion and compassion for patients. His fearlessness, his
leadership. Bill Dalton, a different CEO, a different person with talents but the right person, the
right CEO for the time to lead us, to lead this place from a management standpoint, from an
executive standpoint, a scientific standpoint. And now Alan List, just some crucial decisions that
the board has made collectively.
A lot of the culture that we have here certainly from an employee/employer standpoint, from a
patient standpoint, from a management team standpoint is Nick. Nick Porter's transparency, his
honesty, his sponsorship, mentorship, nurturing of employees, and of his reports.
There are hundreds of people that have been in leadership, or not in leadership, that somebody
has chosen well. On the board's side, some early recruits that Lee brought to the board and
brought to the trailblazing that was done in early years in the battles, the fights, political and
otherwise.
Senator Mack was appointed board chair while Ruckdeschel was the CEO and Center Director.
Mack played a vital role in recruiting Dalton back to MCC, after a brief stint as dean of the University of
Arizona Medical School, to serve as President, CEO and Center Director. Mack served on the board into
List’s tenure as well. He had keen insight into the types of leaders necessary for key periods of growth.
Jack Ruckdeschel was exactly the right person for Moffitt at the time he came. His job was to
make sure we received the designation of a national comprehensive cancer institute. He did
that. And as I've said about others before, like with (former) Speaker (of the U.S. House of
Representatives) Newt Gingrich. Newt is the kind of guy that if the objective was to take the hill,
he came up with the strategy or the tactics to take the hill.
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Bill Dalton, was center director for probably 10, 12 years. I think you would have to give Bill a
tremendous amount of credit for what has happened at the Moffitt Cancer Center. Alan List and
Tom Sellers following on. These are really top flight leaders.
You had leadership at every level. You had the board level, the inspiration from Lee Moffitt who
created the cancer center, and the leaders at the corporate level. Clearly, the leadership team
that Moffitt (MCC) has been able to develop over the years is a major component of the success
that has taken place.
Another long-term participant was Adams. His lengthy tenure on the board, subsequently as
chair, came with staunch adherence to the code that MCC leadership lived by. He understood the
decisions that charted MCC’s path and was committed to the formula of ingenuity and mission while
giving executives, physicians and researchers the space to innovate, create and question existing norms,
traits learned from his mentor.
It all starts with Lee obviously, and the vision and mission. Particularly the vision and mission,
which sprung from Lee. Lee had a lot to do with recruiting of leadership both on the boards and
management that agree with the vision and mission. Recruiting, keeping the institution focused
on mission. A lot of founders, I think, would be unwilling to cede any control at all to anybody. I
really think Lee did a wonderful job of saying, "Here's the kind of talent I need to bring in to
push this place along."
All of our CEOs have done something unique. I think they've all been really well suited for our
point in time when we were where we were. The first CEO (Ruckdeschel) was a very aggressive
person. It really took that to push us forward, to get the original NCI designation. He may not
have been such a good post-person, and so Dr. Dalton came in and had the big vision. Now we
have Alan with a ton of credibility and probably a much better ability to run an organization as
big as this. Because he's got to cede control.
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On the board side, you can't leave out people like Ted Couch who, to this day, continues to do
the hardest lifting we've got here in terms of board work. So there were some giants on those
original boards, and we just need to keep the talent coming.
An entrepreneur, business and philanthropic leader, Droste understood how founders and
leaders can leave an indelible mark on an institution.
I see mirrors of other businesses I'm in where the founders are sometimes some of the hardest
people to deal with, because they do have their vision and its tenacity that got them where they
are. I see that all the time with Lee that he is compassionate, caring, genuine, social, personable.
It's fun to dream about developing this thing that's going to fight cancer, but when the mission is
so substantial, you're not walking into a restaurant where you want to make sure your ticket
times are down and everybody gets a good meal, there’re people going in there, and those four
valet stations are packed, early in the morning to late at night, every one of them needing help
and hope. The patients, above all, really set a tone and an urgency whether it's an appointment
or a lab or anything. Ruckdeschel was a scary guy but I think, at that time, a rebel once in a while
knocks a few doors down. But a lot of organizations at that stage need that or you sit around
and plan all the time.
I was amazed with all the chairman. Bob Rothman had the temperament yet the business
acumen. Allen List is a fantastic CEO as was Bill Dalton. They all have tremendous skill sets and I
think that that's a credit to the quality of the talent that the cream does rise to the top because
it's already such a highly intellectual personable type of management group. If you rise in that
group, you've got that blend that's so fascinating. You can tell that there's a sincereness there of
everyone, but a commonality too that's not in every organization.
Having served as CEO, List had responsibilities of running the day-to-day operations, coupled
with reporting responsibility to the board of directors. Following other trailblazers, List recognized and
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understood the complexities of the organization. As a results-oriented physician, List appreciated the
institutional culture and the committed people around him, starting with the founder.
Lee is the top and he's the one that made it a reality. But Jack Ruckdeschel and Jack Pledger, in
that first 10 years or so, they were critical, they moved mountains, they created. They got some
of the best talent here and provided the support and laboratory space and clinic space that was
needed. That, I think, was groundbreaking so I'm very impressed with what they were able to
accomplish.
Then Bill (Dalton) was here and CEO 10 years. I think when Bill took over, I'm not sure of the
size, I don't know if it was 1,800 employees or in the 2,000 range, but it's grown dramatically
ever since to over 6,000. The other people that are key in all of this, Ted Couch is critical. Bill
Dalton brought a new vision for cancer care. Ted Couch has been quietly behind the scenes not
only supporting us financially with endowed shares and in other ways as well but has always
been there as one of the key board leaders. Even to this day he's influencing people, he's
incredibly effective in influencing other board members, and they all respect him. He's a quietly
honest individual and with that respect he can obviously influence others. He's been critical. Any
of our board chairs have been very important throughout the years. Connie Mack, after Ted, and
remains very influential in helping us. He's been critical as well.
Bob Rothman has been. He served for eight years and he's been incredibly helpful, he's giving a
lot of money but also helped us with connections and remains very active. Tim (Adams) has just
been in his role for the last year and a half or two years, but I think our board has now evolved
so that it's contributing in new ways. We have a much more diverse board as it relates to real
world business experience, particularly in biotech and investment, which is something that we
really needed.
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C. Douglas Letson, M.D., Physician-In-Chief and EVP, began his career at MCC in 1992. Dr. Letson
worked with each of the CEOs and was instrumental in creating an environment enticing physicians
recruited by MCC. He specifically understood and appreciated the roles of MCC leadership and specific
junctures.
I think that there's not one accomplishment that set us off on that course. I think it was a
progression over time. I think certain things had to occur at certain time periods for us to
continue to move forward, to get to the level where we are today. We needed different
leadership at different times, with different styles. I think that if Alan List would have started in
1990 when Ruckdeschel started, he would not have been able to move that needle to get us off
the ground because he didn't have that strong personality, and that leadership approach to take
the risks and chances that Ruckdeschel did. Alan is a very thoughtful individual, that is not a risk
taker, and that he has to have data for every decision that's made. Early on, we didn't have to
have that. You needed to have a risk taker, and so I think having Ruckdeschel early on was
important to move us off that local county approach.
Then we needed to have somebody that really began to get the research involved. We've been
so successful because of innovation, and Ruckdeschel was an operation guy. He was not an
innovator. Although he started us with research and then began the campaign to the
comprehensive cancer center, that was the leadership of Jack Pledger and the research, and
that he was able to install the research. But Ruckdeschel didn't have the vision of the research
and those novel technologies. That's what really set us apart when Bill Dalton came in, that he
was able to be the visionary, and had this great vision. In fact, we were leading the country in
some of this vision on how we were going change cancer care, but he couldn't operationalize it,
and it was really before it's time.
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All of that was important, because the leadership of the board, between H. Lee Moffitt and the
other institutional board leaders, were able to see what the institution needed to get to that
next level. It was the institutional board that realized a change needed to happen every so
often. I don't think that many institutions would be bold enough to do that. When you've gone
from nothing to a high level, changing that personnel that's a hard decision. That is something
that only a very strong board like we've had here is able to see through all that and be able to
make those changes.
1990 Legislative Initiative
The first transformative event, the 1990 legislative initiative, is explained in greater detail than
the others given that it was somewhat of a starting point that allowed for subsequent key decisions that
transformed MCC. This legislation enabled independent governance over the business, medical care,
research and education endeavors of the institution. Had this event not occurred, the course of MCC’s
growth would likely have been much different.
The Legislative Process
The Florida Constitution mandates the structure of state government, including the design and
length of each year’s annual legislative session. (A Constitutional Revision Commission is appointed
every 20 years to review the state’s constitution and articles, make recommendations for change and
write amendments that must be approved by the voters in the November elections.) As of 2018, the
governing structure of the state (as defined in Article III of the Florida Constitution, contained in
Appendix D) reflected the federal governing makeup, including the separation of powers: a bicameral
legislature, House and Senate, an Executive Branch led by the Governor and a Supreme Court.
The House of Representatives consisted of 120 members representing districts; serving two-year
terms. The Senate was comprised of 40 members representing distinct districts and serving four-year
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terms. (In 1992, the legislature passed term limits in Florida, limiting House members to four
consecutive terms of two years each and Senators to two consecutive terms of four years each. The
provision did allow for members to seek office in the other chamber or sit out a term and the process
would renew.)
The legislature was designed as an elective body of citizen legislators who served each year
during the legislative session, then returned to their districts and jobs/businesses for the remainder of
the year. Additionally, by design, legislators received limited compensation for their service. (In 2018
compensation was less than $30,000 annually.)
Article III of the constitution called for a 60-day annual legislative session in the state capital,
Tallahassee, FL. Section 3. (b) states that the session will begin the first Tuesday after the first Monday
in March in odd-numbered years, and the same rule applied for even numbered years unless the
legislature passes legislation stating otherwise (The Florida Legislature, Florida Constitution, Article III).
While each legislative session is limited to 60 days, unless extension or a special session is required,
leaders of each chamber, Speaker of the House and the Senate President, designate “Committee
Weeks” for purposes of organizing committees and subcommittees, hearing proposed legislation (bills)
in those committees and advancing policy and budget initiatives prior to the beginning of session. The
number of weeks designated for committees were the discretion of the presiding officer. While normally
the House and Senate would meet in the same weeks, that was not always the case nor was that
required by any statute. In accordance with the constitution, the legislature must meet 14 days after
election for an organizational session wherein the bodies elect their presiding officers and prepare for
upcoming committee weeks and the legislative session. In an election year, this occurred two weeks
after the November election. Committee weeks would follow as prescribed by the Speaker and/or the
President. Often, five to seven weeks were designated for committee meetings prior to the annual
session.
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That succinct description of the process was necessary for the purposes of understanding that
the legislative process was actually longer than the simple 60-day legislative session as prescribed by the
constitution.
Moffitt traveled to Tallahassee for nearly every committee week and the legislative session. He
knew what had to be done in order to pass his legislative initiative. In his opinion, it was vital to the
growth, independence and success of MCC.
Each chamber of the legislature designed their own committee structure and appointed
members to serve on those committees. Committees appointed chairs who ran the committees, set
agendas and calendared bills to be heard by the committee. Passing nearly any legislative initiative
required a tremendous amount of work. Committee membership varied in size, depending on
jurisdiction. Committees and subcommittees could range from a few members on a narrowly-focused
policy committee to the much larger budget committee. Each member, representing one vote, was
equally important as the next. Staff too played a prominent role in the process.
Passing of a Bill
In order to successfully pass a bill in the legislative process, numerous components had to be
meticulously executed. First, legislation had to be designed and written in adherence to House and
Senate rules. The proposed content had to be clearly defined and linked to the proper statues, or
propose a new statute, and serve a single subject purpose. Each individual bill required a sponsor, who
submitted the proposal to bill drafting where it was refined/written to conform to the chamber’s rules.
Once the bill was drafted and accepted by the sponsor, leadership referred the bill to a committee or
series of committees. (The more committees a bill was assigned to, the more difficult is was to pass. The
lobbyist terminology for multiple committee assignments was “putting more ‘love’ on the bill,” which
was not advantageous.) Once a bill was referred to committee(s), staff conducted a bill analysis. The
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analysis would determine whether the bill met certain criteria, including any fiscal impact to the state
budget (cost to the state) and/or policy initiatives that were either in line with or counter to the
chamber’s ideology at the time. Further, the analysis would describe, in detail, what the specific piece of
legislation intended to do. The staff analysis could enhance the bill’s chance of passage or negatively
impact it.
After committee referrals and staff analysis, the bill could be placed on the agenda of the first
committee of referral. In any legislative session, hundreds or thousands of bills were filed annually. (As
of 2018, House members were limited to six bills each in any given session while there was no limit for
senators. In the 1990’s there was no such limitation in the House.) With so many proposed changes to
Florida law annually, it was impossible to hear every bill in committee, let alone pass them.
The passage of legislation was a delicate balance of both internal and external pressure. In his
stump speeches as a United States Senator, Chair Emeritus of the MCC Board of Directors, Connie Mack,
told his audiences that “government is not a neutral entity” and responded to influences from inside
and outside the elective body. In essence, Newton’s theory of motion simplified; an object in motion will
remain in motion until acted on by an equal and opposite force. Legislation, by design, was action. That
action was supported or opposed depending on policy, ideology, fiscal restraint or any other influences
such as business competition.
Lobbyists acted as an external force within the legislative process, representing businesses
and/or individuals to impact the passage or defeat of certain legislative initiatives. Over the years,
lobbyists had developed a reputation as trying to influence, or buy through political donations, elected
official support. As with other professions, such as law, medicine and business, some of the reputation
was warranted by the “bad apples” who may have stepped outside the bounds of decency. However,
the lobbying community at the state and federal government levels had become a part of the legislative
process, representing their client interests and influencing by regular participation in political and
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legislative activities. There was an old adage the “government can cure you or kill you,” and lobbyists
worked to make sure the latter was not the case.
Moffitt, having transitioned from lawmaker to founding board member of MCC and lobbyist,
knew how the system worked. While Moffitt never received compensation from MCC, and therefore
was not required to register with the state as a lobbyist for the center, he was MCC’s most prominent,
present and focused influencer. Moffitt, at the time, was a lawyer-lobbyist representing paying clients
before the legislature and the Executive Branch. His passion and drive for the center he created was
always at the forefront of his mind, and he spent a significant portion of his time working on MCC issues,
including a very important piece of legislation in the 1990 session.
Once placed on a committee agenda, the bill was heard before the committee of reference,
discussed, debated and put to a vote. If the sponsor and lobbying entity did their job(s) prior to the
hearing, the discussion was minimal and the vote was successful. Lengthy debate and numerous
questions could place a cloud over the bill and diminish the likeliness of passage. The key to good
lobbying was knowing the vote count prior to the committee hearing, not having to present before the
committee and engineering a smooth process. While a bill was before a committee, it was also available,
vulnerable, to the amendatory process. Once a statute was “opened” by a bill, any member could offer
an amendment that might have been contrary to the initial intent of the bill, making passage difficult or
negating the original purpose. Awareness of pending amendment proposals and developing strategies
to contend or counter them was equally as important as the early-stage education and support
requests.
Once a bill passed its initial committee, it would move forward to the next committee of
reference where the same process would repeat. The higher up the committee chain, the more rigorous
the process. As the session progressed, timing was limited to get bills heard in committee. Additionally,
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the higher committees were tasked with passing necessary legislation and budget allocations in order to
end the session within the 60-day prescribed time.
At the end of committee meetings, there were always bills that did not make it through the
process. Even if bills had support and numerous co-sponsors, there was not enough time or support to
pass everything, even worthy legislation. There was a provision that a bill could be “withdrawn from
committees of reference” and brought to the floor for debate and vote if it had not worked its way
through the committee structure. That task, while not impossible, required additional tactical expertise
and, quite often, agreement from the presiding officer.
Regardless of how the bill passed through committees and the floor in one chamber, it had to be
agreed upon by the other. Bills were constructed by the bill drafting staff in each chamber, so while the
House and Senate versions of the bill were similar, they were not always identical. Once a bill passed
one chamber, it was “placed in messages” to the other, meaning it was available for consideration in the
second chamber. If the bill was placed on the calendar, it was brought up for discussion, potential
amendment, debate and passage. If the bill was amended in the second chamber, it was sent back to
the first for additional consideration. That back-and-forth process was dangerous in that, in the final
days of session, the chaotic pace could lead to the bill’s demise due to disagreement between the two
bodies. If the second chamber agreed on final passage of the bill, after certain parliamentary procedures
were followed to align the differing bills into one final version, the chamber would vote and pass the bill.
Once an identical bill passed the House and Senate, it was sent to the governor for approval.
The governor, within a specified period of time, had the right to approve the legislation and sign it into
law or to disapprove and veto the bill. Most bills had implementation dates in the legislation or specified
“upon becoming law.” Florida’s fiscal year was from July 1st through June 30th and a majority of
legislation passed became law on July 1st of the next fiscal year.
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The vast majority of bills were passed in the waning days of each year’s session. Therefore, the
governor did not receive the bills until the legislature had adjourned for the year. If the governor vetoed
a bill at that point, the sponsor and/or supporting entity would have to wait until the following year to
bring a new bill before the legislature. There was a provision for special sessions to deal with budgetary
or other matters wherein, if a vetoed bill was “within the call” of the special session, it could be brought
back up for an override vote of the governor’s veto.
A Defining Moment
Moffitt had served in the Florida House of Representatives, ultimately achieving the prominent
position of Speaker of the House and was an attorney. He knew the process. Additionally, as a staunch
advocate for MCC, Moffitt was focused on protecting and developing the institution. He and his allies on
the board had become concerned and frustrated with the connectivity to the university where the
cancer center resided. The university controlled the campus, had membership on the board, employed
the faculty and, in Moffitt’s mind, had a different set of priorities and a different perspective regarding
MCC’s position and future.
In its early days as a small hospital, MCC hired the Hospital Corporation of America (HCA) to
serve as the administrative structure; supplying a CEO, a Chief Financial Officer (CFO) and a COO. After
three years, MCC hired Nick Porter, EVP and COO at Johns Hopkins in Baltimore, MD, to serve as
Executive Director. Porter was charged with recruiting an internal, MCC-employed CEO. There were a
number of obstacles in that endeavor: the short time in existence, lack of reputation, space for
expansion and new programs and, a huge hindrance, the lack of defined authority that the new CEO
would have in running the center. The search ended in frustration while pursuing early possible
contenders.
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Moffitt had a vision for something far greater than a small cancer center on a university campus
in Tampa, FL. He wanted the center to serve as a resource for the state, a leading research institution
and a trusted and respected cancer facility for patients in Florida and beyond. He had an indelible
memory of his conversations with R. Lee Clark, former Director and Surgeon-in-Chief of M.D. Anderson
Cancer Center in Houston, TX.
R. Lee Clarke, years ago, told me of the mistakes he made at M.D. Anderson. He said that one
things that you have to do if you’re going to be a successful institution is that you have to
remove the shackles of the medical school. And the organization of medical schools is not
conducive to the concept of NCI comprehensive centers where the center director has the
control he needs to be able to run it.
If you’re looking at early on, the critical event in my mind … I’m a lawyer, what in the hell do I
know about cancer centers, hospitals, doctors all of this? … was when I formed a friendship with
R. Lee Clark at M.D. Anderson. He was a surgeon. He wrote the National Cancer Act for Richard
Nixon. He created M.D. Anderson which was 40 years ahead us. He had been down that path
before and out of his sheer generosity and kindness, he took me under his wing and he gave me
a roadmap that I strictly followed that helped, to a large extent, to get us to where we are
today. He truly was a visionary.
Clark told me that we needed to follow the NCI guidelines. We couldn't hire a center director
because of the fact that the center director had no power. The center director would have to go
by chance. The center director here at the cancer center would have to go to each one of the
department chairman and beg for a surgeon or a pathologist or whatever, and didn't have
control over the space, didn't have any control over the hiring, didn't have any control over the
money.
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Others in the founder’s inner circle shared his frustrations with the existing relationship with the
university. Moffitt knew he had to pass his bill to ensure a clear path forward for the institution he
created. The interview answers associated with defining decisions for MCC’s first three decades revealed
that self-governance was paramount. Interestingly, only a few respondents, including the the founder
and general counsel, referred to the 1990 legislation by name or title. Numerous people, however,
stated that MCC needed to create self-identity and control, or recalled legislative changes that led to
MCC’s later state of self-governance. Sen. Mack stated:
Somewhere along the line, someone told Lee how important it was for the institution to be
independent, free-standing, which allowed for decisions to be made and actions taken place in a
very short period of time. Very little bureaucracy.
MCC’s Center Director and EVP, Thomas A. Sellers, PhD, MPH, added:
One of the things that he learned from M.D. Anderson was you have to associate with a
university but don't be married into a single institution. So, M.D. Anderson will always be part of
the University of Texas system. We don't have that restriction and there was a time in our
history where that was very helpful in giving us a little more flexibility to achieve our mission. I
think that was probably the most important one.
The former Executive Director, retired COO and EVP Nick Porter, was involved with nearly every
decision in the early years and had his finger on the pulse of internal and university tensions. When
asked about MCC’s relationship with USF, Porter was not shy.
A little bit like in the 20 years ago with Ireland and Northern Ireland, nobody liked each other.
Well, let me put it this way, since the majority of the faculty were USF and the majority of the
board of directors were non-university related, the board of directors and the chief
administrative people were relatively steadfast Moffittites and the University of South Florida
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was, “Hey, this is our cancer center.” You know, “You people are were supposed to do what we
tell you to do, when are you going to figure that out?” Of course we never figured it out.
When asked about separating from the university Porter explained:
Part of it had to do with the requirements that the NCI had in place to become a comprehensive
cancer center. In order to do that, the center director had to show, in a very formal way, that
the institution they are involved with would give them the space, the money, you could hire
people, to accomplish certain goals. The University of South Florida at that time didn't get it.
They were not willing to make those kinds of guarantees or even begin talks around those
guarantees. So it became a much more viable way of thinking to think how could we, ourselves
empower the center director with those attributes and Lee Moffitt being a (former) legislator
said, well, I think we'll pass a law and we'll put in that law, all those things that are necessary to
allow a center director to have the authority to actually run a cancer center to the ends of
meeting the mission of curing cancer.
As the founder’s frustration grew, he recalled, once again, the advice that R. Lee Clark had
shared with him. In order to be a successful, stand-alone institution, MCC would need to alter existing
state statute.
Nobody wanted to come and be center director of a brand new, wet behind the ears, unproven
cancer center. So Clark said, "You got to do something." So I got the NCI guidelines. And I got my
manual typewriter. And I typed out the statute, the original statute, it's been changed several
times over the years, giving the center director the power to control the space.
Moffitt wrote the legislation and found two hometown legislators to sponsor it for him: Rep.
James Hargrett (D-Tampa) and Sen. John Grant (R-Tampa).
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The Bill(s)
The passage of HB 2899 and SB 1498 became the founder’s focus. It was the most significant
legislative initiative that MCC had pursued since its inception. It decoupled MCC from USF in many
governing, financial and managerial ways. It established, in statute, the powers of the center director
and reorganized the board structure that enabled MCC to begin self-governance in earnest. It was lofty
legislation. By no means would the path be simple. Little did the founder know at the time that the fight
at home was going to be more difficult than the legislative session in Tallahassee.
The proposed legislation made very specific and significant changes to the existing USF-MCC
relationship. The major initiatives in the bill(s) included wide-ranging topics. The bills specified that the
governing structure of the center would be vested in a board of directors, serving without
compensation, would include the president of USF, the chair of the Board of Regents (the precursor to
the Board of Governors that oversaw the state university structure later) or their designee, five
representatives of the university system and not more than fourteen nor less than ten persons who
were not medical doctors or state employees. It further specified that the directors would be elected by
majority vote of the Board of Regents, with the chairman elected by majority vote of the board. The
legislation removed direct control from the university.
The legislation added language that enabled other medical schools, not just USF, utilization of
the hospital resources. Thus, creating separation from sole linkage to USF.
A vital component created, in statute, the role and responsibilities of the center director, complying with
the standards the NCI prescribed to attain Designated Cancer Center and Comprehensive Cancer Center
(CCC) status. This provision gave the center director powers to establish mission-focused programs,
control of the budget and investment from private or public sources. It also granted control of the
facilities, space and equipment.
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Reporting responsibilities were adjusted to include the Chancellor of the Board of Regents, the
president of USF and the president of affiliated universities. Also included in the language, a
requirement that an annual report be submitted to the governor, cabinet and presiding officers of each
chamber of the legislature.
Three amendments to the legislation were filed to further clarify responsibilities. One included a
statement of intent of the legislature that MCC strive to become a CCC. Another amendment directed
the board to create a council of scientific advisors. The final amendment granted the center director the
authority to create departments, hire staff, conduct research, care for patients and engage in
educational training and activities. The last amendment also made staff members eligible for joint
appointments at affiliated institutions. The three amendments are included in Appendix E.
In summation, the legislation clearly defined roles and separated MCC from direct control of the
university. It was a bold and substantive initiative. Moffitt had his work cut out, the university was
clearly not in favor. As Moffitt explained:
The university was up in arms. Clint Brown was on the board of regents at the time. They went
to Clint. Clint came to me. Clint was one of my mentors at the time. And I said, "No." And he
went back and said, "Stubborn little bastard isn't going to move."
Conflict
The moment of truth was upon the founder and his friends at the April 16, 1990, MCC Board of
Directors meeting. The agenda stated that, after the approval of the previous minutes, a report from the
Professional Affairs Committee, the Board Self-Evaluation Summary and a presentation of the financials,
the next agenda item was Senate Bill 1498 and House Bill 2899. The agenda and minutes from this
meeting are included in Appendix F.
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According to the minutes of the meeting on April 16, 1990, eight board members attended,
including the Honorable H. Lee Moffitt. (It is likely, from the interview recollections of general counsel
David de la Parte, Esq., Moffitt attended via phone for a portion of the meeting. He recalls talking with
Moffitt on the phone after the meeting concluded, which de la Parte describes in a later section of this
paper.) Additionally, there were six members of the board absent from the meeting, including some of
Moffitt’s closest confidants.
Included on the board packet was a copy of the bill, a side-by-side analysis of the two bills, a
proposal extended to Jerome W. Yates, M.D., Associate Director for Clinical Affairs at Roswell Park
Memorial Institute in Buffalo, NY, whom MCC was attempting to recruit as center director, and his
subsequent withdrawal letter stating “the lack of strength in the medical school has proved a major
stumbling block in attracting program leaders…” (Likely included to press the point for passage of the
legislative initiative). A University of South Florida College of Medicine Faculty Statement document in
adamant opposition to the legislation was also included in the packet. These materials from the board
packet are included in Appendix F.
The statement document from the faculty identified the university’s opposition to supporting
the legislation. The faculty felt that a mutually interdependent relationship would avoid costly
replication of facilities, equipment, personnel and faculty.
Apparently, at present, there is a body of opinion that believes that the two institutions should
be totally separated with the only common feature being their location on the campus of the
University of South Florida. It would seem, too, that the individuals who propose such
separation are somehow disappointed in what has transpired to date. However, at no point
have we as a faculty been made aware of how or where we have failed. The proposed legislation
has created a great deal of confusion and anxiety among members of the faculty working at the
hospital as to their academic futures.
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The letter continued with a number of points regarding training programs, concern about two
specific departments (Radiology and Pathology), and potential loss of state investment. There was
linkage to the relationship that the Shands Hospital and University of Florida had and a comment that
the relationship should serve as a model for the relationship between MCC and USF. The letter
concluded:
We urge consideration of the points which we have set forth in this document. We protest
strongly that the proposed complete dissociation of the two institutions will profit no one, least
of all the people of the State of Florida and the quality of cancer care for them.
The letter was signed by the chair of the Department of Physiology, chair of Internal Medicine
and the chair of the Department of Radiology.
The minutes state that the meeting began at 9:00 AM, previous minutes were approved, the
Professional Affairs Committee received the semi-annual report on quality assurance and risk
management and that there was a subsequent motion and second to accept the report, which was
approved unanimously. The board addressed the board self-evaluation summary and the February
financials.
At 9:15 AM, Chairman Borkowski (USF president) “advised the board to adjourn to executive
session for discussions relative to the Search Committee and House Bill 2899.” There was a motion and a
second and the meeting ended at 9:15 AM. The minutes reflect that “the revised Moxley Principles and
Policies document was distributed” and discussed. After due motion and second, the principles were
adopted by a 5-1 vote. These principles and policies are shown in Appendix F.
The following is the entire entry that followed:
House Bill 2899
Motion

Adjournment

After discussion, the following motion was proffered.
Mr. Speer moved to recommend the passage of House Bill 2899 related to the
governance of Moffitt Cancer Center; Mr. Smith seconded the motion. The
motion failed with four dissenting votes and three in favor.
There being no further business, the meeting was adjourned at 10:20 a.m.
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There was no description about the discussion/debate which took place. It seems unlikely that
much discussion was necessary for the other item, adoption of the principles. More likely, the majority
of the 65 minutes was spent on the legislative initiative. A record of the final vote was not included in
the minutes. There was one person not attending who was a participant at the 9:00 AM meeting. April
16th would have meant the legislature was in regular session, and Moffitt was always in Tallahassee
during session. Therefore, Moffitt likely called in and hung up to go to a meeting or left the call as to not
be part of the debate and vote. A tie is a loss when it comes to legislation.
The most interesting fact of this discussion is that the board was debating a bill, an existing bill,
not an idea about a bill. Therefore, Moffitt had already done a lot of work on the bill. He had written a
bill, found sponsors in the House and Senate, and those bills had been drafted and assigned bill
numbers. A staff analysis of the House bill (Appendix E) had been released on April 9th and was so
positive it nearly compelled immediate support. If not for the staff signatures, one might assume the
founder wrote it himself. In short, it was already active legislation moving through the process.
Additionally, it was session, not a committee week, so the process had been going on for months.
Moffitt spent a lot of time educating elected officials on the history, purpose and mission of MCC. He
talked about the will of the legislature and how things worked, which he knew as well as anyone.
It is easy to surmise, from the comments of the leaders interviewed for this work, that the founder was
not about to give up on his vision for independence. His focus, tenacity, will and personality were not
about to let a little thing like a directive from his board interfere with his goal.
A few of the early MCC leaders shed light on the time and some of the events. de la Parte was a
strong advocate for the center and the founder. He recalled issues around a significant board meeting
during the 1990 legislative session.
It was at one of a number of inflection points in the cancer center’s maturity and evolution that
could have gone differently. Could have not been one in a series of inflection points that's led to
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an extraordinary successful enterprise and fruition of a dream. It could have led to the dream
not being realized and the cancer center being mediocre, not extraordinary. It was at a time
when the cancer was struggling to marshal the resources and the focus around cancer and
around growing the political enterprise and positioning ourselves for the research enterprise
and untangling ourselves from the larger University of South Florida; the larger health sciences
center and medical school. At that time, they employed all our physicians. We didn't have that
many scientists at that time, but they employed all our physicians. We employed the nurses and
the staff, but all the doctors, and to the extent that there were PAs (Physicians Assistants) were
employed by USF by the USF practice plan.
The doctors were spread across all the departments in the College of Medicine. The problem
with that is the traditional departments in the College of Medicine, they didn't have just cancer
to deal with, they weren't just training cancer docs. They weren't just treating cancer patients.
That, on top of the fact that their enterprise was being used to offset the cost of education and
the cost of the larger campus. The necessary focus wasn't there, the resources weren't there,
and H. Lee knew that in order to beat this disease, we had to be laser focused, we could not be
distracted. All resources, human and otherwise, needed to be focused on cancer, and as part of
the University of South Florida, that could not be accomplished. H. Lee with a little bit of help
from me, devised a restructuring of the cancer center from a legal standpoint that would give
the center director of the cancer center absolute control over all the resources needed to do the
job that we'd been charged with doing. Control over the labs, control over the faculty, control
over all the money that was generated by virtue of the cancer care, the grants, the research
grants that were coming in, which at that time went to the University of South Florida. Once the
university finished subtracting all their fees and tariffs and overheads and administrative
expenses, and reallocation to other parts of the university that had less resources. We would get
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what was left over to put to cancer research, put to recruiting physicians, what have you. And it
wasn't enough, and it wasn't ever going be enough.
At that time, a significant percentage of the board of directors were university individuals. The
dean of the College of Medicine, the vice president of Health Sciences, the president of
university, and when the restructuring that vested really in the chief executive officer of the
cancer center, all those things needed to do the job, and remove those from the university,
were voted on by the Moffitt board of directors in the form of a bill, draft legislation to be
submitted to the legislature to restructure, reform the cancer center so it could better achieve
its mission. I presented that proposal at the board meeting. We were in the middle of session. H.
Lee was in Tallahassee running the bill. He wasn't at the board meeting. The board voted not to
support that legislation. And as I recall, it was one or two votes. What had historically been
unanimous votes on almost everything, if not everything, and has since then been almost
unanimous votes on almost everything, almost everything turned into this split, very
contentious vote, where people voted along the university lines and voted along the Moffitt
Cancer Center lines.
I remember calling Lee to report the outcome of the board meeting. No way of knowing that I'd
failed. Part of my job was to advocate, why it was going to be good for the cancer center. I was
not able to pull that off, nor were Lee's dear friends that he had brought onto the board who
were committed to killing for him if they had to. And I'm waiting for Lee to just really hammer
me over that failure and I'd say, "Lee I have to tell you, unfortunately the board did not vote to
approve this bill, this legislation. Lee just very, very calmly said, "Well David look, you know, you
did the best you could. You did a good job, but the legislature's going do want it wants to do. I
mean they created us, we're a creature of the legislature, and if the legislature chooses to
reform or restructure the cancer center, I mean really it's out of the board's hands. I mean
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they're going have to comply with it." And lo and behold the legislature chose to reform and
restructure the cancer center.
Putting the exclamation point on the successful outcome of the 1990 legislative session for MCC,
Nick Porter concluded:
So years and years ago that negotiation with the legislature began and obviously ended up
happening and it was also a combination of the, and this is not just the University of South
Florida, but almost any university in its utter lack of wisdom, not understanding that partnership
is much better than divisions. So rather than saying, “Look, the university says you do it this way
or we're going to squish you,” you know, people don't like being threatened and they typically
can find ways to survive. The university just never got it, and therefore they ended up being
totally surprised one morning waking up saying, oh my God, this place has actually pulled it off.
The founder had won. Working through the legislative process, Moffitt had designed a bill,
found sponsors, worked the bill(s) through the committee process, met with staff, members and
leadership and did his job lobbying the legislature to pass his bill. The founder and others acknowledge
that the passage of SB 1498, included in Appendix E, was the most important adjustment to state
statute for MCC since H. Lee Moffitt created the cancer center while serving as Speaker of the House.
Interdisciplinary Care
Universities normally structured their healthcare professional departments by area of training
and expertise. Surgeons worked in the Department of Surgery, radiologists in the Department of
Radiology and other professionals in departments that train and practice in specific areas of medicine.
Practitioners in the community often reflected that organizational structure in private and/or group
practice. When a person received troubling news from their family doctor, they were often referred to
multiple doctors in varying locations. Using a tumor as an example, a patient received news that a tumor
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had been identified. The family physician referred the patient to a surgeon, who was trained to remove
such things. Additionally, for good measure, they were referred to an oncologist, who treated the
majority of casework with chemotherapy. And lastly, patients would receive a referral to a radiation
oncologist, with training and expertise in radiating tumors to shrink and possibly eliminate them. Each
physician was highly skilled and trained impeccably. However, it is possible that the patient, after
multiple trips to different parts of town or beyond, may have been advised of three completely different
treatment regiments. Oftentimes, the patient was frustrated, frightened and confused as to who was
right and what advice they should follow.
Consider the old adage of “If you’re a hammer, everything looks like a nail.” In the context of
cancer care, if a particular treatment option was the center of a given practice, then it was likely to be
highly utilized. Surgeons were trained to cut out tumors. Radiation oncologists were trained to shrink
tumors through radiation. Whether trained to deliver chemotherapy or any other area of expertise,
doctors were trained, performed and practiced in the areas in which they excelled.
Like many universities, USF was structured by department. The majority of physicians who
practiced at MCC were part of that structure. At the time, the faculty at MCC were USF employees. MCC
paid the university for the practices through hospital and clinical care revenue, but the doctors still wore
white jackets with the USF emblem. Additionally, the practice groups followed the same structure at
MCC as they did within the university.
The 1990 legislative initiative not only gave MCC the power of self-governance but also codified
the duties and powers of the center director in state statute. That legislation made it more possible that
MCC could find and recruit a superbly qualified candidate to serve as center director. Prior to the
passage of the legislation, MCC had been frustrated by top candidates turning down, or not even
showing interest in, discussion on the position (Appendix F includes letters showing correspondence
with Jerome W. Yates, M.D., Associate Director for Clinical Affairs at Roswell Park Memorial Institute in
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Buffalo, NY, whom MCC was attempting to recruit as center director). That significant piece of legislation
enabled MCC to recruit a center director who knew the scope and boundaries prior to hire.
Dr. John (Jack) C. Ruckdeschel was a medical oncologist who specialized in lung cancer. An
Albany Medical College graduate, Ruckdeschel interned at John Hopkins School of Medicine, did his
residency at Beth Israel Deaconess Medical Center and did fellowship programs at the NIH and
Baltimore Cancer Research Center. Ruckdeschel was recruited and hired as MCC’s first center director
and first CEO under the governance structure after passage of the 1990 legislation.
Also a significant impact person identified in the interviews, Ruckdeschel made a transformative
decision at MCC early in his tenure. With experience from his time in Albany, he focused on the patient
as the center of treatment, not the area of expertise of a physician. Ruckdeschel designed and
implemented a model of care called interdisciplinary care, focusing on disease site as opposed to
departments of like-trained faculty. Some respondents referred to this methodology as multidisciplinary
care. MCC’s Physician-in-Chief, Letson, clarified:
They are relatively interchangeable. Moffitt has been a multidisciplinary team, but we have
been gravitating to an interdisciplinary approach.
Multidisciplinary: people from different disciplines working together, each drawing on their
disciplinary knowledge.
Interdisciplinary: integrating knowledge and methods from different disciplines, using a real
synthesis of approaches.
Ruckdeschel described his experience with this methodology and how MCC adopted it as its
method of diagnosis and treatment:
When I was in Albany we had a couple of pseudo teams. We had one really good team which
was the thoracic team. A thoracic surgeon who's a M.D., PhD, came down from Minnesota, and
he and I were mostly on faculty at the time. We went out to Chicago, and met with the thoracic
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group there, and it was a medical oncologist, the radiologist, and the surgeon, went down to
radiology and looked at x-rays together. We thought we could do better than that. We set it up,
we got everybody involved with it. It worked well in Albany. So when I went to Tampa I knew
the model, I knew how it worked. I knew that I couldn't let departments like radiology, or the
thoracic program, or even pathology assign a specialist of the week.
Ruckdeschel took his base of knowledge from Albany, refined the process and implemented the
care model to better serve patients. With all the physicians, surgeons, radiologists, medical oncologists
and others in the same room to review results, an agreed-upon treatment protocol could be more
readily established. MCC referred to these meetings as tumor boards, where the physicians, all experts
in their fields, were joined in one room to seek agreement on protocol. Those meetings created an
environment for healthy debate, and there was sometimes debate, about patient treatment. Was
surgery first, or radiation or chemo? The professional had to make their case, debate the merits,
research facts and data and then the group would come to a mutual decision.
From an ease-of-use perspective, the patient had to visit only one location. They may have seen
multiple doctors during the diagnoses phase, but the decisions about treatment were made at the
tumor board and the patient received the agreed-upon protocol at the same location where they went
for diagnosis.
From a physician perspective, departments organized by disease site enabled communication,
idea sharing and discovery information to flow freely between the team. Ruckdeschel stated:
I made it clear in my offerings to the board before I came that, in order to distinguish the
institution from the community practice we had to do complete interdisciplinary care. Being a
lung cancer specialist, I need to go to one conference a week that includes all the thoracic
surgeons, medical oncologists, radiation therapists, radiologist, pathologist, nurses, dieticians,
and trainees once a week. And I'm completely up to date with not only what I've learned in my
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meetings and in my reading, but what all those other individuals bring from the surgical, the
radiotherapeutics, the biology, the pathology, literature, to it. So, I'm updated every single week
all the patients with lung cancer in the institution. And there were quite a few.
A private practitioner in the community doesn't just see lung cancer. He sees breast cancer, lung
cancer, colon cancer, lymphoma, everything. That's the nature of the job. He doesn't have time
to go to a dozen different conferences a week. It's extremely rare that they ever talk about the
cases between them. He might say to a radiotherapist, "Hey I got a patient with this problem.
Can you take care of that?" And that's about it.
But after a patient has seen a surgeon, a radiotherapist, a medical oncologist who has a complex
plan of care outline, then it is not likely as ever to happen that all of those practitioners will get
together on a conference call out in the community and discuss exactly what to do with the
patient, while looking at all their x-rays and everything at the same time.
I think Moffitt was really the first of the cancer centers to really go completely to
interdisciplinary care. What it meant was doing away with medical oncology clinic, doing away
with surgery clinic, doing away with hematology clinic, and making sure that all of those were
done. We were able to do that and divvy up the space differently. As we hired, we hired into
teams. We never again hired a general oncologist, or general hematologist. They came into
specialized areas. They were either myeloma experts, or transplanters, or pancreatic specialists,
whatever, but they went to a team. We never again hired just generalists in the place.
I think that was really the core of the success clinically of the place. Because we very quickly
distinguished ourselves as not doing the same thing as the community people. We went from
under 3,000 patients a year when I got there to 17,000 when I left. And it'd already become
when I left, the third largest cancer center in America.
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From the board perspective, leaders understood what the decision meant for patients and the
culture at MCC. Tim Adams served on the MCC board for nearly three decades and was later named
chairman. For the board, fiscal stability was very important. However, the instilled culture of the
organization, the passion for patient care through treatment and research, and living up to the mission
superseded everything else. As a nonprofit, MCC’s leaders needed to make sure the books were
balanced, but they didn’t have to worry about stock prices, earnings ratios or dividends; they could
center everything on the patient and concern themselves with reputation by outcomes.
Tim Adams, long time board member who served as chairman beginning in 2017, described the
situation from the internal, not university, viewpoint.
We were frustrated for a number of years because the faculty sat at USF, and no fault of USF,
but they're in traditional medical school kind of slots. So the surgeons are in the department of
surgery; the radiation people are in the department of radiology. At Moffitt, we practice a teambased approach. You want surgeons working with radiologists working with medical oncologists.
That just couldn't really work well in the medical school environment. So, the interim step was
to form a department of interdisciplinary oncology where the people left their functional silos
and went into a department of interdisciplinary oncology that essentially was the docs who
worked at Moffitt. That precipitated a little better team-based care, but they still sat in matrixes.
So, you're in the department of interdisciplinary oncology but you're also in the department of
surgery, and so there was still friction there, and ultimately USF and Moffitt agreed it'd be best
to just have the doctors come completely over to Moffitt so that they didn't have that sort of
friction that was impacting patient care really. (Subject of a following section)
Dr. Letson began his career at MCC in 1992 and played a part in the transformation of the
patient care model. A graduate of Louisiana State University, Letson pursued a fellowship in
musculoskeletal oncology at Massachusetts General Hospital Harvard Medical School. As MCC’s
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Physician-in-Chief, he was a leading proponent of the multidisciplinary design from both the physician
and patient perspectives.
Moffitt cancer center is a specialty cancer center that is a multidisciplinary cancer center that
takes care of a patient from beginning to end. From diagnosis to novel treatment therapies, to
either end of life, or for continuing care. The cancer center is special in that it is an institution
that has its own hospital, and that specialized only in cancer care. Where many institutions have
a cancer center within a medical system, or hospital system. This is a very rare situation.
Essentially, all the people that are hired by the Moffitt cancer center are supportive to cancer
treatment.
Interdisciplinary care is an opportunity… In order to treat cancer effectively, you have to treat it
with multiple disciplines, multiple modalities. Moffitt is special in that you can have these
interdisciplinary care teams that all worked for one institution. We have one goal in mind, and
that's cancer therapy. Interdisciplinary oncology teams here at Moffitt specialize in cancer care
for a specific type of cancer, which is rare. In most institutions around the United States, you
might have a medical oncologist that treats solid tumors, and might treat lung cancers, and GI
cancers. Here, the interdisciplinary team takes care of a specific type of cancer, such as the lung
cancer team. You'll have the medical oncologist, surgical oncologist, radiation oncologist, all
giving therapy for a specific type of lung cancer. But you'll also have pathologists and
radiologists that are specialists only in lung cancer. And you will have nurses, PA's, and other
personnel dealing with the overall cancer care. Whether it’s physical therapists, occupational
therapists, they're all on a specific organ team. So the interdisciplinary care means that you're
treating cancer in its totality, and here the interdisciplinary care teams are all focused on one
specific type of cancer.
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University structure is, for the most part, made up as an academic structure, where you have
departments of surgery, departments of medicine, departments of pathology. These separate
departments will have multiple individuals in those departments, of which, they will have some
sort of sub specialty in a specific disease type.
Here at Moffitt, we don't have a traditional academic structure. We have clinical programs set
up as disease specific programs. Your research, your education, your clinical care, everybody is
focused on one specific disease. So that means that when you're getting your clinical program
together, and you're doing retreats, clinical meetings, everybody is focused only on one type of
cancer.
Former board chair and retired US Senator Connie Mack summed up his assessment of
interdisciplinary care concisely.
One of the fundamental things that they came up with was this notion of "get rid of the silos,”
this interdisciplinary approach to treatment. I think that's number one.
Multidisciplinary care teams providing patient-centered care were described in the 2017 MMG
Annual Report as physician teams that included surgical oncologists, medical oncologists, radiation
oncologists, diagnostic imaging radiologists, experts in anatomic pathology, hematopathology and
laboratory medicine, anesthesiology, hematology, cancer genomics, internal and hospital medicine,
cardio-oncology and supportive care. Advanced practice professional teams included advanced
registered nurse practitioners, physician assistants, certified registered nurse anesthetists,
anesthesiologist assistants and registered radiologist assistants. The use of multidisciplinary clinics made
it possible for patients to meet each member of the care team in one day. Rather than making multiple
trips for multiple appointments, by having one extended appointment patients were able to be
evaluated by multidisciplinary team members and leave the same day with a treatment plan. Thus, the
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multidisciplinary clinic visit reduced the time from evaluation to treatment. Table 4 shows the
impressive list of MCC interdisciplinary departments (Moffitt Medical Group, 2017).

Table 4. MCC Interdisciplinary Departments, 2017
•
•
•
•
•
•
•
•
•
•

•
•

Adolescent & Young Adult
Anatomic Pathology
Anesthesiology
Blood & Marrow Transplant & Cellular
Immunotherapy
Breast Oncology
Cutaneous Oncology
Diagnostic Imaging & Interventional Radiology
Endocrine Oncology
Gastrointestinal Oncology
Genitourinary Oncology
Gynecologic Oncology

•
•
•
•
•
•
•
•
•
•

Hematopathology & Laboratory Medicine
Individualized Cancer Management Internal
& Hospital Medicine
Malignant Hematology
Malignant Hematology & Cellular Therapy at
Memorial Healthcare System
Neuro-Oncology
Radiation Oncology
Sarcoma
Senior Adult Oncology
Supportive Care Medicine
Thoracic Oncology

Head & Neck Oncology-Endocrine

Comprehensive Cancer Center (CCC)
Each of the landmark decisions that became transformational events at MCC over time are
inextricably linked. Without the passage of the 1990 legislation, the search for a center director would
have continued to be stymied by structural confusion and blurred lines of authority and decision-making
ability. If not for that first center director, Jack Ruckdeschel, the interdisciplinary methodology of faculty
department design and patient treatment may not have come to fruition. Additionally, the passage of
that legislation attached the powers of the center director while mandating, in statute that the center
strive to become NCI-designated CCC. Beyond the evolution of the care model, Ruckdeschel was also
tasked with creating an environment to promote and excel in cancer research.
The NCI awards designations to specific entities for research achievement in cancer. The first
designation is that of Designated Cancer Center. The CCC designation is the most prestigious and
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sought-after award. As of 2018, there were 49 institutions in the country that carried such distinction.
CCC designation is based solely on research, not patient care. Many institutions touted the CCC
designation in marketing as a differentiator, including MCC, which could be interpreted as better patient
care. The following is the NCI’s description of the impact of cancer centers on cancer care (National
Cancer Institute, NCI-Designated Cancer Centers, 2018):
The cancer centers develop and translate scientific knowledge from promising laboratory
discoveries into new treatments for cancer patients. Many cancer centers are located in
communities with special needs and specific populations. As a result, these centers not only
disseminate evidence-based findings into communities that can benefit from these findings, but
the centers can also, through the experience of working with those patients, help inform
national research and treatment priorities.
Each year, approximately 250,000 patients receive their cancer diagnosis at an NCI-Designated
Cancer Center. An even larger number of patients are treated for cancer at these centers each
year, and thousands of patients are enrolled in cancer clinical trials at NCI-Designated Cancer
Centers. The centers also provide public education and outreach programs on cancer prevention
and screening, with special attention to the needs of underserved populations.
The rapid pace of discovery and the improved cancer treatments that the NCI-Designated
Cancer have helped pioneer have contributed substantially to the increase in the number of
cancer survivors in the United States, as well as to the quality of their lives (NCI, NCI-Designated
Cancer Centers).
The NCI had very strict guidelines for awarding the designation. Once awarded, renewal was
required every five years which was not a perfunctory process. With the designation, research money to
awarded to each institution over the five-year period. The NCI described why the Cancer Centers
Program is important to cancer research as follows:
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The NCI grant funding to the cancer centers supports shared research resources, provides
developmental funds to advance scientific goals, and fosters cancer programs that draw
investigators from different disciplines together. In addition, individual cancer center
investigators are highly successful at obtaining research funding from NCI and other funding
agencies and organizations. Indeed, research proposals from cancer center investigators
account for about three-quarters of the successful investigator-initiated grants that are awarded
by NCI.
The centers also offer training for scientists, physicians, surgeons, and other professionals
seeking specialized training or board certification in cancer-related disciplines (NCI, NCIDesignated Cancer Centers).
To begin establishing a significant research program, strong leadership was required, someone
who understood what the process would take. The institution had its center director and Ruckdeschel
knew the expectations. Nick Porter, who was responsible for the daily operations at the center, was
involved with recruiting Ruckdeschel to the center and worked diligently on the transformation under
new leadership. Porter, too, was cognizant of the mandate to create a research entity worthy of
designation.
It took an individual like Jack Ruckdeschel, who was the center director, he might not have been
a PhD, but he certainly understood science to a certain degree. He certainly understood cancer
and he was very willing to be very aggressive in recruiting. He had the foresight to recruit Jack
Pledger, who was a basic scientist, who was highly trusted throughout the basic science world,
which then would allow him to recruit other basic scientists to Moffitt. (That) allowed us to
bring in many of the earliest basic scientists who were genuinely superb individuals and begin to
weave that together.
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It allowed us to present to (the) NCI that we had programs with scientific merit, scientists that
were competitive, and that the cancer center, administration and board of directors were there
to make sure that they were successful. When Jack Ruckdeschel was hired in ‘93, it was about
10 years later that we became an NCI Comprehensive Cancer Center. There was not one living
individual when I went there who would have even bet a penny that we could become an NCI
Comprehensive Cancer Center. But we put the dominoes in the right order and worked very
hard to prove that we could do the science and that we really mirrored what the NCI wanted to
support with the core grant. Which was to provide resources to allow scientists and others to be
the most effective they could possibly be in a cancer setting.
As to why the designation is so important, Porter continued:
Ruckdeschel knew the importance of the CCC designation: what it meant to MCC, what it meant
to the center’s reputation and what it meant for the future. Again, while not a PhD scientist with
an enormous research history, he had the foresight, the vision, and the fortitude to push for
excellence. He surrounded himself with people of distinction and created a research enterprise.
The ability to meet challenges was common to other MCC leaders, including the founder. His
leadership and tenacity willed the institution forward.
The comprehensive status was ours. That was where the importance was. It's like getting the
Nobel Peace prize or it's like winning the World Series. I mean, that's what we did to show that
we were excellent. And we used it heavily in marketing. But in point of fact, the comprehensive
designation, even the NCI designation, has nothing to do with the quality of your patient care.
Zero!
So to me, the comprehensive designation, as I think it was to Lee, was the mark that not only
had we done this, but we had done it right. We had done it to the highest standards, and we
were as good as any place in the country.
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MCC’s first CEO, William S. Dalton, acknowledged the institution’s efforts after being recruited
from the University of Arizona. Asked about what decision(s) set MCC on a course to build its reputation,
Dalton commented:
The first was the commitment to becoming an NCI-designated center. Arizona was one of the
first NCI-designated centers, and to be honest with you, when we were designated, it was like,
"Hey, we got it." And that was it. No one talked about it and it wasn't a big deal.
When I was recruited here (to MCC) and it was real clear that that was the goal, I had never seen
such a concentration and commitment by everybody to achieve NCI designation. When it was
achieved, it was a massive celebration. I think it tells you the value that people feel that they can
create. So, I think gaining NCI designation was the first pivotal and then followed by
comprehensive status.
COO and EVP John (Jack) A. Kolosky added commentary about the utilization of
“comprehensive” by some other institutions:
There have been places that have used the word comprehensive cancer center in their title, and
they may be community cancer centers, and I know that they're trying to boost their reputation
locally. But, the definition of comprehensive as we use it really is to try and differentiate
ourselves as the only NCI cancer center, National Cancer Institute center that has earned the
reputation, earned the title of Comprehensive Cancer Center, and the only one that is based in
the state of Florida. That's something that's unique and clearly above and apart from anybody
else in the state of Florida.
Dr. Thomas Sellers, MCC’s Center Director and EVP and a nutrition and genetics scientist,
oversaw the research endeavors at the center. Sellers was responsible for growing the research
enterprise and recruiting new scientists. Sellers saw the CCC designation as a necessary tool to recruit
the best and brightest minds from around the globe.
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Well there's only 70 (designated centers) in the country. There's only 45 that are comprehensive
(CCC). It is a difference because, at least for patients, you're going to get tomorrow’s standard of
care today. To get an opportunity to participate in clinical trials.
I think in terms of the scientists, being able to recruit a scientist, the cancer center support grant
provides funding that builds an infrastructure. So get access to the latest and greatest
technologies and tools, and that matters.
In 2018, MCC was the only NCI CCC based in Florida. Mayo Clinic had a presence in Jacksonville,
FL, but its CCC designation was linked to the campus in MN. Since MCC opened its doors in 1986, the
population of the state of Florida had more than doubled, becoming the third most populous state in
the nation. Other centers, the University of Florida (UF Health Cancer Center, formerly Shands) and the
University of Miami (Sylvester Comprehensive Cancer Center), planned to seek designated status from
the NCI but had not yet been reviewed. (Note: Sylvester had been CCC in the past but had lost the
designation decades prior). Many saw the concept of multiple centers designated in Florida as a growing
necessity. With more than 120,000 cases of cancer diagnosed in Florida annually, the burden of cancer
care was great and continued to grow. While the designation is not directly related to care, the benchto-bedside discoveries at CCC’s could enable patient access to clinical trials and new treatments.
A founding board member and former chair, Ted Couch had served on the board prior to when
the first building was constructed. He was a participant in all the key decisions and had watched MCC
grow from nothing to a small hospital with just over 400 employees to a CCC with more than 6,100
employees.
So it is the only one in the state of Florida thus far. I think there's the possibility that some other
medical centers are going to attempt to have an NCI designated status, and I would encourage
them to do so because the state's becoming a huge population center and it's pretty hard for
Moffitt to be able to serve everybody the way we'd like to serve.
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The CCC designation carried with it an institutional reputation as a national leader in research. It
defined a cancer center and contributed to the ability to recruit innovative researchers who made
dramatic discoveries. The statute passed in 1990 enabled MCC to advance under self-governance.
Ruckdeschel became the chief sailor, but he needed a steady hand on the rudder, someone to steer the
ship to land at the proper destination. For Ruckdeschel, that person was W. Jack Pledger, PhD. Prior to
joining MCC in 1995, Pledger had been a professor at Vanderbilt University and the University of North
Carolina Medical School. He also spent time at the Dana Farber Cancer Center and Harvard Medical
School. Pledger had credentials and he knew a lot of people in the research community. He was hired to
build the team of research professionals who would prepare MCC for NCI designation.
Moffitt Cancer Center had a mission to contribute to the prevention and cure of cancer. In
addition, the standard by which it would be recognized as reaching its potential, to become a
Comprehensive Cancer Center at the NCI. To reach that particular standard which is the highest
the government can give to any cancer center, Moffitt needed to not only have an incredibly
very good cancer treatment center but they also had to have a research emphasis that would
put them up in the leaders of the country.
So the idea would be to develop the research programs that would support a Comprehensive
Cancer Center which required at least three programs. One of those could be a clinical research
program. In addition, a population science program so that'd be a total of four.
In developing cancer centers and to be able to qualify, you have to have at least three programs
and each of those programs have to have at least three funded investigators and the total
amount of research will actually be the driving force for the kind of funding you can get from the
NCI. My job was to develop the basic research programs that could support this Comprehensive
Cancer Center. To recruit the faculty. To make sure they all became funded with NCI funds so we
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could prove that we were doing cancer research and to develop the core facilities that would
support that research.
A cancer center core grant provides money to the institution. But 80-90% of that money that
they will provide is given to you to support NCI funded research. So if you don't have any
research, there's no reason to have a cancer center. What we did over the first three years was
to develop the programs that allowed us to become NCI-designated cancer center and I'll point
out that took three years.
Then the other part was to become comprehensive. In the late '90s you had to become a clinical
cancer center like we had just become. And then, on your next competing renewal after a threeyear window, you could then seek comprehensive status. Now that since was changed a little bit
but after we developed the NCI designated cancer center, two years later we went in for our
competing renewal where we sought comprehensive status and we were awarded
comprehensive status. From the time that I got there until comprehensive status was reached it
was a five-year period.
The cores that we used for the NCI to support have really increased and technical abilities have
increased in the number of people they serve and are now ranked as some of the best technical
support facilities in the country. So it continues to grow and continues to be the beacon.
According to the MCC website, “…as a National Cancer Institute-based Comprehensive Cancer
Center, Moffitt is committed to continually developing and evaluating new therapies that can improve
patient outcomes and quality of life. At Moffitt, patients can access the “gold standard” in cancer
treatment, as well as novel options, such as immunotherapies, targeted treatments, interventional
radiology services and hormone therapies, through our robust clinical trials program” (MCC, Cancer
Treatment).
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Moving Faculty to MCC (MMG and MRI)
Building on the institutional advancements after MCC gained self-governance, moving the
faculty to MCC employ, and the subsequent creation of the MMG and the MRI, was a bold and visionary
decision. Prior to 2008, the faculty at MCC, physicians and researchers, were employees of USF. MCC
paid the university from its revenue generated from the hospital and clinical operations, and the
university, in turn, paid the physician salaries. That system gave the faculty university privileges for
teaching and research purposes. Additionally, tenure was conferred by the university. The structure, not
including the multidisciplinary care model for patient care, was similar to other university-connected
hospitals and practice groups. The majority of faculty had been trained in such an environment and
were used to the structure.
For MCC leadership and the board, institutional reputation and recognition was a major focus.
MCC had just gone through a rebranding effort to clarify its independent identity and simplify its
marketing identification, including its logo. Its former logo utilized a lot of information in a small
amount of space. Further, it included linkage to the university. MCC’s former information, on business
cards, letterhead, marketing advertising and consumer materials stated: “H. Lee Moffitt Cancer Center
and Research Institute at the University of South Florida. An NCI designated Comprehensive Center.”
The former branding colors were comprised of manila and teal. The rebranding effort shortened the
marketing image to simply, “Moffitt Cancer Center” and updated the brand colors to blue and white.
While the new branding effort created the image of an independent institution, dropping the university
connectivity in the material, many faculty walked the halls of MCC donned in white lab coats with the
green and gold USF insignia while others wore the new MCC logo. While not a subject of critical
proportion, it did create some confusion, visually and otherwise.
More importantly, the ideological and individual institutional differences did not dissipate after
the passage of the 1990 legislation. Tensions still existed between the two entities and the strong
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personalities of those involved: board members on both sides, the university president, Moffitt CEO,
lawyers on both sides and internal faculty who adopted differing viewpoints. The details of all of those
situations and issues could have been the subject of a lengthy book or, at minimum, a fascinating reality
TV show. An example, without wading into tabloid description of individual personalities by name, will
illustrate one instance of the interinstitutional chess maneuvers.
MCC faulty being paid by the university were accustomed to receiving paychecks on a regular
schedule. During one heated period, the university did not pay the faculty on a particular Friday and
waited until the following Monday to submit payments. The faculty, needless to say, were apoplectic.
Confronting the issue, a MCC executive inquired. The resulting answer from a university representative
was a simple “Do I have your attention now?” It’s not hard to imagine the ensuing conversation.
While institutional tensions played a role, for MCC the compelling issue was, once again,
separation and self-governance. In order to have full authority and guidance of the medical staff and
research operations, MCC made the decision to bring the faculty in-house. Related to that decision, from
a managerial and organizational perspective, MCC created the MMG and the MRI. The decision to
employ the faculty was not taken lightly and required delicate, yet strong, leadership. Faculty,
accustomed to a university structure, were not unanimous in supporting the decision. Concern over
tenure, university privileges for teaching and research and lack of connectivity with a university were
very concerning issues. It took a lot of effort to work through all of the issues. MCC and the university
negotiated legal terms and, at the conclusion of the negotiation process, the faculty became MCC
employees rather than university employees. The university granted privileges in return for an annual
stipend and the cancer center granted tenure.
Dr. Jack Pledger lamented:
Back when I was there, Moffitt gave the money to USF to pay all of our salaries and the
physicians more or less were responsible to department chiefs in the medical school even
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though the Moffitt was paying their salaries. Moving all the faculty in there finally came to
fruition when (former CEO) Bill (Dalton) was there. Then later the complete kind of destruction
of the relationship between USF, where we tried to work out the things like IP ownership and
pursue the patents and all that stuff. And then all that split up. The first decision to become a
comprehensive cancer center followed by bringing the faculty into Moffitt and making them
members of Moffitt and then the breaking down of the old ownership. The thought of whether
Moffitt was, yes directly, on its own and not in any way overseen by the university. Sort of the
total independence.
And then probably one of the later things that I felt was very good. And all this involves with the
doctors practice going in (to the) DIO (Department of Interdisciplinary Oncology). So it really
gives the Moffitt Cancer Center a lot more control on their own employees that they're paying
for.
I started pushing to develop a separate entity for the cancer center called a Moffitt Research
Institute. Which then allowed everybody to have the research part put under this research
umbrella. And, of course, that's where they put the (NCI core) grant and Dr. Sellers is the
director of that institution and the grant. So those are the kind of the ones that I was involved
in. But probably the main thing was just making the separation very clear.
We were still bringing in money to the institution through USF and were getting like a 40-45%
indirect and they were only giving us probably 20% of that. With the cost to do research it was
just ridiculous. We couldn't keep that up very long.
Former board chair Ted Couch linked the decision to employ the faculty as significant and aided
physicians and researchers, propelling MCC forward.
I would say that one of the significant accomplishments is what we've been able to do to build
our research capacity. What we've been able to do that I think is significant is that research
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capacity, the NCI status that we earned in a very short period of time, I think that probably is
one of our main accomplishments. And then, probably the next thing, was to be able to manage
our medical staff. To be able to hire our medical staff, that was probably another significant
move that was costly to go into. But I think that probably it's been a very meaningful
accomplishment in being able to run the hospital.
James J. Mulé, PhD, EVP and Associate Center Director, recalled the decision to hire the faculty
and the care and communication required.
The other is the separation from USF, was the decision to bring all the faculty over here, was the
right thing to do for all the right reasons and do it in a way that both organizations felt it was
good and productive and would not necessarily be adverse to each organization. So, I look at
that as a win-win, and I think it was crucially important to the history of the organization. So, I
view it as it was necessary. I could understand the angst of the faculty members at the time,
because they're academics, they're used to having their paycheck come from university and
have their academic professorships at the university. So this was a period of time where we had
to settle those concerns and maintain the ability for them to have appointments at USF, which is
still important to the active faculty here.
I think it was a testimony to the leadership and the board to allay those concerns and make it
whole for the employees, for the academics. It was a lot of transparency, a lot of
communication, a lot of meetings with faculty to ensure them that this was the right thing to do,
and put together a promotion and tenure system, which we didn't have before, and have the
faculty involved in every decision that was made, including being members of that committee,
set up the departments, the academic departments, similar to what's done in the university, and
I think the results speak for itself.
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Board chair Tim Adams, having served on the board for more than 26 years, also had a front row
seat over MCC’s rapid growth period. He was part of the decision-making process during all of the
landmark decisions that matured and propelled the institution.
We were the first in the nation, Cancer Center, to employ our clinical faculty. So, if I look at one
single thing that really impacted us, that's probably the biggest because the faculty, the way we
care for cancer is pretty unique. It's team-based. You can't do that with a faculty that's off-site
or not part of the organization, and so pulling that clinical faculty in and having them align with
mission and with the Moffitt culture probably really set us apart from everybody else.
And other people, obviously in the last four or five years, lots of clinical enterprises have
employed physicians, but as far as I know we were the very first Cancer Center to do it and we
were way ahead of most other people. And I think that really, really positioned us to pursue
mission.
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CHAPTER 6: DISCUSSION AND CONCLUSION

This study identified the factors and events that led the Moffitt Cancer Center (MCC) to evolve
from a direct-support organization (DSO) at the University of South Florida (USF) into a self-governing
institution of transformational change. The role of the founder, leadership and culture, key factors, led
to a mission-driving organization that was stymied by cultural, organizational and governance
differences with the university regarding directional growth. A critical inflection point, MCC’s
organizational and governance future was indelibly altered by the passage of legislation in 1990. The
legislative success, coupled with three additional transformative events, evolved MCC into an
organization with a future of limitless possibilities.
Individual interviews of MCC board chairs and members, chief executive officers (CEO) and
executive leaders revealed the three fundamental factors and four transformational events enabled
MCC’s evolution. The findings were used to address the study’s three research questions. A review of
the literature regarding founders, visionary leadership, culture and transformative organizations showed
that while some facets of MCC were similar to those of other large organizations, MCC was also unique,
as discussed later.
Summary of Major Findings
The interview data was analyzed using interpretivist analysis and sensemaking to identify
common themes across the interviews in order to determine how factors and events transformed MCC.
Primary areas of interest, based on the study’s research questions, were discovery of who or what
impacted MCC and the decisions made to propel the institution. The overarching goal was to depict how
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and why MCC became and institution of transformational change. There were two key findings, which
are described in this section. Finding 1 pertains to the foundational factors that were critical to MCC’s
evolution. Assessment of this data led to the identification of three foundational factors that were the
focus of a comprehensive literature review. Finding 2 pertains to transformational events. This analysis
led to the identification of four decisions that were most significant in MCC’s advancement. Notably, the
decision that came first chronologically made possible each of the subsequent decisions. Each of these
key findings are described in this section.
Key Findings
Finding 1
Iterative analysis of the interview data revealed three key factors that were deemed to be
important foundational factors: 1) Founder, 2) Visionary Leadership and 3) Culture. These factors, along
with Transformational Organizations and Societal Benefit were the focus of the literature review
conducted for this study. The literature supported the role and impact of these factors in relation to
MCC’s evolution: founder (Conte et al, 2018; Ellis et al, 2017; Leavy, 2016), visionary leadership (Cote,
2018; Taylor et al, 2013; McLarney, et al, 1999; Westley & Mintzberg, 1989) and culture (Bass & Avolio,
1993; Giberson, et al, 2009; Sarros, et al, 2011). Transformational organizations and societal benefit,
included in the literature review (Carr, et al, 2004; Ebrashi, 2013), sought to gain perspective regarding
organizational creation and adaptation or evolution resulting in high-impact societal enhancement.
MCC also appeared to be unique in some ways, including the ongoing involvement of the
founder in a non-executive leadership position. MCC’s societal benefit as an institution of
transformational change also had a unique quasi-public/private quality in that it was created as an
instrumentality of the state yet operated as a private non-profit. The perceived similarities and
differences are further interpreted and described in the discussion section of this chapter.
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Finding 2
Analysis of the research led to the discovery four key decisions that were deemed to be
transformational events: 1) 1990 Legislation, 2) Interdisciplinary Care, 3) Comprehensive Cancer Center
(CCC) and 4) Moving Faculty to MCC. These pivotal events, particularly the first event which was the
most unexpected and informative finding, were determined to be the impactful events that enabled
MCC to emerge as an institution of transformational change with societal impact.
The first transformational event, the 1990 legislation, made it possible for the subsequent
events to occur. While only a few interviewees explicitly mentioned the 1990 legislation specifically, a
recurrent theme in participant interviews was MCC’s need for self-governance in the years following its
creation. Familiarity with the political process and the impact of such a statutory change helped identify
the 1990 legislation as a fundamental decision that allowed for self-governance. Appendix G contains a
summary of the recurring themes in the interviews that identified the 1990 legislation as a monumental
event, paving the way for future transformative decisions or events.
Interdisciplinary or multidisciplinary care were explicitly stated in several interviews; described
as the way MCC organized patient care by disease site. A differentiator, MCC transformed patient care
by eliminating a university-style department structure and created teams of specialists focused on a
particular type of cancer.
MCC’s status as a CCC was revealed as a monumental achievement in institutional
transformation. CCC status is the highest-ranking award by the National Cancer Institute (NCI), part of
the National Institutes of Health (NIH). The decision to pursue, and ultimate success in achieving, the
coveted NCI-CCC designation was crucial.
The decision to move faculty to MCC was identified as a key event based on the recurring theme
of separating from the university and “moving all the faculty in here” or “the next thing was to manage
our medical staff.” A bold and visionary decision was made to make faculty employees of MCC rather
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than USF. The Moffitt Medical Group (MMG) and the Moffitt Research Institute (MRI) were important
organizational additions to accommodate distinct groups, physicians and researchers, in their areas of
expertise.
Findings were used to assess the three research questions that were developed to address the
aims of this study.
Research Question 1: Can we ascertain factors that were critical to the foundation of MCC as a
transformational institution?
MCC CEOs and board chairs were identified as the prominent leaders who made a significant
and lasting contribution to MCC. While numerous other individuals were mentioned, the majority of
responses fell into these two categories of leadership.
The research identified leadership groups which led to the key factors that became a basis of the
literature review: 1) Founder, 2) Visionary leadership, 3) culture. Additional research regarding specific
actions, decisions and leadership qualities/traits of those individuals could lead to additional substantive
findings in future work.
Research Question 2: Can we determine events that set MCC on a course to become an
institution of transformational change?
Four key decisions made at the board and/or executive level were identified as having set MCC
on a certain trajectory: 1) 1990 Legislation, 2) Interdisciplinary Care, 3) CCC and 4) Moving Faculty to
MCC. Through this analysis, these four decisions were deemed to be transformational events for MCC,
yielding the most significant findings in the research.
Research Question 3: What does MCC need to do to continue to be an institution of
transformational change with societal benefit?
The research did not yield concise information to address the question of what MCC needs to do
to continue to be Florida’s premier cancer center. The need for continuity in funding and commitment
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to the organizational culture were mentioned in several interviews. However, due to the lack of
consistency to identify what would have been interpreted as common themes, this question is an area
for future research.
Explanation of Model
Figure 4 below shows the final model of foundational factors and events that impacted MCC’s
evolution as an institution of transformational change. Findings of this research were used to evaluate
the relative impact of factors and events. The perceived influence of each is indicated (+) in the model.
The conceptual model (Figure 1) explained, in broad terms, in essence a roadmap that could be
utilized by organizations to transform, enabling greater economic and/or societal impact. The
conceptual model was utilized to describe the factors and events that transformed MCC into an
institution of transformational change (Figure 4).
MCC’s three key factors, founder, visionary leadership and culture were overlaid into the model.
Similarly, the four transformational events; 1990 legislation, interdisciplinary care, CCC and moving the
faculty from the university to MCC were also placed in the model. Finally, weighting of the factors and
events, with a (+) designation; denoted on the arrows. The boxes and circles represented the key factors
and the transformational events that led to the evolved organization; an institutional of
transformational change. The arrows signified causation, reading from left to right, in the model.
The first box, highly skilled, trained, impassioned founder was exemplified by MCC founder, H.
Lee Moffitt. As Speaker of the House in the Florida Legislature, the founder utilized his position of power
and influence to create MCC in state statute. Moffitt’s founder imprint was significant and his continued
participation on the board impacted the direction of the institution. H. Lee Moffitt, in box one, was a
high-impact factor in the creation of the organization, the second box, visionary leadership, upper circle,
and culture, lower circle. Arrows indicate causation. The creation of the organization was his
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accomplishment, therefore the founder’s impact on MCC, the organization (+++), visionary leadership
(++) and culture (+) was substantial.
The second box, organization, was the cancer center (MCC). The organization, although small
and a Direct Support Organization (DSO) on the university campus, served its envisioned purpose to
deliver cancer care to patients in the region and state. Not only did the founder impact its creation
(+++), visionary leadership (++) of the board and senior executives and the culture (+) they, therefore,
impacted the organization. Equally the organization was impacted by key factors, visionary leadership
(++) and culture (+). The organization, MCC (+++), visionary leadership (++) and culture (+) each
influenced the transformational events.
The research brought forth four transformational events, the large circle, which evolved MCC
into a new organization, listed in the circle. Those combined events (++++) created an institution of
transformational change with societal impact through its new structure under self-governance, a
(+++++) organization. Further description is presented in the discussion section.
Discussion
This worked was based on interviews of twenty-one individuals involved with the creation,
growth and evolution of MCC. One question, “Who or what impacted Moffitt greatly?”, presented as the
defining question of the study, as it yielded responses to help identify the foundational factors and
transformative events that re-directed MCC’s course. In this section, the major findings of this research
are discussed in terms of their perceived meaning of MCC’s transformation related to existing literature.
This chapter 7 includes this study’s limitations, recommendations for future research, and concluding
remarks.
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Figure 4. Model of Foundational Factors and Events of a Transformational Institution
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Foundational Factors
MCC’s growth and success were shaped by the role of the founder, successful leadership
practices and an integrated organizational culture. The founder, a cancer survivor himself, utilized his
political position in the state legislature to create the cancer center. The literature showed that founders
impact the organizations they create through their experiences and their personal history (Conte, et al.,
2017, p. 276). Moffitt did not cease after the building was erected. For more than three decades, he
served as a founding board member and remained intimately involved in MCC’s directional and policy
development. More than thirty years after the center opened its doors, the founder still traveled to
Tallahassee each legislative session to lobby for MCC. The founder’s visionary leadership was imprinted
on the institution and the leaders, executive and board members, recruited to MCC possessed or
adopted similar characteristics. Leading by example, founders impacted employee’s commitment
(Crotts, et al., 2005, p. 61). Moffitt was a visionary leader who sought like-minded professionals to join
the cause.
The visionary leadership of the founder created an environment of opportunity to attract
additional leaders who shared in his corporate vision. As the “proselytizer,” the founder evangelized his
creation and drew talent to MCC (Westley & Mintzberg, 1989, p. 25). The cast of leaders created an MCC
culture of commitment and dedication, coupled with the freedom to pursue creative solutions to the
scourge of cancer. Schein (1983), mentioned often in culture centered literature, stated that culture was
not an immediate occurrence, but over time, cultural values became part of the fabric of an organization
(p. 46-47). The founder and the early adopters created an evolutionary culture that changed and
adapted throughout the years.
Literature on the three foundational factors enriched the content and enhanced understanding
for this work. MCC, as a private non-profit, while also serving as an instrumentality of the state, had a
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quasi-private, quasi-public role that was not predominate in the literature. However, material pertaining
to the basic foundational factors was plentiful.
Figure 4 above depicts the final model of factors and events. The model, evolved from Figure 1
though research and discovery, shows impactful factors leading to events that transformed MCC. Impact
is signified by a number of (+) signs near each corresponding arrow. The preponderance of the interview
respondents listed the founder as a significant factor not only in the creation of MCC, but also of his
continued leadership and impact on the institution decades later. Visionary leadership and culture
presented as important factors in addition to the founder. Figure 4 shows the causality through arrows
and the weighted impact that each factor or event had on subsequent boxes or circles. The founder
impacted the creation of the organization, visionary leadership and culture. Those factors, in turn
impacted the institution. Once the factors became part of the corporate fabric, the founder, visionary
leadership and culture created the institutional impetus to purse transformative initiatives that changed
the institution’s societal impact.
Transformational Events
Four specific decisions, as described by the interviewees, elevated MCC as a nationally
recognized cancer center and established it as an institution of transformational change.
The 1990 legislative initiative specified and empowered the position of center director. The
legislation enabled self-governance, control of the board of directors, control of facilities, statutory
authority to create departments to fulfill the institute’s mission, and control of the budget and research
grant dollars. Passage of the legislation codified those important changes and made MCC accountable,
on an annual reporting basis, to the state university system governing board, the Board of Regents (later
the Board of Governors) in state statute. That was the single most significant transformational event.
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But for the passage of that legislation, the additional three transformational events would not have
been possible.
The creation of an interdisciplinary approach was impossible for MCC pre-1990. MCC’s decision
to reorganize the patient care model, the second transformational event, designed care around disease
site as opposed to departmental organization by area of training and expertise. Rather than stand-alone
departments such as surgery and radiation oncology where physicians treat many types of diseases,
MCC’s model organized healthcare teams in a defined department that included professionals targeting
that specific disease. To clarify by example, all care deliverers focused on skin cancers, melanoma, basil
cell or squamous cell carcinoma, were in a department focused only on cutaneous diseases.
The decision to pursue CCC status was possible because the institution, via the 1990 success,
controlled the facilities and had authority to create departments and control grant awards. In order to
achieve CCC status, a research enterprise was created and MCC recruited researchers from around the
country and beyond. CCC was based solely on research and was not awarded based on patient care or
number of patients served. As of 2018, there were 49 CCC’s in the United States and MCC was the only
Florida-based center in the state. CCC designation was a differentiator and set MCC apart from other
centers in the state and region. Without the freedom to create a research enterprise, enabled by the
1990 legislation, control of grant funding and the freedom to recruit highly qualified individuals focused
specifically on cancer, MCC’s effort would have been greatly hindered.
The final transformational event, moving the faculty to MCC was also not possible under the
previous structure. Under the previous structure most physicians and researchers were employed by the
university yet worked fulltime at MCC. MCC paid the university and USF granted faculty tenure. The
2008 initiative moved faculty to MCC. Subsequently, the cancer center paid a stipend to the university
for faculty campus privileges while MCC granted tenure. The decision was not simple as faculty were
used to a more direct university structure. However, by creating the Moffitt Medical Group (MMG) and
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the Moffitt Research Institute (MRI), control of the faculty through that transformational event further
separated MCC from direct connection to the university and reinforced self-governance. Those
combined events, pivotal inflection points MCC’s history, transformed in the institution.
The final box, an institution of transformational change, showed the evolved cancer center as a
freestanding institution with the authority and ability to guide its own future. The transformed
institution made decisions, including the creation of new departments, innovative business ventures,
and strategic research and education collaborations. Three examples are described at the end of this
work. The institution of transformational change (+++++) evolved into a new organization with societal
benefit, furthered its mission and achieved the mandate set forth in state statute.

Figure 5. Final Depiction of Four Transformational Events

Figure 5, evolved from Figure 3, depicted that the 1990 legislation enabled the subsequent three
transformational events. Lines to the other events signified linkage, enabling the other three events, not
causation. While the three events that followed the 1990 legislation were made clear through the
research process, concise identification by the respondents, the legislative event itself required an

119

interpretivist and thematic approach. Creswell (2013) stated “coding involves aggregating the text or
visual data into small categories of information” where themes “are broad units of information” (pp.
184-186). The 1990 legislative initiative was only mentioned by title or timeframe by a few participants.
Other respondents mentioned numerous factors that they interpreted as important to MCC evolution
and maturation, but not any specific initiative or event.
The conclusion that the 1990 decision was, indeed, a key transformational event presented itself
through a process of assessing the key phrases, words or concepts that the respondent shared. Each of
these information pieces led to the conclusion that the event or outcome described could have only
happened due to the passage of the legislation. Specifically, responses such as “we needed to govern
ourselves,” “we need to control our research awards” or “we needed to be able to hire a center
director,” thematically were linked to the legislative outcome and were only made possible by its
passage (Appendix G).
As of 2018, MCC was the only CCC based in Florida and had served patients from every county in
the state, every state in the nation and more than 130 other nations. Many organizations engaged
initiatives aimed to benefit society while still operating as a successful business (Zimmerman, et al.,
2014, p. 18-21). From a small hospital with 409 employees in 1986, MCC had grown to more than 6,100
employees serving over 64,000 individual patients annually. It was a mature, transformational
institution fighting cancer and serving a social benefit. Social innovation has been described as the
implementation and utilization of new ideas to meet common goals (Mumford, 2002, p. 253-261). MCC,
as an institution of transformational change, likely exceeded the expectations of even its founder.
This project was designed to extrapolate knowledge of successful leadership practices,
determine what led to and cultivated MCC’s mission-driven organizational culture and identify
transformational events that re-defined the institution. Data was collected from individual interviews
and assessed using thematic analysis and sensemaking. This process led to the discovery of critical
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foundational factors and transformative events that contributed to understanding how MCC evolved
into one of the country’s top cancer centers. While the literature helped to make clear many ways in
which MCC was similar to other large organizations, there also appeared to be gaps in the current
knowledge base, particularly in terms of the unique role a founder who does not assume a senior
leadership role in non-profit organization that serves a societal purpose.
Limitations
Future qualitative and quantitative research projects could focus directly on two distinct areas;
1) decision making and decision outcomes of non-profits designed to address specific areas of concern
and 2) non-profit institutions of societal impact.
This project began with three research questions, yielding fruitful information from two of the
questions. The third, “What does Moffitt need to do to continue to be Florida’s premier cancer center?”
did not yield notable data for this research project. Results included reimbursement rates for services,
research money, culture, leadership and a number of other unrelated responses. A series of more
targeted questions may provide richer data that could be subdivided into categories or themes for
review and analysis.
Qualitative research projects relying on interview data can present numerous obstacles.
Answers to questions are drawn from the opinion or recollection of the respondent. Responses are
derived from the interviewee’s memory regarding an event, conversation or occurrence. Therefore,
factual accuracy regarding times, places, circumstances or results are subject to the recall of the
respondent and/or their willingness to be forthcoming. In interview-based research, if possible, a
greater number of interviewees, logically, should yield a clearer picture with corroborating interview
data.
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Interview questions must be clearly designed in order to answer the research questions. If
particular data is sought, a narrow line of questioning should be considered. Open-ended questions
would be useful to elicit responses without targeted outcomes.
Research regarding founders who did not assume leadership positions such as CEO or board
chair was not clearly present in the literature. Targeted research regarding company founders who
participate in, but do not own or run the organization may be useful. Further, non-profit founders who
are committed to a particular cause could be a topic for future societal impact research.
Specific topics for research that could be explored in future studies from this work include
legislatively created institutions and societal benefit. Governments at all levels allocate tax resources for
a multitude of purposes. Government waste has been the subject of much research and media
attention. However, research regarding government investment in institutions of societal impact may be
a valuable tool for transforming organizations with shared benefit.
This research project included twenty-one interviews with MCC leaders and program directors.
The majority of the program director data was not included in the scope of this work but may be useful
in future research endeavors.
Contributions
The aim of this research was two-fold: 1) discovery regarding the creation of MCC via leadership,
culture and growth, and 2) institutions of transformational change and societal benefit. The findings of
this project could be utilized in future research for non-profit and for-profit entities regarding
transformational events that alter the trajectory of an organization. Furthermore, this research adds to
current knowledge regarding how visionary leadership and culture contribute to transformational
decisions creating societal benefit.
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Through data examination of the research material, this study adds to current knowledge and
literature pertaining to transformational change and societal impact, while utilizing existing literature
regarding such factors as visionary leadership, culture and founder research. The findings in this
research contribute to the current base of knowledge.
Conclusion
Drive, personal experience, ambition, perseverance and vision have led to the creation of
remarkable enterprises that became organizations of societal impact. MCC’s founder had an idea. Due
to the death of three close friends, he envisioned a cancer center in Florida to serve the needs of the
state. Over a three-decade period, the founder’s creation grew from a small regional cancer hospital
into a nationally renowned CCC. MCC earned numerous recognitions, recruited some of the best and
brightest minds from around the globe, and led cancer care and research in Florida and beyond. The
institution that started with an idea became not only an economic engine for the community and state
but also served as an institution of transformational change with societal benefit.
The research illuminated specific elements that contributed to the growth, success and impact
of MCC. The concept of the institution started with one person, the founder. His vision, actions, evolving
role and constant attention were explored through the research process. Regarding the institution, the
concepts of founder, visionary leadership and culture emerged through the interview process as key
factors for this study. Recurring results revealed through interview data helped identify the key factors
that made a significant and lasting contribution to MCC. Additionally, four pivotal transformational
events that changed the course of the center were identified. The factors led to key events, the events
led to an institution of transformational change providing societal benefit.
Three topics exemplify what MCC did with the new freedoms that came with self-governance
and the subsequent transformational events.
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In 2007, MCC created a partnership with Merck & Company, a giant in the pharmaceutical
industry. The partnership, with investment from Merck, enabled MCC to create a for-profit subsidiary
company. M2Gen, a health informatics company was designed to accelerate personalized medicine.
Created by then CEO, William S. Dalton, PhD, MD, M2Gen sought to combine annotated clinical data and
tissue samples for study, clinical trials and drug discovery. Drug development was expensive and clinical
trials took a lot of time to develop and receive Food and Drug Administration (FDA) approval. One
component of the early M2Gen business plan was to create a data base that could house millions of
data points and tissue samples, linked to certain genetic markers, for utilization of pharmaceutical
companies to fill clinical trials. Clinical trials could take years to fill and complete. M2Gen provided an
opportunity to change that by establishing a data base that could match patients to trails in a matter of
days or weeks as opposed to years. In business time is money. For cancer patients time is precious. As of
2018, personalized medicine was the future; treating each patient based on their own genetic makeup.
The creation of M2Gen was a direct result of MCC transformational change.
Previously unheard-of research was also possible due to transformation. MCC created a
Department of Mathematical Oncology which was designed to explore mathematical study of tumor
growth prediction. Though that innovative department’s work, findings and clinical trial results showed
promise in altering treatment. Mathematicians in the department challenged long establish protocols by
exploring how lower doses of radiation or chemotherapy may have advantage over the most tolerable
dosages, as had been the norm for decades. Through clinical trials their research showed promising
signs in numerous cancers that dosing just enough to impact the disease, taking a break and continuing
only when the statistics elevated positively impacted the quality of life for patients and extended life in
cases.
In 2008, MCC formed a partnership with the Personalized Cancer Center in Tianjin, China. MCC
trained graduate students, post-doctoral fellows, nurses and physician-scientists as part of the exchange
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between the two cancer centers. Sharing of information and exporting expertise, the two-way
agreement augmented research and aided both entities in the cutting-edge field of personalized medical
treatment.
Freedom to partner with other organizations and/or educational institutions was made possible
by MCC’s foundational factors and the key events that created an institution of transformational
change. The societal impact had only just begun. There was no limit to the potential due to the vision of
one man, the people he surrounded himself with, the visionary leadership they possessed, the
organizational culture they created and the transformational decisions they made.
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The 2000 Florida Statutes

Title XVI
Chapter 240
View Entire Chapter
EDUCATION
Postsecondary Education
1240.299 Direct-support organizations; use of property; board of directors; activities; audit;
facilities.-(1) DEFINITIONS.--For the purposes of this section:
(a) "University direct-support organization" means an organization which is:
1. A Florida corporation not for profit incorporated under the provisions of chapter 617 and approved by
the Department of State;
2. Organized and operated exclusively to receive, hold, invest, and administer property and to make
expenditures to or for the benefit of a state university in Florida or for the benefit of a research and
development park or research and development authority affiliated with a state university and organized
under part V of chapter 159; and
3. An organization which the Board of Regents, after review, has certified to be operating in a manner
consistent with the goals of the university and in the best interest of the state. Any organization which is
denied certification by the Board of Regents shall not use the name of the university which it serves.
(b) "Personal services" includes full-time or part-time personnel as well as payroll processing.
(2) USE OF PROPERTY.-(a) The Board of Regents is authorized to permit the use of property, facilities, and personal services at
any state university by any university direct-support organization, and, subject to the provisions of this
section, direct-support organizations may establish accounts with the State Board of Administration for
investment of funds pursuant to part IV of chapter 218.
(b) The Board of Regents shall prescribe by rule conditions with which a university direct-support
organization must comply in order to use property, facilities, or personal services at any state university.
Such rules shall provide for budget and audit review and oversight by the Board of Regents.
(c) The Board of Regents shall not permit the use of property, facilities, or personal services at any state
university by any university direct-support organization which does not provide equal employment
opportunities to all persons regardless of race, color, religion, sex, age, or national origin.
(3) BOARD OF DIRECTORS.--The chair of the Board of Regents may appoint a representative to the
board of directors and the executive committee of any direct-support organization established under this
section. The president of the university for which the direct-support organization is established, or his or
her designee, shall also serve on the board of directors and the executive committee of any direct-support
organization established to benefit that university.
(4) ACTIVITIES; RESTRICTION.--A university direct-support organization is prohibited from giving, either
directly or indirectly, any gift to a political committee or committee of continuous existence as defined in s.
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106.011 for any purpose other than those certified by a majority roll call vote of the governing board of the
direct-support organization at a regularly scheduled meeting as being directly related to the educational
mission of the university.
(5) ANNUAL AUDIT.--Each direct-support organization shall make provisions for an annual postaudit of
its financial accounts to be conducted by an independent certified public accountant in accordance with
rules to be promulgated by the Board of Regents. The annual audit report shall include a management
letter and shall be submitted to the Auditor General and the Board of Regents for review. The Board of
Regents and the Auditor General shall have the authority to require and receive from the organization or
from its independent auditor any detail or supplemental data relative to the operation of the organization.
The identity of donors who desire to remain anonymous shall be protected, and that anonymity shall be
maintained in the auditor's report. All records of the organization other than the auditor's report,
management letter, and any supplemental data requested by the Board of Regents and the Auditor
General shall be confidential and exempt from the provisions of s. 119.07(1).
(6) FACILITIES.--In addition to issuance of indebtedness pursuant to s. 240.2093(2), each direct-support
organization is authorized to enter into agreements to finance, design and construct, lease, leasepurchase, purchase, or operate facilities necessary and desirable to serve the needs and purposes of the
university, as determined by the systemwide strategic plan adopted by the Board of Regents, upon
approval of such agreements by the Board of Regents and approval of the project by the Legislature.
Such agreements are subject to the provisions of s. 243.151.
(7) ANNUAL BUDGETS AND REPORTS.--Each direct-support organization shall submit to the university
president and the Board of Regents its federal Internal Revenue Service Application for Recognition of
Exemption form (Form 1023) and its federal Internal Revenue Service Return of Organization Exempt
from Income Tax form (Form 990).
History.--s. 10, ch. 75-302; s. 21, ch. 79-222; s. 6, ch. 85-313; s. 67, ch. 87-224; s. 1, ch. 88-237; s. 75, ch. 90-360; s. 14,
ch. 91-55; s. 5, ch. 94-230; s. 819, ch. 95-148; s. 16, ch. 95-243; s. 27, ch. 95-392; s. 96, ch. 96-406; s. 1, ch. 98-99; s. 1,
ch. 2000-267; s. 3(7), ch. 2000-321.
Note.--Repealed January 7, 2003, by s. 3(7), ch. 2000-321, and shall be reviewed by the Legislature prior to that date.

1

Note.--Former s. 240.182.
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Interview Questions
Wilson Dissertation

1) What is your current role/affiliation with Moffitt?
2) How long have you been affiliated with Moffitt?
3) What is Moffitt Cancer Center?
4) What is your perception about Moffitt’s reputation?
5) What is the role of Moffitt?
6) As the only Florida based CCC, is Moffitt distinguished differently than other cancer centers? If
so, how?
7) How did Moffitt achieve its position?
• Policy
• Leadership
• People
8) Tell me about Lee Moffitt
9) How about his leadership?
10) Who or what has impacted Moffitt greatly?
11) What is the role of the board?
12) What about leadership?
13) If you could point to one or more decisions, what was important to Moffitt’s success?
14) What are the needs for the future?
15) Looking forward, what are the potential pitfalls/danger areas that Moffitt Cancer Center may
face?

137

APPENDIX C: INTERVIEWEE BIOS

138

Timothy (Tim) J. Adams
Tim Adams is former president of Time Customer Service, Inc. (TCS) and was responsible for all TCS
activities conducted on behalf of Time Inc. TCS employs 700+ people and occupies in excess of 300,000
square feet of office and light industrial space. TCS’s primary responsibility is the fulfillment of
subscriptions for the Time Inc. family of magazines, the National Geographic Society, American Express,
Kiplinger, National Wildlife, Wenner Media, Foreign Affairs, Smithsonian, and The Week.
Tim is from Webster Springs, West Virginia. He received his Bachelor of Science in Industrial Engineering
from West Virginia University.
Adams has incredible financial acumen that has guided Moffitt’s 1.5 million-square-foot expansion over
two decades. He was a key negotiator behind a recent $75 million investment in Moffitt subsidiary
M2Gen that will benefit countless patients nationwide through precision medicine-based clinical trials.
His support of partnerships has enabled Moffitt to extend its expertise globally, to Tianjin Medical
University in China, and statewide, including partnerships with Memorial Healthcare System’s Broward
County hospitals.
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Theodore (Ted) J. Couch, Sr.
Ted Couch, Sr. graduated from Jesuit High School in 1954, entered a Roman Catholic Seminary for one
year and thereafter attended the University of Tampa and the Louisiana State University School of
Banking.
His full time working career began in 1956 with the newly formed First Industrial Savings Bank of Tampa
where he was employed as a runner. In 1958 First Industrial became the Northside Bank of Tampa and
moved to a North Tampa location as a full commercial bank. By this time Mr. Couch had worked his way
up to becoming an officer of the bank and after holding every office position in the bank in 1966 he
earned the title of President. In 1977 Mr. Couch left the bank to pursue the development of commercial
real estate in the North Tampa area and to date continues to manage the properties he developed over
the last 30 years.
In 1981, Mr. Couch and his partner George Cortner agreed to fund a chair in cancer research at the
University of South Florida. This financial support from the community assisted in the appropriation of
funding by the Legislature and through the persistence of then House Speaker, H. Lee Moffitt, the
Moffitt Cancer and Research Center on the campus of USF became a reality. Mr. Couch chaired the
board of directors of the Moffitt Cancer Center for 7 years. In 2000, he stepped down to chair Moffitt’s
first capital campaign. This ambitious effort concluded in 2006 after exceeding the $87 million goal.
During his working career, Mr. Couch has chaired the University Community Hospital board and is now
emeritus after 27 years of service. He has served on numerous boards and foundations in the
community and has been a consistent donor to countless charities in the Tampa Bay Community. He
maintains that wealth demands increased responsibility along with personal discipline and that wealth
does not bring happiness to a person’s life but sharing of wealth does.
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William (Bill) S. Dalton, PhD, MD
Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company. Additionally, he is
founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s
brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and CEO of Moffitt
from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and
innovation. He facilitated the launch of M2Gen and the development of Moffitt Total Cancer Care®. Dr.
Dalton received his Ph.D. and medical degree from Indiana University School where he completed an
internship in medicine. He then completed a residency in medicine and fellowships in oncology and
clinical pharmacology at the University of Arizona in Tucson. He joined the University of Arizona medical
school faculty, where he became professor and dean of the College of Medicine. He also directed the
Bone Marrow Transplant Program at the Arizona Cancer Center.
Dr. Dalton joined Moffitt in 1996 and served as associate center director for clinical investigations and
deputy director of the cancer center. He also founded and chaired the Department of Interdisciplinary
Oncology at the University of South Florida where he is a professor of oncology. Dr. Dalton left Moffitt
briefly in 2001 to serve as dean of the College of Medicine at the University of Arizona, returning in 2002
as the cancer center’s president, CEO and center director. A medical oncologist, Dr. Dalton has been a
principal investigator or co-investigator for numerous research studies in his specialty of malignant
hematology. Over his career, Dr. Dalton has published extensively, served on numerous editorial
advisory boards for professional publications, participated extensively on committees for National
Institute of Health/National Cancer Institute, American Association of Cancer Research, American
Society of Hematology and the American Society of Clinical Oncology. He has also served on many
university-based scientific advisory boards.
Education & Training:
Board Certification:
• Medical Oncology
Fellowship:
• University of Arizona - Oncology
• University of Arizona - Clinical Pharmacology
Residency:
• University of Arizona - Medicine
Medical School:
• Indiana University - MD
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L. David de la Parte, Esq.
Mr. de la Parte is Executive Vice President and in-house General Counsel at H. Lee Moffitt Cancer Center
and Research Institute. He joined Moffitt Cancer Center to establish its in-house General Counsel office
in March 2007 after leaving de la Parte & Gilbert, P.A. as its managing partner. He received his
Bachelor’s Degree in political science from Florida State University in 1983 and his Juris Doctor from
Stetson University College of Law in 1985. While in private practice, Mr. de la Parte concentrated his
practice in the general representation of clients in the health care industry and the representation of
governmental and quasi-governmental agencies. He became Moffitt Cancer Center’s outside General
Counsel in 1990.
He was admitted to The Florida Bar, the United States District Court for the Middle District of Florida
and the United States Court of Appeals for the Eleventh Circuit in 1986. He is also a member of the Bar
of the United States Supreme Court. He is a member of the American and Florida Bar Associations and
was the founding chair of the Hillsborough County Bar Association Health Law Section. He is also a
member of the American Health Lawyers Association and the Florida Hospital Association Academy of
Healthcare Attorneys. He is considered an “AV” rated attorney by the Martindale-Hubbell Law Directory,
which is the highest rating conferred by Martindale-Hubbell for legal skills and ethical conduct. In 2004,
he was recognized by Florida Trend magazine as one of Florida’s "Legal Elite."
Mr. de la Parte is past chair of the District 6 Health and Human Services Board for Hillsborough and
Manatee Counties. In 1995, he served as co-chair of the Governor’s Special Panel on Child Protection,
which investigated the death of Lucas Ciambrone. He is past chair and currently serves on the Board of
Directors of Youth Environmental Services, Inc., and Tampa Marine Institutes, Inc., nonprofit
organizations which operate programs for the rehabilitation of delinquent youth.
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Edward (Ed) C. Droste
Ed Droste was appointed in 2014 to Moffitt Cancer Center’s national Board of Advisors, a growing group
of prominent individuals who serve as Moffitt ambassadors and offer their expertise and counsel on
issues relating to the cancer center.
Ed Droste is chairman of Provident Management Corporation. He also is the co-founder and partner in
Hooters Restaurants, originating in Clearwater, Fla. in 1983. Hooter’s currently has more than 400
restaurants nationwide with sales of nearly a billion annually, as well as locations in 28 countries. Droste
was involved in the conceptualization, development and marketing of Hooters Casino Hotel in Las
Vegas. He graduated from Iowa State University in 1973, with a B.S. degree in Industrial Administration
and Political Science. He was President of his graduating class and was named National Top Alumnus of
the Year for his fraternity, Tau Kappa Epsilon. He later dedicated a study hall in his name at Iowa State’s
business school.
In conjunction with Hooters Restaurants, Droste formed Provident Advertising and Marketing to
coordinate the chain’s promotional activities for the brand and other ventures in a number of
industries. Through Provident, Droste also co-founded several successful restaurant concepts, including
Pete & Shorty’s Tavern, Adobe Gila’s and Splitsville, which recently opened a location in Downtown
Disney.
Droste has served in leadership positions of multiple societies and boards. He currently serves as
chairman of Moffitt’s Foundation Board of Directors. Droste was appointed by Gov. Rick Scott to the
Florida Prostate Cancer Advisory Council. He also was honored by the Florida Council on Economic
Education for his induction into the 2012 Tampa Bay Business Hall of Fame.
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Robert (Bob) A. Gatenby, MD
Robert Gatenby, MD is the Chairman of the Department of Radiology at Moffitt Cancer Center and CoDirector of the Cancer Biology and Evolution Program. He joined Moffitt in 2008 from the University of
Arizona where he was Professor, Department Radiology and Professor, Department of Applied
Mathematics since 2000. He received a B.S.E. in Bioengineering and Mechanical Sciences from Princeton
University and an M.D. from the University of Pennsylvania in 1977. He completed his residency in
radiology at the University of Pennsylvania where he served as chief resident. Bob remains an active
clinical radiologist specializing in body imaging. While working at the Fox Chase Cancer Center after
residency, Bob perceived that cancer biology and oncology were awash in data but lacked coherent
frameworks of understanding to organize this information and integrate new results. Since 1990, most
of Bob's research has focused on exploring mathematical methods to generate theoretical models for
cancer biology and oncology. His current modeling interests include: the tumor microenvironment and
its role in tumor biology, evolutionary dynamics in carcinogenesis, tumor progression and therapy,
information flow in living systems and its role in maintaining thermodynamic stability.

Discipline:
• Molecular Oncology
• Integrated Mathematical Oncology
• Diagnostic Imaging and Interventional Radiology
• Myeloma
• Cancer Imaging and Technology
• Center for Immunization and Infection Research in Cancer
• Cancer Biology and Evolution Program
• Evolutionary Therapy
• Education & Training

Board Certification:
• Diagnostic Radiology
Fellowship:
• University of Pennsylvania, MD
• Hospital of U Penn, Chief Resident - Radiology
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Anna R. Giuliano, PhD
Anna R. Giuliano, PhD, is the founding director of the Center for Infection Research in Cancer (CIRC) at
the Moffitt Cancer Center. Her career had its inception in the relationship between human
papillomavirus (HPV) infections and cervical cancer in women and has evolved over the past several
decades to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious
diseases and their causal relationships with various cancers. Her work has contributed significantly to
our understanding of the rate at which HPV infections are acquired and cleared, the proportion that
progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.
An expert in the field of cancer research with a longstanding and successful record of National Institutes
of Health funding since 1990, she has been actively involved in cancer epidemiology and prevention
studies conducted among diverse populations in the United States and abroad. In the course of those
endeavors, Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The
Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report that
concluded for the first time that HPV is a cause of multiple cancers in women and men. In 2013, at the
100th anniversary of the American Cancer Society (ACS), she was the recipient of the ACS Distinguished
Achievement in Cancer Award. Dr Giuliano has authored more than 330 peer-reviewed publications.

Discipline:
• Cancer Epidemiology
• Head and Neck-Endocrine Oncology
• Cancer Epidemiology Program
• Center for Immunization and Infection Research in Cancer
Education & Training:
• Tufts University, School of Nutrition, Medford, MA, MS - Nutrition
• Tufts University, School of Nutrition, Medford, MA, PhD - Nutritional Biochemistry
• New England Epidemiology Institute, Fellow - Epidemiology Statistics
• University of Arizona, NCI Cancer Prevention Fellow - Cancer Prevention Epidemiology
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The Hon. Ralph H. Haben, Jr., Esq.
Ralph was raised in Palmetto Florida. He attended Manatee County schools and received his B.A.E. in
Education from the University of Florida in 1964. He graduated from Cumberland College of Law in 1967
and began private practice in Manatee County in 1968. He served as an assistant state attorney and as a
municipal judge.
In 1972 Ralph was elected to the Florida House of Representatives. He served on every major committee
and won many legislative awards culminating in his election as Speaker of the House in 1981. While
serving in the Legislature, Ralph was an integral part of the revisions of the Florida Criminal Code, the
Evidence Code and the Probate Code. As Chairman of the Committee he had to carefully evaluate the
existing law, the relevant cases and the public policy questions involved in the revisions.
Since 1982, Ralph has maintained a successful law practice in Tallahassee, Florida.
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John (Jack) A. Kolosky, CPA, MBA
Jack Kolosky is Chief Operating Officer of Moffitt Cancer Center in Tampa, FL, and serves as the
President of Moffitt Hospital. He joined the Cancer Center in November 1999.
Mr. Kolosky is responsible for ensuring that high quality care is provided to its many patients and that
the Cancer Center is compliant with regulatory agencies and accrediting bodies, continually monitoring
Moffitt's service and delivery systems. Mr. Kolosky also has the role of corporate Executive Vice
President/Chief Operating Officer, where he oversees Patient Care Services as well as corporate
functions as Information Technology, Internal Audit and Facilities and Support Services.
Mr. Kolosky has more than 30 years of health care leadership experience, including multiple hospital
environments, clinic settings and academic, tertiary health care delivery systems. Prior to coming to
Moffitt, he served as the Chief Financial Officer for the Georgetown University Medical Center in
Washington, D.C., and
Mr. Kolosky is a Fellow in the Healthcare Financial Management Association, a member of the American
College of Healthcare Executives, and is active in a number of other professional organizations. He
serves on the board of directors of Moffitt Genetics Corporation (M2Gen), the Tampa Bay Partnership
and is the past chair of Chapters Health System (the parent corporation of LifePath Hospice). Mr.
Kolosky is currently the Board Chair of the Alliance of Dedicated Cancer Centers and the Board Chair of
the Florida Hospital Association. He previously served on the board of the Nevada Cancer Institute.
as the Associate Vice President and Chief Financial Officer of the University of Texas M. D. Anderson
Cancer Center in Houston, Texas.
Mr. Kolosky received his bachelor's degree in Accounting from Western Illinois University and an MBA in
Finance from Drake University. He holds a Certificate from the Harvard University School of Public
Health and is a Certified Public Accountant.
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G. Douglas (Doug) Letson, MD
Dr. Douglas Letson is executive vice president of clinical affairs and physician-in-chief at Moffitt Cancer
Center, as well as prior chair of the Sarcoma Department. In addition, he is a professor of surgery,
radiology and orthopaedics at the University of South Florida and director of the USF Orthopaedic
Residency Program. As an orthopaedic oncology surgeon, Dr. Letson’s research and clinical interests
include: novel therapeutic agents to treat sarcoma; limb salvage for bone and soft tissue tumors; as well
as segmental prosthesis, new hinge designs and soft tissue attachment for metallic prosthesis. Dr.
Letson has a keen interest in new techniques and design of instrumentation for minimal invasive
reconstructive surgery. He collaborated with Stanmore Corporation in England to develop a non-invasive
leg lengthening implant, and he is the only physician in the United States to implant and lengthen the
limbs of several children successfully.
A graduate of Louisiana State University School of Medicine, Dr. Letson completed his residency in
orthopedics at LSU affiliated hospitals, where he was chief resident at LSU Children’s Hospital. He
pursued advanced training through a musculoskeletal oncology fellowship at Massachusetts General
Hospital-Harvard Medical School and was awarded Clinical Oncology Fellow of the American Cancer
Society. Prior to joining Moffitt in 2000, he was with the Watson Clinic in Lakeland, FL, and with the
Florida Orthopaedic Institute in Tampa. Dr. Letson is a frequent guest speaker at local and international
physician conferences and has received numerous awards, including American Orthopaedic Academy
Honor Society, Professor of the Year at Orlando Regional Healthcare, Teacher of the Year for the USF
Radiology Department and Best Doctors in America.

Education & Training:
Board Certification:
• Orthopaedic Surgery
Fellowship:
• Massachusetts General Hospital – Harvard Medical School - Musculoskeletal Oncology
Residency:
• Louisiana State University Medical School Affiliated Hospitals - Orthopaedics
Medical School:
• Louisiana State University - MD
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Alan F. List, MD
Dr. Alan List is the president and CEO of Moffitt Cancer Center. He is a senior member in the
Department of Malignant Hematology and the Experimental Therapeutics Program. In addition, Dr. List
is a professor of internal medicine and oncology at the University of South Florida Morsani College of
Medicine. After earning his medical degree from the University of Pennsylvania, Dr. List completed a
residency in medicine at Good Samaritan Medical Center in Phoenix, AZ. He pursued fellowships in
hematology and medical oncology at Vanderbilt University Medical Center in Nashville, Tenn.
Prior to joining Moffitt in 2003, Dr. List was a professor of medicine and director of the Leukemia and
Bone Marrow Transplant Program at the University of Arizona Tucson, as well as Associated Center
Director of the Division of Translational/Clinical Research. Dr. List is internationally recognized for his
many contributions in the development of novel, more effective treatment strategies for
myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). His pioneering work led to the
development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which went on to receive
fast-track designation from the U.S. Food and Drug Administration and approval for the treatment of
patients with MDS and multiple myeloma.
He is the author of more than 330 peer-reviewed articles and co-editor of Wintrobe’s textbook of
Hematology. He serves as a member of the Board of Directors of the Myelodysplastic Syndrome
Foundation and the AA & MDS International Foundation and is the President-Elect (2017-18) for the
Society of Hematologic Oncology (SOHO). He also is an active member of the American Society of
Clinical Oncology; American Society of Hematology; American Association for Cancer Research;
International Society for Experimental Hematology; J.P. McCarthy Foundation Medical Advisory
Committee; and the Southwestern Oncology Group.

Education & Training:
Board Certification:
• Medical Oncology
• Hematology
Fellowship:
• Vanderbilt University Medical Center, Nashville, TN - Oncology
• Vanderbilt University Medical Center, Nashville, TN - Hematology
Residency:
• Good Samaritan Medical Center, Phoenix, AZ - Internal Medicine
Medical School:
• University of Pennsylvania - MD
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The Hon. Connie Mack III
Senator Connie Mack represented the State of Florida in the United States Congress for 18 years,
including 12 years in the United States Senate where he played a leading role in economic and health
care issues. Senator Mack led a historic bipartisan Congressional effort to double funding over a fiveyear period for biomedical research conducted through the National Institutes of Health. At the time of
his retirement in 2001, Senator Mack served as the Republican Conference Chairman, making him the
third-ranking member of the Senate Republican leadership.
Senator Mack became the first Republican in Florida history to be re-elected to the U.S. Senate in 1994
when he received more than 70 percent of the vote, more than any other Republican candidate in the
nation. Prior to his election to the Senate, he served three two-year terms as a member of the House of
Representatives from southwest Florida. In April 1994, Mack was named by Campaign and Elections
magazine as one of the 20 most popular elected officials in America. As a House member, U.S. News and
World Report identified him as one of the nation’s most effective “new rising political stars.”
For the past 10 years, Senator Mack has worked with clients to develop and implement strategies to
successfully achieve their legislative policy goals. In 2007, he became a founding Partner and Senior
Policy Advisor with Liberty Partners of Florida, LLC in Tallahassee and continued in these roles as the
partnership expanded in January 2010 into Liberty Partners Group, LLC in Washington, DC. Appointed by
President Bush in 2005, Senator Mack served as Chairman of the President’s Advisory Panel for Federal
Tax Reform. Currently, Senator Mack serves as Chairman Emeritus, serving after years as Chairman of
the Board of Directors of the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida. He
was a founding trustee of the American Cancer Society Foundation and served as past President. The
Senator is a member of the Board of Directors of the Mutual of America Life Insurance Company, is Vice
Chairman of M2Gen, and serves on the Board of the Moffitt Cancer Center, where he is the Chair
Emeritus.
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Jennifer (Jenny) L. Moffitt, PhD
Jenny Moffitt is assistant professor of English at Florida Southern College in Lakeland, Florida. Before
joining the faculty at Florida Southern, she taught for seven years at Florida State University, first as a
graduate student and then as a visiting lecturer. Her research and teaching interests include American
literature, gender theory, and visual culture studies. Jenny is the recipient of the J. Russell Reaver Award
for Outstanding Dissertation in American Literature or Folklore, and the Bryan Hall Award for Excellence
in Teaching First-Year Composition. She holds a B.A. in English from Appalachian State University, a M.A.
in Literature from Humboldt State University, and a Ph.D. in Literature from Florida State University.
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The Hon. H. Lee Moffitt, Esq.

Moffitt was born in Tampa and attended Henry B. Plant High School in Tampa, graduating in 1959. He
later obtained his Bachelor of Arts from the University of South Florida in 1964 and his Juris Doctor
from Cumberland School of Law in 1967.
Moffitt was elected to the Florida House in 1974, serving Tampa, Florida. He served
as Democratic member of the Florida House of Representatives, holding various positions throughout
his ten years of service there. In 1976 he was selected as the Most Effective First-Term House
member and presented with the Allen Morris Award by the Florida Times-Union. From 1978 to 1980 he
chaired the Commerce Committee, and the House Reapportionment Committee from 1980 to 1982.He
was again selected by St. Petersburg Times (now Tampa Bay Times) as the "most Effective Member of
the House" in 1982, as Chairman of the House Reapportionment Committee. In November 1982, he was
elected Speaker of the Florida House of Representatives and served in this capacity until 1984. He
retired from the legislature in 1984 to return to the practice of law.
While a member of the house of representative, Moffitt spearheaded a project to build a cancer
treatment center in Florida. Moffitt had been diagnosed with a malignant tumor in his left knee at age
29, for which he did a tumor resection. It was this experience, along with the death of friends, Joseph
Lumia, Judy Barnett and George Edgecomb, from cancer, that motivated Moffitt to lobby for a cancer
treatment center in Tampa. He secured an initial $70-million via the Legislature for the commencement
of the construction
The H. Lee Moffitt Cancer Center & Research Institute officially opened on October 27, 1986, three years
after its groundbreaking. Despite Moffitt's objection, the Florida legislature voted to name the facility in
his honor. In 2006 he was honored by the Association of Community Cancer Centers' (ACCC) Annual
Achievement Award for his commitment to combating cancer through the center he founded. Since its
founding the center has expanded its services and was designated an NCI Comprehensive Cancer Center
in 2001.
Also, during his legislative career he passed constitutional resolutions that created a merit selection
process for the Florida Appellate Judiciary and granting Floridians a right to privacy. Both constitutional
amendments were approved by Florida voters. He also led the effort to pass the Water Quality and
Assurance Act of 1983, and the Growth Management Act of 1985.
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James (Jim) J. Mulé, PhD
Dr. Mulé joined Moffitt in 2003 as the associate center director for Translational Science. His research
focuses on characterizing and validating genomic signatures of immunotherapy response, as well as
designing and translating novel vaccine and adoptive T-cell transfer strategies to patients with advanced
solid tumors. s been named a Master of Immunology by the American Association for Cancer Research
(AACR) publication Cancer Immunology Research. The distinction recognizes his life’s contributions to
cancer research; in particular, his work to better understand how anti-tumor immune responses develop
and are regulated by the body. The results of his life’s work have helped shape the future of cancer
therapy through the development of personalized immunotherapies that use a patient’s own immune
system to fight his or her disease.
The clinical application of immunotherapy for cancer is rapidly moving forward in multiple areas, which
incorporate the adoptive transfer of antitumor-reactive T cells and the use of 'therapeutic' vaccines.
Both clinical and immunologic endpoints have shown new promise to the field. Novel dendritic cellbased vaccine strategies designed in the laboratory and proven in preclinical animal tumor models are
now entering the clinic, with the intent of providiyvettng therapeutic efficacy. Improvements on this
approach involve breaking tolerance to tumor 'self' antigens by inhibiting regulatory cells, boosting T cell
co-stimulation, and administering combinations of recombinant cytokines and other defined molecules
with 'immuno-enhancing' activities. Development of these improvements is the primary research
interest of Dr. Mulé.

Discipline:
• Cutaneous Oncology
• Translational Research
• Radiation Oncology
• Immunology
• Melanoma Research Center of Excellence
• Center for Immunization and Infection Research in Cancer
Fellowship:
• Fred Hutchinson Cancer Research Center, PhD - Tumor Immunology
• University of Washington School of Medicine, Postdoctoral Fellow - Surgery
• National Cancer Institute, Bethesda, Maryland, Fellow - Surgery
• University of Washington, School of Medicine, MS - Cellular Immunology
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Warren Jackson (Jack) Pledger, PhD
Warren Jackson (Jack) Pledger is a molecular cell biologist who is the Associate Director for Research and
Deputy Director of the Gibbs Cancer Research Institute in Spartanburg, South Carolina. He has held
academic appointments and tenure at the University of North Carolina School of Medicine (Assistant
and Associate Professor of Pharmacology and Program Leader of the Cell Biology Program at the
Lineberger Cancer Center), Vanderbilt University School of Medicine (Professor of Cell Biology) and the
University of South Florida College of Medicine (Professor of Biochemistry and Oncology.)
He moved to the Moffitt Cancer Center in 1994 as Associate Center Director for Basic Research and was
awarded the Cortner-Couch Endowed Chair in Cancer Research. Dr. Pledger was responsible for the
development, administration and quality of all research programs and cores at Moffitt. He was also
responsible for recruiting investigators to Moffitt to support the application for a National Cancer
Institute (NCI) Comprehensive Cancer Center. Moffitt grew into a national research institution during his
tenure as Associate Center Director for Basic Sciences. He instituted and developed the Moffitt Research
Institute and was its Founding Director. Moffitt/University of South Florida Ph.D. program in Cancer
Biology was organized under his leadership, which continues to train students. He also served as the
Deputy Center Director (2001 to 2013). In addition, he served as the principal investigator at Moffitt’s
National Functional Genomics Center (NFGC).
Pledger has received peer-reviewed funding for more than 30 years. He has held numerous National
Institute of Health (NIH) and NCI grants, participated in three Program Project Grants (PPG) and was the
principal investigator of one PPG. He has served as the principal investigator on several institutional
grants including the American Cancer Society (ACS) Institutional Research Grant, the National Genomics
Center Grant (Department of Defense), and a U56 / U54 partnership grant with the Ponce School of
Medicine Cancer Center He has over 150 publications in journals, including ScienceNature, Proceedings
of the National Academy of Sciences, USA, Molecular Cell Biology,[ and Journal of Cell Biology Dr.
Pledger is also an associate editor for the Journal of Cellular Biochemistry, Critical Reviews in Eukaryotic
Gene Expression and Cancer Research. He has served as a permanent member on NIH, ACS and VA grant
review panels and has served on several NIH and NCI ad hoc panels that reviewed Program Project
Grants and Center Grants. He was the first recipient of Moffitt Cancer Center's Scientist of the Year
Award.
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Nicolas (Nick) C. Porter
Nick Porter is a senior advisor with the THEO Executive Group who builds strong cultures of excellence
with senior executives of medical and academic institutions. From 1988 to 2011, Nick was with the
Moffitt Cancer Center as its chief operating officer and then as its executive vice president for
institutional advancement and corporate relations. Throughout his tenure, Nick was the primary liaison
for Moffitt’s board of directors. Prior to joining Moffitt, Nick was chief operating officer of Johns Hopkins
Hospital. Nick has served on the board of trustees and the finance committee of the National
Comprehensive Cancer Network; the executive committee of the Alliance of Dedicated Cancer Centers;
the finance committee of the Association of American Cancer Institutes, and other community boards.
He holds a B.A. degree from the University of Baltimore and a Master’s of Education from Loyola
College.
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John C. Ruckdeschel, MD
Dr. John C. Ruckdeschel is the Cancer Institute director and Ergon Chair in Cancer Research for the
University of Mississippi Medical Center.
Ruckdeschel, who previously served as the director of the Moffitt Cancer Center in Tampa, led that
institution to National Cancer Institute Comprehensive Cancer Center designation and to become the
third-largest clinical cancer program in the United States.
He then moved to the Barbara Ann Karmanos Cancer Center in Detroit, where he re-acquired its NCI
comprehensive status and completed the process of making Karmanos a free-standing cancer hospital.
In both settings he built strong clinical networks by working with community physicians and patients,
developing effective inter-disciplinary clinical teams and creating strong programs across clinical, basic,
translational and population research.
As a clinician, Ruckdeschel's career has focused on lung cancer and other thoracic malignancies. He's
credited with more than 150 peer reviewed manuscripts and co-editorship of the Textbook of Thoracic
Oncology. He is currently a North American editor for the Cochrane Lung Cancer Review Group.
Ruckdeschel completed his undergraduate education in biology at Rensselaer Polytechnic Institute and
received his medical degree from Albany Medical College in New York. He went on to an internship at
Johns Hopkins, residency at the Beth Israel Medical Center in Boston and fellowship at the National
Cancer Institute's Baltimore Cancer Research Center.
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Thomas A. Sellers, PhD, MPH
Dr. Thomas Sellers is center director of Moffitt Cancer Center and executive vice president. Dr. Sellers
research program seeks to integrate a basic science background in nutrition and genetics with
observational research methods to try to understand questions such as, why do less than 20 percent of
cigarette smokers develop lung cancer and why is a proven effective cancer treatment beneficial to only
a subset of patients? His studies are based on genetic analysis of germline DNA and the increasing
incorporation of acquired (somatic) events.
The primary focus of his research is ovarian cancer, which is a devastating disease with no clear warning
signs and high mortality rates. Dr. Sellers also has active collaborations that involve cancers of the
breast, lung and prostate. The underlying theme is identifying inter-individual differences in cancer
susceptibility and using that to inform approaches to cancer prevention, early detection and precision
medicine to enhance outcomes after diagnosis.
Critical to the success of this effort is team science, necessitating collaborations with geneticists,
pathologists, biostatisticians, biomedical informaticists and clinicians. The Moffitt environment enables
that to happen naturally.
Dr. Sellers earned his Master of Public Health from Tulane University School of Public Health and
Tropical Medicine and his Ph.D. in Epidemiology from Tulane. He was a postdoctoral fellow in genetic
epidemiology at Louisiana State University Medical Center.)

Education & Training:
• Postdoctoral Fellow, Louisiana State University Medical Center, 1989 - Genetic Epidemiology
• PhD, Tulane University, 1988 – Epidemiology
• MPH, Tulane University, School of Public Health and Tropical Medicine, 1984 – Epidemiology
• BS, University of California at Davis, 1982 - Community Nutrition
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Yvette Tremonti, CPA, MBA
Yvette Tremonti is the Chief Financial and Administrative Officer of Moffitt Cancer Center in Tampa, FL
and is responsible for overseeing the financial operations of the center, Digital Innovation initiatives,
Information Technology, Construction Planning & Design and the Enterprise Project Management Office
aligned with Process Excellence.
In this capacity, Ms. Tremonti also oversees Payor and Partnership Strategy, Strategy and Planning, and
Human Resources. Ms. Tremonti supports the successful navigation of the organization through a
dynamic healthcare terrain and ensures that department leaders are aligned with Moffitt’s strategy to
transform cancer care.
As part of the senior leadership team, she is responsible for ensuring the development and achievement
of the long-term strategic and financial goals of superior value, partnership, financial health, research
and translation and education. She has worked for Moffitt Cancer Center since 1996. Prior to her current
role, Ms. Tremonti served as Executive Vice President of Strategy and Business Development and as Vice
President of Human Resources.
Ms. Tremonti has approximately 22 years of health care finance experience. She spent nine years with
Ernst & Young in the audit practice focused on for-profit and not-for-profit health care entities. In
addition, she served as campus coordinator, recruiter and program instructor for Ernst & Young.
Ms. Tremonti holds a bachelor’s degree in Business Administration from the University of South Florida
and a Masters of Business Administration from Auburn University. She is a member of the American and
Florida Institute of Certified Public Accountants, the Healthcare Financial Management Association and
the Society for Human Resource Management.
She places a high priority on the cancer center’s community involvement, encouraging Moffitt’s
leadership and her own direct reports to be involved in organizations and activities that help to enhance
the Tampa Bay community. She has taken an active role on the board of directors of the Greater Tampa
Chamber of Commerce, the Hillsborough Education Foundation, and the National Comprehensive
Cancer Network (NCCN) Board of Directors. She currently is the treasurer of the Hillsborough Education
Foundation.
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The Hon. William (Will) W. Weatherboard
Speaker Weatherford was the 84th Speaker of the Florida House of Representatives, serving from 20122014, during which time he was the youngest Speaker in America. Throughout his four consecutive
terms in office, Will was a strong advocate for social upward mobility through free enterprise and
education reform. He was also a thought leader on other pro-growth solutions including lower taxes,
pension reform, and free market health care.
Will is the Managing Partner of Weatherford Capital, a firm with deep roots in Florida and a strong
global network that partners with owners and management teams of high integrity to build great
businesses through the provision of capital and strategic business advisory services.
Will serves on the board of Sunshine Bankcorp, the National Coalition for Capital, the U.S. Global
Leadership Collation, the Republican State Leadership Committee, Take Stock in Children and Jobs for
America’s Graduates. Will also served as a Rodel Fellow at the Aspen Institute.
Will spent six years as a board director at Florida Traditions Bank prior to its sale to Home BancShares in
July 2014. Will is the Founder of Red Eagle Group, a boutique investment and business consulting firm.
Will Weatherford attended Jacksonville University, where he received a degree in business in 2002.
After graduation, Weatherford worked in commercial real estate but was recruited by Allan Bense, his
father-in-law and the Speaker of the Florida House of Representatives, to join state government.
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APPENDIX D: FLORIDA CONSTITUTION, ARTICLE III
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CONSTITUTION
OF THE
STATE OF FLORIDA

ARTICLE III
LEGISLATURE
SECTION 1. Composition.—The legislative power of the state shall be vested in a legislature of the State of
Florida, consisting of a senate composed of one senator elected from each senatorial district and a house of
representatives composed of one member elected from each representative district.
SECTION 2. Members; officers.—Each house shall be the sole judge of the qualifications, elections, and
returns of its members, and shall biennially choose its officers, including a permanent presiding officer selected
from its membership, who shall be designated in the senate as President of the Senate, and in the house as
Speaker of the House of Representatives. The senate shall designate a Secretary to serve at its pleasure, and the
house of representatives shall designate a Clerk to serve at its pleasure. The legislature shall appoint an auditor to
serve at its pleasure who shall audit public records and perform related duties as prescribed by law or concurrent
resolution.
SECTION 3. Sessions of the legislature.—
(a) ORGANIZATION SESSIONS. On the fourteenth day following each general election the legislature shall
convene for the exclusive purpose of organization and selection of officers.
(b) REGULAR SESSIONS. A regular session of the legislature shall convene on the first Tuesday after the first
Monday in March of each odd-numbered year, and on the first Tuesday after the first Monday in March, or such
other date as may be fixed by law, of each even-numbered year.
(c) SPECIAL SESSIONS.
(1) The governor, by proclamation stating the purpose, may convene the legislature in special session during
which only such legislative business may be transacted as is within the purview of the proclamation, or of a
communication from the governor, or is introduced by consent of two-thirds of the membership of each house.
(2) A special session of the legislature may be convened as provided by law.
(d) LENGTH OF SESSIONS. A regular session of the legislature shall not exceed sixty consecutive days, and a
special session shall not exceed twenty consecutive days, unless extended beyond such limit by a three-fifths vote
of each house. During such an extension no new business may be taken up in either house without the consent of
two-thirds of its membership.
(e) ADJOURNMENT. Neither house shall adjourn for more than seventy-two consecutive hours except
pursuant to concurrent resolution.
(f) ADJOURNMENT BY GOVERNOR. If, during any regular or special session, the two houses cannot agree
upon a time for adjournment, the governor may adjourn the session sine die or to any date within the period
authorized for such session; provided that, at least twenty-four hours before adjourning the session, and while
neither house is in recess, each house shall be given formal written notice of the governor’s intention to do so, and
agreement reached within that period by both houses on a time for adjournment shall prevail.
History.—Am. C.S. for S.J.R. 380, 1989; adopted 1990; Am. S.J.R. 2606, 1994; adopted 1994; Am. proposed by
Constitution Revision Commission, Revision No. 13, 1998, filed with the Secretary of State May 5, 1998; adopted
1998.
Source: The Florida Legislature, The Florida Constitution. Retrieved on October 27, 2018 from:
http://www.leg.state.fl.us/statutes/index.cfm?submenu=3#A3S01
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Summary Table of Themes – 1990 Legislation
Source

Quote(s)

Context/topic

Nick Porter

It’s a freestanding cancer center, meaning it’s not part of an academic institution.

Evolution of Moffitt

The Moffitt Cancer Center, almost from the beginning, began to understand that in order to completely devote it’s time,
effort and resources towards the mission of the cancer center, to contribute to the prevention and cure of cancer, it could
not stay with strong links to the University of South Florida.

Discussion of board makeup and relationship with
USF

At the time it was, I think, written into the bylaws that the chair of the Moffitt Board of Directors had to be the president of
the university. That was later changed.

Evolution of Moffitt

Sen. Connie
Mack

…somewhere along the line, someone told Lee how important it was for the institution to be independent, free-standing,
which allowed for decisions to be made and actions taken in a very short period of time. Very little bureaucracy.

Question regarding MCC’s
reputation

Dr. Bill Dalton

I think creating an instrumentality of the state, which creates an incredible ability and opportunity to work with anybody and
still be independent is phenomenal and it’s key.

How Moffitt achieved its
position

Ed Droste

Because it’s cancer only. Because it’s not necessarily under the governance of another educational institution...

Decisions

Dr. Alan List

There’s certain milestones, I would say, or paradigm shifts that I think are very important.

Decisions

We are an instrumentality of the state with a mission for the state.

Post interview addition

Dr. Jack Pledger

…the biggest one was the development of the cancer center and then…becoming completely independent from USF.

Decisions

Ted Couch

…the structure of Moffitt…the existence of Moffitt statutorily, the support that Moffitt gets from the state, the fact that we
are independent of the medical school or a university system gives us some advantage…in being nimble in our decisions.

How Moffitt achieved its
position

Dr. Jim Mule’

I think local and state governments play a crucial role in Moffitt’s success…

Role of Moffitt

We’ve got to be entrepreneurial and we’ve got to set up a system which takes advantage of the research and clinical
efforts…not only on paper but certainly in Tallahassee and elsewhere…

Recalling a conversation,
quoting Moffitt. Decisions.

One of the things he learned from MD Anderson was to associate with a university but don’t be married into a single
institution. MD Anderson will always be part of the University of Texas system. We don’t have that restriction and I know
there was a time in our history where that was helpful in giving us more flexibility to achieve our mission. I think that was the
most important one.

Decisions

Dr. Tom Sellers
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